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Background 
Bone is a dynamic and highly vascularized tissue, which is continuously being remo-
deled throughout an individual’s lifetime. As a part of the skeletal system, it is 
responsible for mechanical support for the soft tissues and muscles, body shape and 
movement, and provides protection for the internal organs of the body. In addition, 
bone is closely associated with mineral and blood homeostasis through its storage 
of mineral components and with blood production by regulating the bone marrow 
microenvironment. When normal bone damage occurs after traumatic injuries, its 
high regenerative capacity ensures the majority of defects to heal spontaneously with 
or without minor (surgical) intervention. However, large bone defects resulting from 
trauma, tumor resection, infection or nonunion represent a significant clinical problem 
for over 1 million people in Europe each year [1, 2]. This incidence is expected to grow 
given increasing life expectancy and larger numbers of patients with compromised 
medical conditions and inferior bone healing capacity in aging individuals.
Current approaches in bone regeneration
Autografts, which are often harvested from the iliac crest, are currently used as the 
“gold standard” option for clinical treatment of bone defects. However, complications 
including infection, bleeding, and additional chronic pain at the harvest site exist after 
harvesting autografts. More crucially, the supply of autografts within the human body 
is limited. Allografts, which are acquired from cadaveric bone and xenografts from non-
human species, can solve the problem of supply, but are restricted by immunological and 
disease transmission issues and lack osteoinductive potential [3, 4]. As an alternative 
to tissue-based bone grafts, synthetic biomaterial developments over the last decades 
have resulted in many bone substitute materials available for clinical applications. 
However, their biological performance remains to be inferior to autografts [5]. Toward 
improving the biological performance of bone substitute materials, the use of cell-
based constructs, in which autologous cells are combined with a (synthetic) biomaterial 
scaffolds [6], are being explored.
Most cell-based constructs focus on the use of (adult) stem cells, generally isolated as 
so-called mesenchymal stromal cells (MSCs) from either bone marrow or adipose tissue 
because of their biological characteristics [6]. This idea appears to be promising since 
it allows MSCs to directly generate new bone tissue and contribute to improving bone 
healing [7, 8]. However, this approach is restricted by its time-consuming and costly in 
vitro expansion procedure. Furthermore, signaling molecules and cells involved in the 
processes initiated prior to bone healing are largely ignored in MSCs-based approaches, 
which frequently has resulted in unsatisfactory performance due to donor variation, 
limited vascularization, and uncontrolled inflammation. From this perspective, the 
optimal strategy for cell-based bone regenerative approaches should be practical in 
the clinic and follow the natural chronological order of bone healing.
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Involvement of the innate immune system in bone regeneration
In view of the natural bone healing process, three distinct but overlapping stages occur 
from a few hours to several weeks [9]: (1) the early inflammatory stage; (2) the repair 
stage; and (3) the late remodeling stage. It is tenable to speculate that the inflammatory 
response, which is evoked by the host immune system, initiates and primes the later 
bone repair process. In fact, the immune and skeletal systems have been reported to 
share a number of signaling molecules and regulatory networks [10]. Research on the 
topic of bone remodeling has shown the influence of the immune system on bone healing 
success and has led to the emergence of “osteoimmunology” [10], which identifies the 
immune system as a potential tool for new therapeutic approaches to bone healing. 
The innate immune system in particular is rapidly activated within a few hours after 
bone injury, with platelets, neutrophils, and monocytes being the first components 
present at injured sites. They release a wide variety of inflammatory cytokines, growth 
factors, and chemokines to further promote leukocyte recruitment, modulate the 
immune response and activate MSCs [9]. During this procedure, monocytes, and the 
descendant macrophages, multinuclear giant cells (MNGCs), and osteoclasts, are 
recognized as key elements for the orchestration of the bone healing processes [11-13] 
(Figure 1).
1. Monocytes
Monocytes are the largest type of leukocytes circulating in the blood, bone marrow, 
and spleen and are the precursor of many other immune cells, such as macrophages 
and dendritic cells. After bone injury, monocytes are recruited to the injury site to clear 
cell debris and to destroy any pathogen or foreign body by secreting molecules such as 
reactive oxygen species (ROS) [14]. Monocytes also secrete cytokines and chemokines, 
which can recruit additional immune cells to the injured sites and stimulate endothelial 
progenitor cells, fibroblasts, and MSCs to orchestrate the bone repair response [13]. 
Monocytes per se secrete several osteogenic cytokines and growth factors, such as 
bone morphogenetic protein 2 (BMP-2) [15], tumor necrosis factor-α (TNFα) [16], and 
oncostatin (OSM) [17], to promote the osteogenic differentiation of bone forming 
cells (e.g. MSCs and osteoblastic progenitors) present at the injury sites. Furthermore, 
monocytes are well-known to regulate bone turnover by controlling the differentiation 
and activity of osteoclasts (i.e. the bone resorbing cells). This information suggests that 
monocytes are key players in bone homeostasis, acting both in osteoblast mineralization 
through cytokine secretion and in bone resorption by regulating osteoclast activity.
2. Macrophages
Macrophages are heterogeneous myeloid lineage cells, the majority of which differen-
tiate from bone marrow-derived monocytes circulating in the blood. Two types of 
macrophages were identified to be involved in bone remodeling and regeneration 
according to their positions: OsteoMacs and inflammatory macrophages [18]. Osteo-
Macs were present in resting osteal tissues and increased at sites undergoing active 
PSM 20180528 Proefschrift Yang Zhang BW.indd   13 13-06-18   17:55
Chapter 1
14
bone anabolism. In contrast, inflammatory macrophages are derived from a distinct 
population of blood monocytes that rapidly infiltrate tissues after bone damage. 
Depending on the micro-environment, macrophages also display distinct polarization 
states and give rise to two populations with distinct receptor expression, cytokine 
secretion, and functions: the “classically activated” pro-inflammatory M1 type 
macrophages and the “alternatively activated” anti-inflammatory M2 type macrophages 
[19]. M1 macrophages exert pro-inflammatory activities to lead to immune stimulation; 
in contrast, M2 macrophages are involved in debris scavenging, inflammation 
resolution, and tissue remodeling. After bone damage, inflammatory macrophages and 
OsteoMacs coexist within the injury site and start a cascade of events that facilitate 
the recruitment of MSCs and initiate bone healing [20]. Recent studies depicted a 
Figure 1. Schematic representation of the involvement of monocytes, macrophages and osteoclasts in 
bone regeneration. Monocytes extravasate from peripheral blood vessels and migrate to bone damage 
sites, where they differentiate into macrophages. These macrophages are further polarized into different 
phenotypes i.e. pro-inflammatory M1 macrophages or anti-inflammatory M2 macrophages to modulate 
the bone healing process. Macrophages can also fuse into multinucleated giant cells (MNGCs) in a certain 
microenvironment. Furthermore, both monocytes and macrophages can develop into mature osteoclasts, 
which resorb the damaged bone and secrete several stimulatory signals (e.g. matrix-derived TGF-β and 
IGF-1, secreted collagen triple helix repeat containing 1 (CT-1), and sphingosine 1-phosphate (S1P)) to 
stimulate new bone formation. It needs to be emphasized that cell-cell interactions also exist between 
different cell types and that osteoblastic cells also reversely regulate the behavior of immune cells.
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switch in macrophage subtype from the M1 subtype to the M2 subtype during the 
bone healing process [21], suggesting differential roles of these macrophage subtypes 
and their secreted cytokines on the behavior of MSCs. However, how different types of 
macrophages contribute to the osteogenic differentiation of MSCs and which factors 
affect macrophage subtypes remains to be investigated, which represent an important 
step to develop new bone regenerative strategies.
3. Osteoclasts
Osteoclasts, which are the only cells capable of resorbing bone, are multinucleated 
giant cells formed from hematopoietic precursors of monocytes and macrophages. 
After bone damage, osteoclasts attach to the bone surface, seal and acidify a resorbing 
compartment by secreting H+ ions, facilitate dissolution of the bone mineral and thereby 
expose the organic matrix to proteolytic enzymes to degrade it [22]. The resorption of 
bone matrix releases several osteogenic factors, such as BMP-2, Transforming growth 
factor β (TGF-β), platelet-derived growth factor-BB (PDGF-BB) or epitopes, and some 
ions such as Ca2+, which can promote migration and osteogenic differentiation of 
MSCs [22, 23]. However, recently emerging data suggest that osteoclasts affect bone 
formation by secreting bone anabolic signals independent of their bone resorption 
activity [24, 25]. With the findings of different types of osteoclasts in physiological 
and pathological conditions [26], osteoclasts seem to carry out more crucial functions 
to affect bone formation and bone quality than previously thought. This information, 
however, is largely ignored in the previous bone graft design and gained much attention 
in recent studies on the mechanism of bone formation [27, 28].
Objective of this thesis
Overall, during bone regeneration, innate immune cells not only directly differentiate 
into bone-resorbing cells to get involved in bone remodeling, but also affect the 
osteoblastic cell recruitment, migration and osteogenic differentiation to establish 
bone formation. This information encourages researchers to consider immune cell 
implementation for bone regeneration. On the one hand, immune cells are plastic 
and sensitive to the local environment, which provides the potential to modulate the 
microenvironment, such as changing material properties, adding particular cells or 
cytokines to manipulate the immune system in a favorable manner for enhanced bone 
repair and regeneration [29]. On the other hand, due to the easy isolation procedure 
and high yield of immune cells, particularly monocytes compared to MSCs, immune 
cells have great practical potential to be utilized in cell-based approaches given reduced 
cost and (absence or short) time of in vitro expansion procedures.
In view of this, the overall aim of this thesis was to contribute to a better understanding 
and application of using immune cells to aid in bone regeneration. More specifically, 
this thesis aimed to 1) investigate the role of different macrophage subtypes on 
osteogenic differentiation of osteoblast progenitors, 2) exploit the potential to promote 
osteogenic differentiation and bone formation by co-culturing and co-seeding MSCs 
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with monocytes/macrophages, 3) modulate the macrophage phenotype by material 
properties, 4) elucidate the function of osteoclasts in bone formation, and 4) utilize 
material properties to affect osteoclast formation and characteristics for functional 
steering of osteogenic differentiation.
As a scientific approach for these (sub)aims, we addressed the following research 
questions:
1. What is the state of and problem with current cell-based bone regenerative 
approaches and how can immune cells and other easily accessible cells be 
utilized for bone regeneration in an intraoperative manner? (Chapter 2)
2. To what extent do different macrophage subtypes modulate osteogenic 
differen tiation of adipose tissue MSCs (Chapter 3)?
3. Does co-seeding stromal vascular fraction or adipose MSCs with monocytes/
macro phages enhance bone regeneration compared to conventional MSC-
based approaches in orthotopic bone defects (Chapter 4)?
4. Do material surface properties differentially activate platelets and affect 
macrophage behavior (Chapter 5)?
5. Does material roughness modulate macrophage activation and polarization? 
(Chapter 6)
6. As the derivative of monocytes/macrophages, what is the role of osteoclasts in 
ectopic bone formation? (Chapter 7)
7. Does material roughness affect osteoclast formation and characteristics, 
and hence have an effect on coupling osteoclastic with osteoblastic activity 
(Chapter 8)?
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Intraoperative construct preparation: 
a practical route for cell-based 
bone tissue engineering
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Introduction
Large bone defects and fractures are still clinical problems that require surgical 
intervention, especially in a condition where the regenerative process is compromised 
[1]. Although autografts are currently considered as the gold standard for such treatment, 
their application is restricted by the limited supply and associated complications [2]. 
Besides, allografts from cadaveric bone and xenografts from non-human species, are 
considered as the other alternative for reconstructing bone defects but are restricted 
by immunological rejection and disease transmission issues [3, 4]. Attempts to find 
superior substitutes for bone graft have resulted in the emergence of bone constructs 
based on tissue engineering principles. The term Bone Tissue Engineering is defined 
to develop biologic bone graft substitutes with a synthetic scaffold, osteogenic cells or 
growth factors to repair damaged bone or regenerate new bone [5]. In particular, cell-
based bone tissue engineering has gained much attention due to the vast investigation 
on stem cells and controlled bone regeneration over grows factor based strategy.  
The classical procedure of cell-based bone tissue engineering consists of isolating MSCs 
from a patient, which, after expansion and differentiation in culture, are seeded onto a 
suitable scaffold before implantation back into the same patient [6] (Figure 1a). MSCs 
from different sources, such as bone marrow, adipose tissue, peripheral blood, and 
dental pulp, have been explored extensively and have demonstrated favorable bone 
regenerative capacity in many animal studies (reviewed by Ma et al.) [7]. Furthermore, 
several clinical trials with cell-based constructs for bone regeneration have been 
conducted and also showed feasibility and efficacy regarding bone formation (reviewed 
by Grayson et al.) [8]. Despite great advances, several limitations of bone tissue 
engineering have been brought forward. Firstly, the routine bone tissue engineering 
needs expansion and osteogenic priming of the isolated cells in vitro to obtain sufficient 
cell numbers and to foster the osteogenic potential of seeded cells. This procedure, 
which takes several days to weeks, is time-consuming and costly (Figure 1a). In this 
perspective, the clinical application of tissue-engineered bone constructs is not a cost-
effective alternative for auto-/allo-/xenografts. Secondly, the ex vivo cell manipulation 
increases the risk of pathogenic contamination and immune rejection related to the 
use of animal serum and the risk of genetic alterations during cell passages. Lastly, two 
invasive procedures, one to harvest autologous cells and the other to implant constructs, 
is not patient-friendly and convenient. These problems hinder the practical application 
of bone tissue engineering and delay their approval by regulatory authorities for clinical 
applications. This has encouraged researchers to consider the possibility to prepare 
tissue-engineered bone constructs during the time of surgery without cumbersome in 
vitro manipulation, which is defined as intraoperative preparation of tissue-engineered 
bone constructs.
The intraoperative preparation of tissue-engineered bone constructs implicates 
that the manufacturing process, including harvest of autologous cells, generation of 
constructs, and finally implantation, can be combined with the surgical procedure to 
treat bone defects (Figure 1b). This method entails several benefits compared to the 
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conventional bone tissue engineering strategies: 1) without in vitro cell manipulation 
and expansion procedure, surgery can be performed within several hours, which would 
dramatically reduce the cost and labor and is more patient-friendly; 2) without using 
exogenous components such as animal serum for several passages expansion, the 
risk of gene mutation and pathogenic contamination likely become negligible; 3) due 
to the manipulation and surgery performed entirely within one operating room and 
the minimal manipulation of cells or tissues, this approach would ease the route to 
regulatory approval.
In the following sections, we will review current approaches to intraoperatively prepare 
tissue-engineered constructs, with which cells can be harvested, minimally manipulated, 
and implanted to bone defect areas during the surgery. Based on the reviewed articles, 
we here discuss the cells that are intraoperatively available to prepare such constructs 
and provide an overview of the available data of preclinical and clinical studies using 
intraoperatively prepared tissue-engineered bone constructs. Furthermore, the 
therapeutic efficiency and future perspectives and technologies to develop such 
intraoperatively prepared tissue-engineered bone constructs are discussed. 
Available cell sources
Osteogenic cells are the most essential component to intraoperatively prepare tissue-
engineered bone constructs, which endow grafts with high osteogenic activity. Although 
cells with osteogenic potential are present in many tissues, to meet the requirements 
for intraoperative preparation, only few tissues have been explored, namely, bone 
marrow, adipose tissue, and peripheral blood. The advantages and disadvantages of 
utilization of these tissues for cell isolation are displayed in Table 1.
1. Bone marrow
Bone marrow (BM) is to date the most common tissue source applied both 
experimentally and clinically for preparing intraoperative tissue-engineered bone 
constructs, which mainly relates to its high osteogenic capacity and relatively easy 
access. The firstly developed strategy was the direct use of bone marrow aspiration 
concentrate cells (BMACs) [9, 10], which are a mixture of erythrocytes, granulocytes, 
hematopoietic cells (HCs), endothelial progenitor cells (EPCs), MSCs, lymphocytes and 
immature monocytes amongst others. This approach can be performed in a short time 
and at relatively low cost, and few studies reported positive effects of using these 
cells for bone regeneration [11-13]. However, the majority of studies involving BMACs 
demonstrated a lack of stimulatory effects on bone regeneration [9, 14, 15], which can 
likely be attributed to the relatively low numbers of osteogenic cells and a high number 
of non-effective cells.
After aspiration of bone marrow and elimination of erythrocytes and granulocytes, 
a heterogeneous cell population, i.e. bone marrow-derived mononuclear cells 
(BMNCs), can be achieved. This fraction includes a higher number of HCs (around 
4%), MSCs (around 0.1%), and EPCs (around 5%), from which MSCs play a major 
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role in bone healing [16-18]. Multiple animal studies have demonstrated beneficial 
effects of BMNCs on bone healing [14, 19-21]. A large-scale clinical report also 
demonstrated the safety and efficacy of BMNCs for intraoperatively prepared 
tissue-engineered bone constructs [22]. However, due to the limited volume of 
bone marrow in one patient (maximal ~300 ml) and the relatively low yield of 
MSCs in bone marrow (maximum 100 colony-forming unit fibroblasts (CFU-f)/ 
million MNCs in young people), only 1500-3000 MSCs/ml in healthy human bone 
marrow can be obtained [23] cannot provide the desired or required numbers of MSCs, 
especially in elderly or otherwise compromised (e.g. osteoporotic) patients. 
2. Adipose tissue
In contrast to the limited supply of bone marrow, adipose tissue is largely available and 
has recently attracted much attention as a promising alternative source for osteogenic 
cells. Fat tissue can be collected through a less invasive method with minimal morbidity 
upon harvest and in larger quantities of effective stem cells than bone marrow. The 
numbers of MSCs in adipose tissue (i.e. 1-3×104 CFU-f/million MNC) is 100 to 300 times 
higher compared to bone marrow [24], and the number of stem cells that can be 
isolated per unit volume of lipoaspirate is approximately 10-fold greater than that from 
bone marrow (i.e. 3×104 MSCs/ml of lipoaspirate). Consequently, small adipose tissue 
reservoirs can already provide sufficient numbers of MSCs for clinical applications. 
Figure 1. The schematic representation of (a) conventional bone tissue engineering and (b) intraoperative 
concept based bone tissue engineering. In the conventional bone tissue engineering, cells are isolated 
from a biopsy, expanded in monolayer culture, seeded onto a 3D scaffold and cultured in vitro for a certain 
period. The engineered graft is finally implanted into the patient. This procedure generally takes from 
one to three weeks. In contrast, the intraoperative concept-based tissue-engineered bone constructs 
circumvents the monoculture and expansion procedure by isolating cells from harvested tissue and then 
preparing a construct during the same surgery. The whole procedure can be finalized in several hours. 
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Additionally, perivascular stem cells (PSCs), another stem cell type that is abundant 
in fat tissue [25], have been demonstrated to have a mesenchymal potential equal or 
even superior to conventional MSCs in some cases [26, 27]. James et al. demonstrated 
the efficacy of using PSCs for the intraoperative preparation of tissue-engineered bone 
constructs.
Stromal vascular fraction (SVF), the freshly isolated fraction from the lipoaspirate or fat 
patch, is a mixture of several cell types, including MSCs, EPCs, pericytes, and monocytes 
[28]. Since the isolation of SVF can be achieved within a few hours, it is suitable for 
a one-step surgical procedure to prepare tissue-engineered bone constructs. One 
additional important advantage of SVF is the presence of endothelial lineage cells 
among the heterogeneous cell mixture. These cells, which are typically lost during 
prolonged monolayer cultures, but preserved upon direct construct preparation, have 
shown to contribute to the formation of blood vessels in recipient sites, which is critical 
for the survival and function of cells in implanted tissue-engineered bone constructs 
[29]. Nevertheless, few studies have postulated concerns that the osteogenic capacity 
of SVF is significantly lower than that of MSCs isolated from bone marrow [30, 31].
3. Peripheral blood
As blood is more easily accessible than bone marrow and adipose tissue, the advantages 
of using peripheral blood as a source of MSCs is emerging. Mononuclear cells (MNCs) 
from PB contain both hematopoietic stem cells (HSCs) and EPCs [32]. The osteogenic 
potential of PB-derived MSCs (PBMSCs) has been suggested by accumulating evidence 
from both in vitro and in vivo experiments [33, 34]. However, only small numbers of 
stem cells exist in PB (less than 20 CFU-f/million MNCs) compared to numbers in BM 
[35], which is a major obstacle for an intraoperative approach using cells derived from 
PB. Several steps have been taken to enrich stem cells in PB, such as mobilizing them 
from BM with granulocyte colony-stimulating factor (G-CSF) [36, 37], chemotherapeutic 
agents [38], or using CD133 selection [39]. This can concentrate PBMSCs over 20 times 
(to reach levels comparable to those in fresh bone marrow). However, this CFU-f value 
is still far from the effective implantation threshold (≥ 1000 cells/cm3 for BMSCs) [40]. 
Therefore, the application of PBMSCs for intraoperatively prepared tissue-engineered 
bone constructs has not been reported to date. Other cell types, e.g. CD31+ EPCs 
[41] and CD34+ endothelial/hematopoietic progenitor cells [42], are present in large 
quantities in PB, independent of the individual’s age and gender. When applied to rat 
femoral bone fractures, advanced bone tissue restoration was observed [41, 42]. Given 
its availability (between 70-80%) and general leukocyte enrichment efficiency (4×106 
cells/ml), 5 ml of peripheral blood would provide 1×107 CD31+ cells, which is sufficient 
to prepare tissue-engineered bone constructs without expansion cultures.
Cell isolation approaches
Isolation or concentration of desired cells is needed to prepare tissue-engineered bone 
constructs. This step can select a certain cell mixture or even a specific type of cells 
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and remove detrimental cells. For bone marrow-derived cells, density separation (DS) 
and selective retention (SR) are mostly adapted methods for isolating desired cells. DS 
involves the use of a centrifuge to concentrate nucleated cells and connective tissue 
progenitors while SR involves adsorbing connective tissue progenitor cells through 
a porous substrate. Recently, a method based on red cell lysis to isolate BMNCs was 
established to concentrate BMNCs over 50 times [11]. This method is more efficient, 
faster and more easily standardized compared to DS and SR, showing promise in clinical 
applications for preparing bone marrow-derived intraoperative bone constructs.
To obtain SVF for intraoperative preparation of tissue-engineered bone constructs, 
adipose tissue is generally harvested via minimally invasive techniques, and processed 
by enzymatic digestion and centrifugal enrichment. This can be achieved with a single 
surgical procedure lasting less than 2 hours. To meet the requirement from regulatory 
authorities for ‘less than minimally manipulated’ cells, a non-enzymatic method was 
recently developed to obtain highly enriched adipose tissue-derived elements by mild 
mechanical forces [43], showing another option to intraoperatively obtain desired cells 
from lipoaspirate. To further select a subpopulation from SVF, such as CD31+ or CD34+ 
cells, cell sorting by flow cytometry is mostly used based on the surface markers of 
desired cells. Due to the special format of PB, the isolation of blood-derived cells is 
generally easily performed by a concentration of the buffy coat with a sedimentation 
agent such as hydroxyethyl starch, and sorting by flow cytometry afterwards. 
Preclinical studies with intraoperative tissue-engineered bone constructs
Following the above-mentioned screening procedure, 33 preclinical studies meeting 
the criteria were identified (Table 2): 7 animal studies using ectopic implantation 
models and 27 animal studies using an orthotopic model. Among these preclinical 
studies, 12 studies used bone marrow-derived cells, 19 studies used adipose tissue-
derived cells and 4 studies used peripheral blood-derived cells to generate bone with 
an intraoperative preparation concept. 1 study utilized cells from different sources (i.e. 
adipose tissue and bone marrow) to evaluate their bone healing capacity.
To prepare tissue-engineered bone constructs, normal tissue aspiration combined with 
either SR, a centrifugation step, or cell sorting (e.g. flow cytometry (FACS) or magnetic 
sorting) is the common approach to get “easily available cells”. To support these intra-
operatively isolated cells, different cell carriers were utilized, including allografts, 
xenografts, collagen, synthetic bioceramics, and polymers. Additionally, platelet-rich 
plasma (PRP), which can be intraoperatively obtained as well, was used as a ‘glue’ to 
entrap cells or as an inducer in 8 studies. The effect of PRP addition on bone formation, 
however, was investigated in none of these studies.
Regarding the mode of action of these intraoperatively prepared tissue-engineered bone 
constructs, there are a few possibilities. Bone regeneration could be established through 
direct differentiation of intraoperatively grafted cells [44, 45]. Also, one study indicated 
that potential paracrine effects, including modulatory effects on vascularization, 
osteogenesis and inflammatory responses of host tissue, play a more important 
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role than the intrinsic cell differentiation potential [46]. It is also possible that both 
mechanisms act simultaneously based on the type of cells and the conditions in which 
cells are grafted. For instance, when PB-derived CD34+ cell-based bone constructs were 
applied to femoral fractures, direct vasculogenesis and osteogenesis by transplanted 
PB-derived CD34+ cells were detected. Moreover, grafted cells significantly enhanced 
the intrinsic angiogenesis and osteogenesis of the recipient cells by upregulating VEGF, 
Angiopoietin-1 (Ang-1), and bone morphogenetic protein-2 (BMP-2) gene expression at 
the fracture sites [44, 45]. Therefore, it seems likely that these “easily available cells” 
act using both direct and indirect mechanisms to aid in bone healing by promoting 
neovascularization and osteogenesis.
Clinical studies with intraoperativel tissue-engineered bone constructs
Among the 29 clinical studies (Table 3), 21 publications dealt with cells obtained from 
bone marrow, 7 from adipose tissue, and 1 from peripheral blood. Bone marrow-derived 
cells, especially enriched BMNCs, dominated the clinical trials involving intraoperative 
preparation of tissue-engineered bone constructs. This is different from what was 
reviewed for preclinical studies, where adipose tissue was the main source for usage. 
This discrepancy probably results from differences in the moment of discovery of the 
presence of adult stem cells in these tissues and the concomitant amount of (in vitro 
and preclinical) evidence regarding the bone regenerative potential of isolated cells 
from these tissues.
One interesting observation from all clinical studies is that researchers used medical 
devices to intraoperatively isolate cells in half of the retrieved clinical studies. This would 
assumedly improve the reproducibility of intraoperatively prepared tissue-engineered 
bone constructs. Moreover, these isolation devices are closed systems and can be used 
in the operating room without cell laboratory support, which makes intraoperative 
preparation more feasible and applicable. To isolate bone marrow-derived cells, DS 
is more frequently used than SR. Although these two methods have been compared 
in preclinical studies, their effect on bone formation has not been reported in any 
clinical study. For adipose tissue-derived cell isolates, tissue aspiration combined with 
a collagenase digestion step was generally used to isolate SVF. Only one study utilized a 
filtration device to obtain ADMSCs without enzymatic collagenase treatment [47]. With 
regard to cell carriers, auto-/allo-/xenografts (11 of 29 studies) were more frequently 
used in clinical compared to preclinical studies. Further, bioceramics and collagen are 
the second most commonly used cell carriers in the retrieved clinical studies. When 
these two cell carriers were compared in the same condition, the postoperative 
bone formation appeared 7 weeks earlier and bone healing was 5 weeks faster for 
bioceramics versus collagen [48]. Cells without a carrier, but with native fibrin were 
applied in 5 studies [49-53]; however, its efficacy was not compared to constructs with 
a certain cell carrier. Notably, PRP, which acts as a cell carrier as well as a cytokine 
reservoir, was widely used in these clinical studies.
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Efficiency of intraoperative approach
The literature search results show that using ‘easy access cells’ to intraoperatively 
prepare tissue-engineered bone constructs has been explored in numbers of pre- 
and clinical studies so far. These studies used different cells, isolation procedures and 
seeding strategies, which led to dissimilar therapeutic effects. It is valuable to compare 
these studies and draw some conclusions to aid the future design of intraoperatively 
prepared tissue-engineered bone constructs.
1. Does the intraoperative approach improve bone healing compared to acellular 
controls?
From 28 animal studies using an orthotopic model, 24 studies compared intraoperative 
tissue-engineered bone constructs to cell-free constructs. Amongst these, 12 studies 
used intraoperatively available sorted cells. Irrespective of the source (e.g. from bone 
marrow (BMNCs), adipose tissue (PSCs) or peripheral blood (PB-derived EPCs and ECs)), 
these cells enhanced bone formation compared to cell-free constructs [10, 11, 14, 
15, 22, 25, 42, 44, 54-57]. In contrast, unsorted cells (e.g. BMACs, SVF, and PBMNCs) 
appeared inconclusive regarding their regenerative capacity. 14 studies demonstrated 
a promotive effect on bone healing [9, 11, 14, 15, 45, 56-64], while 4 studies showed 
comparable bone healing compared to cell-free constructs [15, 54, 65, 66]. This 
discrepancy may be associated with the cell density used to make these constructs. A 
high density of desired cells (106/cm3 and 105/cm3) seeded on the scaffold generally led 
to the bone formation, while a low density (104/cm3) did not [44, 45]. Still, the optimal 
number of seeded cells required in a graft site remains unknown. 
Due to the difficulty to set up a control group in clinical cases, comparison of these 
intraoperatively prepared tissue-engineered bone constructs with cell-free constructs 
is not practical. Only 3 studies reported the comparison between SVF- and BMNCs-
based with cell-free constructs in a clinical setting and demonstrated superior bone 
healing for SVF- and BMNCs-based constructs [44, 67, 68]. 2 studies used autografts as 
controls and demonstrated comparable bone formation of constructs prepared with 
bone marrow-derived cells [21, 69]. Cell density similarly appears to play an important 
role in the clinical outcome as in animal studies, as indicated by the superior bone hea-
ling outcome for constructs with higher numbers of progenitor cells (6000 CFU-f/cm3) 
[49, 50]. 
2. Do the intraoperatively prepared bone constructs performance superior to con-
ventional bone tissue engineering approach?
The aim of the intraoperative construct preparation is to overcome limitations of 
conventional cell-based bone tissue engineering for bone regeneration. However, 
how efficient of intraoperative approach compared to conventional approach is rarely 
reported. In all searched publications, only 4 studies compared therapeutic effects of 
intraoperatively prepared constructs to conventional tissue-engineered constructs 
(Table 4). All studies showed an inferior capacity of intraoperatively prepared constructs 
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in promoting bone healing [9, 58, 65, 66], which indicates the necessity to improve the 
osteogenic potential of seeding cells. Besides, limitations of this comparison exist as 
none of these studies used human-derived cells and donor-matched comparison. 
3. Is sorted cell-based approach superior to unsorted cell-based approach?
In the retrieved publications, both sorted and unsorted cell populations for intraoperative 
preparation of tissue-engineered bone constructs were used. The use of sorted 
homogeneous cells, such as ADMSCs and PSCs, facilitates improved standardization 
and greater control on the outcome of bone healing. The disadvantages include 
longer processing times and a requirement of extra instruments. In contrast, unsorted 
heterogeneous populations, such as BMNCs, SVF, and PBMNCs, contain multiple cell 
types (e.g. MSCs, ECs, pericytes, and monocytes) and may enable accelerated bone 
regeneration through heterotypic interactions among endogenous cell populations. 
The drawback of this method is the uncertain composition of the heterogeneous cell 
isolate. 7 studies compared the therapeutic efficiency of sorted and unsorted cell-
based intraoperative approach, enriching cell isolates showed superior bone healing 
capacity in 6 studies compared to constructs prepared using unsorted cells [20, 25, 41, 
42, 56, 70], except for one study that demonstrated similar bone healing results [12]. 
This information further suggests the importance to enrich desired cells during the 
intraoperative preparation of tissue-engineered bone constructs. 
4. Which tissue-derived cells have superior bone healing effects for intraoperatively 
prepared tissue-engineered bone constructs?
Respecting the bone formation capacity of cells from different tissues, only one study 
compared effects of SVF (adipose tissue) with BMAC (bone marrow), which showed the 
superiority of BMAC over SVF regarding bone formation [54]. More comprehensive, 
donor-matched comparison is desired to draw a clear conclusion. 
Future perspectives
Both preclinical and clinical results showed a large potential of intraoperatively 
prepared tissue-engineered bone constructs for repairing damaged bone. However, 
further improve ments in their therapeutic efficacy are suggested, which can likely be 
achieved by taking into consideration the following issues:
1. Enrichment of desired cells
Previous studies revealed a positive correlation between bone regeneration and the 
number of osteoprogenitors in BMNC-based constructs [11, 50]. Except for the reported 
DS and SR methods to isolate BMNCs, cell sorting methods based on cell surface 
markers of specific cell types have been developed to select the target, and remove 
unwanted cell populations. For instance, a highly homogenous CD34+ cell population 
can be concentrated from peripheral blood by immunoselection in short time by flow 
cytometry [38]. This was also applied to select CD34+ MSCs from adipose tissue, which 
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exhibited 5 times more bone formation after 8 weeks compared to unsorted SVF 
cells [71]. With the same principle, magnetically activated cell sorting has been used 
to isolate bone marrow-derived connective tissue progenitors on the basis of their 
hyaluronan antigens [20]. Based on this idea, an easier, inexpensive, and more feasible 
method was invented to use DNA aptamers, which are single-stranded DNA or RNA 
with high specificity and affinity to membrane proteins of target cells [72]. Notably, 
these aptamers can be customized by labeling them with functional groups and retain 
their activities after binding on cell carriers and after implantation [73]. So far, this 
method has only been conducted to isolate bone marrow cells. It seems worthwhile 
to assess effects of cells isolated by this strategy on bone healing and its application 
on adipose or other tissue in the future. Of note, all these immunoselection-based cell 
sorting methods are premised on the basis of a well-defined marker panel of desired 
cells.
2. Co-culture methods
Except for the interaction between unfractionated cells, whose mechanism and benefits 
on bone formation has not been well illustrated and proved, the reported cell-cell 
interactions between purified cells can be utilized to potentially improve bone healing. 
More importantly, this strategy can use intraoperatively available cells from different 
tissue(s), which will fully take advantage of various cell types. For instance, cells from 
bone marrow have high osteogenic potential while CD34+ cells from fat tissue have 
high vascular potential. This gives rise to the possibility to intraoperatively use cells 
from bone marrow and adipose tissue to generate vascularized tissue-engineered bone 
constructs, which not only keep the advantages of intraoperative preparation but also 
improve the outcome of these tissue-engineered bone constructs. Another example 
is PB-derived cell subsets, such as monocytes and circulating EPCs. All these cells can 
be easily obtained and have been proved to be involved in endogenous tissue healing, 
which in certain cases can promote bone regeneration [45, 74]. Therefore, these 
PB-derived subpopulations have the potential to improve adipose tissue-, peripheral 
blood-derived stem cell-based bone healing, which has an insufficient osteogenic 
potential. Future studies can also focus on the use of macrophages [75], regulatory 
T cells [76, 77] and haematopoietic cells [78], together with certain easily available 
cells to promote desired regeneration events, as all of them have been shown to be 
essential for bone formation and widely present in peripheral blood and adipose tissue.
3. Cell carrier design
To date, intraoperative preparation of tissue-engineered bone constructs is rather 
simplistic, typically seeding cells on the carriers without control over cell composition, 
phenotype, and function in vivo. However, based on the aforementioned clinical 
evidence, bone healing following treatment with intraoperatively prepared tissue-
engineered bone constructs depends on cell carrier characteristics [67, 79]. An ideal 
design of a carrier is able to concentrate and sort progenitor populations and to cause 
more rapid attachment of specific cell types during seeding, to promote cell survival 
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and direct cell fate toward desired differentiation after seeding and to improve bone 
and blood vessel formation after implantation. This design includes, but is not limited 
to chemical, physical and mechanical properties. Future technologies in material 
science and chemistry will greatly aid the development of optimized cell carriers, which 
certainly requires a fundamental biological understanding of cell-material interactions.
Conclusion
From a practical view, intraoperative bone construct preparation will dramatically 
decrease the time, costs, safety concerns and favoring patient comfort. Cells from bone 
marrow, adipose tissue, peripheral blood provide the possibility to utilize this approach 
toward effective bone healing. Both preclinical and clinical studies displayed promising 
outcome when the intraoperative preparation concept is applied, especially with the 
benefits from new technologies, such as cell isolation devices, co-culture method and 
advanced design of cell carriers. Collectively, the intraoperative approach demonstrate 
the tremendous promise to advance stem cell therapies for bone repair and will serve 
as a new trend to make cell-based regenerative transplants.
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Table 1. The advantages and disadvantages of using easily available cells from different tissues to make 
intraoperative concept based bone constructs
Cell source Cell type Advantages Disadvantages
Bone marrow BMACs high osteogenic potential
endothelial sub-population
donor variation
no minimal invasive harvest
BMNCs high osteogenic potential
extensively studied
low yield
no minimal invasive harvest
Adipose tissue SVF abundant tissue 
easy harvest procedure
endothelial sub-population
donor variation
multi-step isolation procedure
low osteogenic potential
PSCs high yield from adipose tissue
homogenous cell population
low osteogenic potential
loss of endothelial 
sub-population
Peripheral blood PBMNCs non-invasive harvest procedure 
endothelial sub-population
low yield of osteogenic cells
presence of undesired cells
PB-derived EPCs/ECs non-invasive harvest procedure
easy isolation method
low yield of osteogenic cells
not widely studied
BMACs: bone marrow aspiration concentrate cells; BMNCs: bone marrow derived mononuclear cells; SVF: 
stromal vascular fraction; PSCs: perivascular stem cells; PBMNCs: peripheral blood mononuclear cells; PB: 
peripheral blood; EPCs: endothelial progenitor cells; ECs: endothelial cells.
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Introduction
Bone defects resulting from trauma, cancer and fractures represent a significant clinical 
problem for over 9 million people worldwide each year [1]. The treatment of these bone 
defects relies predominantly on transplantation of autografts or allografts, and to a lesser 
extent on the use of synthetic biomaterial scaffolds. In order to improve the efficacy of 
synthetic biomaterial scaffolds, major efforts have focused on cell-based constructs that 
combine such synthetic biomaterial scaffolds with cells from the patients [2].
Most cell-based constructs focus on the use of (adult) stem cells, generally isolated 
as so-called mesenchymal stromal cells (MSCs) from either bone marrow or adipose 
tissue. It is remarkable that in view of the chronological order of wound and bone 
healing, signaling molecules and cells involved in the processes prior to wound healing 
are largely ignored. In the natural healing process of damaged tissue, three distinct but 
overlapping stages occur from a few hours to several weeks [3]: 1) the early inflammatory 
stage; 2) the repair stage; and 3) the late remodeling stage. It is reasonable to speculate 
that the inflammatory response, which is evoked by the host immune system, initiates 
and primes the later bone repair process. In fact, the immune and skeletal systems have 
been reported to share a number of signaling molecules and regulatory networks [4]. 
Research on the topic of bone remodeling has shown the influence of the immune system 
on bone healing success [5] and has led to the emergence of “osteoimmunology” [4], 
which identifies the immune system as a potential tool for new therapeutic approaches 
to bone healing. Among the cells of the innate immunity, macrophages are recognized as 
key elements for the orchestration of the processes to re-establish tissue integrity and 
function after damage [6, 7]. Thus, for instance, inflammatory bone disorders generally 
resulted in increased bone resorption and decreased bone formation [8] and ablation 
of macrophages has shown to inhibit intramembranous bone healing [9]. Nevertheless, 
the fundamentals of macrophage involvement in the behavior of osteoprogenitor cells 
and bone formation remain unclear.
It is well documented that following bone injury, monocytes are rapidly recruited to 
the injury site and differentiate into macrophages, where they persist throughout the 
bone repair process [10, 11]. In supporting the multiple events occurring during the 
healing process, versatile subtypes of macrophages have been distinguished depending 
on the environmental stimuli [12]. M0 macrophages, after in vitro differentiation 
from monocytes by macrophage-colony-stimulating factor (M-CSF) or phorbol-12-
myristate-13-acetate (PMA), are mature macrophages with larger and more flattened 
morphology compared to monocytes [13]. Further, two macrophage phenotypes are 
present as extremes of a continuum of functional states. M1 macrophages, in vitro 
classically polarized by lipopolysaccharide (LPS) and interferon gamma (IFN-γ), present 
a pro-inflammatory profile with high antigen-presenting capacity and increased 
secretion of pro-inflammatory cytokines (e.g. interleukin 1β, IL-1β, and tumor necrosis 
factors alpha, TNF-α). In contrast, M2 macrophages, alternatively polarized by inter-
leukin 4 (IL-4) and interleukin 13 (IL-13), secrete high levels of anti-inflammatory 
cytokines (e.g. transforming growth factor beta, TGF-β and interleukin 10, IL-10), 
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regulate and scavenge debris, and promote angiogenesis and tissue remodeling [12]. 
Recent studies depicted a switch in macrophage subtype from the pro-inflammatory 
M1 subtype to the anti-inflammatory M2 subtype during the bone healing process [14, 
15], suggesting differential roles of these macrophage subtypes, and their secreted 
cytokines on the recruitment, proliferation and differentiation of MSCs. However, more 
detailed information is required to clarify macrophage contribution to the osteogenic 
differentiation of MSCs.
The objective of this study was to elucidate the effect of different macrophage subtypes 
on the osteogenic differentiation of MSCs in co-culture models. We hypothesized that 
M2 macrophages are able to promote the osteogenic differentiation of MSCs, while M0 
and M1 macrophages inhibit this process. Therefore, human monocytes were activated 
and/or polarized into M0, M1 and M2 macrophages and then directly co-cultured with 
human MSCs at different ratios to determine their osteogenic capacities. Further 
studies on the mechanism by which these macrophages affect MSCs were performed 
by an indirect co-culture set-up to reveal paracrine effects of macrophage subtypes on 
the behavior of MSCs and to identify the involved signaling molecules.
Materials and methods
1. Reagents and cells
Dulbecco’s Modified Eagle Medium (α-MEM), RPMI-1640 medium, 1% penicillin-
streptomycin (1% P/S) was purchased from Gibco (GrandIsland, USA). Fetal bovine serum 
(FBS), bovine serum albumin (BSA), trypsin, basic fibroblast growth factor (bFGF), PMA, 
LPS, IFN-γ, IL-4, IL-13, glycerol 2-phosphate disodium salt hydrate (β-glycerophosphate), 
dexamethasone, and ascorbic acid were purchased from Sigma-Aldrich (St. Louis, USA). 
Collagenase was purchased from Roche Diagnostics (Mannheim, Germany). TNF-α 
and TGF-β ELISA kits were purchased from eBioscience (San Diego, USA). BMP-2 and 
OSM ELISA kits were purchased from R&D systems (San Diego, USA). Monoclonal anti-
human CCR7 antibody was purchased from Abcam (Cambridge, UK), mouse purified 
anti-human CD36 was from Biolegend (San Diego, USA) and mouse anti-human CD68 
was from Dako (Heverlee, Belgium). All secondary antibodies and 4, 6-diamidino-2-
phenylindole (DAPI) was purchased from Invitrogen (Waltham, USA). All cell culture 
flasks and plates were purchased from Greiner Bio-one (Frickenhausen, Germany).
Human adipose tissue MSCs were isolated and expanded as previously described [16]. 
In brief, human subcutaneous adipose tissue was obtained from the Department of 
Plastic Surgery (Radboudumc, Nijmegen, the Netherlands) after informed consent. 
Obtained adipose tissue was minced using surgical scalpels and washed with PBS. The 
aspirated lipid fraction was diluted with an equal volume of 0.1% collagenase digestion 
solution and then incubated at 37 °C for 60 min under rotation (250 rpm). After Ficoll 
density centrifugation (600g for 10 min), the cell pellet was resuspended and filtered 
through a 100 µm cell strainer. Mononuclear cells were adjusted to 1×107 cells per 15 
ml and then cultured in 10% FBS, 1% PS, and 1 ng/ml of bFGF supplemented α-MEM. 
The attached cells are designated as adipose tissue MSCs and characterized by positive 
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expression of CD73, CD90 and CD105 and negative expression of CD45 [17]. Cells in 
passage 3-5 from three donors were used in this study.
The human monocytic cell line (THP-1) was purchased from the American Type Culture 
Collection (Manassas, USA) and cultured in RPMI-1640 medium supplemented with 
10% heat inactivated FBS and 1% P/S.
2. Polarization and characterization of macrophages
THP-1 cells were differentiated and polarized according to established protocols [18, 
19]. Briefly, 1×106 cells were plated in 6-well plates with 3 ml culture medium plus 50 
ng/ml PMA for 48 hours to activate monocytes into M0 macrophages. For polarization, 
M0 macrophages were treated for another 48 hours, either with an addition of 
20 ng/ml IFN-γ and 100 ng/ml LPS to obtain M1 macrophages or with 20 ng/ml IL-4 
and 20 ng/ml IL-13 to obtain M2 macrophages. Conditioned medium from polarized 
macrophages was used for measuring TNF-α, TGF-β and IL-10 via ELISAs following the 
instructions of the manufacturer. Activated and polarized macrophages were fixed 
with 4% paraformaldehyde and then subjected to immunocytochemistry. The M1 
macrophage marker CCR7 [18] and M2 macrophage marker CD36 [18] were stained 
with the primary antibodies, rabbit monoclonal anti-human CCR7 and mouse purified 
anti-human CD36, respectively, for 2 h in PBS with 1% BSA. Cells were then washed and 
incubated for 1h with goat anti-mouse Alexa-488 labeled IgG and donkey anti-rabbit 
Alexa-568 labeled IgG in the dark. After washing, cells were stained with DAPI for 5 
min. Immunofluorescence images were acquired with a fluorescence microscope (Zeiss 
AxioCam MRc5, Carl Zeiss Microimaging GmbH, Germany) and the relative intensity of 
fluorescence was analyzed using ImageJ (U.S. National Institutes of Health, Bethesda , 
USA). The values of red (Alexa-568) and green (Alexa-488) fluorescence of each sample 
were further normalized to the value of blue fluorescence (DAPI).
3. Direct co-culture of macrophages and MSCs
3.1 Direct co-culture of macrophages and MSCs at different ratios
THP-1 cells were differentiated and polarized into the various subtypes of macrophages 
(i.e. M0, M1, and M2) as described above. Macrophages were detached by trypsin and 
counted by a hemocytometer (LO-Laboroptik GmbH, Friedrichsdorf, Germany). Then, 
8×104, 2×104 and 5×103 M0, M1 or M2 macrophages were plated into 24-well plates, in 
which 2×104 adipose tissue MSCs had been seeded 6 hours before. A mixture of THP-1 
cell culture medium and osteogenic medium (mixture medium, 10% heat-inactivated 
FBS with 10 nM dexamethasone, 100 µM ascorbic acid, and 10 mM β-glycerophosphate) 
was used and refreshed every 3 days.
3.2 Immunostaining of direct co-culture
Cells were seeded on plastic coverslips (Thermanox, 13mm; MA, USA) in 24 well plates. 
After 4 weeks, the coverslips with attached cells (8×104 macrophages groups) were 
washed with PBS and then fixed with 4% paraformaldehyde, followed by blocking with 
1% BSA. Cells were then stained with mouse anti-human CD68 and goat anti-mouse 
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Alexa-488 labeled IgG and DAPI. After staining and mounting, coverslips were imaged 
with a fluorescence microscope (Keyence International, Mechelen, Belgium). The 
number of macrophages and MSCs were counted based on nuclear staining (shape; 
macrophage nuclei were round; MSC nuclei were elongated) and CD68 positive cells 
(macrophages) by counting four random fields per well (magnification 400x). Cell 
densities were then normalized to the area of the fields.
3.3 Mineralization of direct co-culture
For mineralization tests, direct co-cultures were maintained for 4 weeks, washed twice 
with PBS, and incubated overnight with 1 ml 0.5 N acetic acid on a shaking table at 
room temperature. The calcium content of each well was quantified by a calcium assay 
as described previously [16].
4. Indirect co-culture of macrophages and MSCs
4.1 Indirect co-culture of macrophages and MSCs by a transwell system
8×104 macrophages were plated into 0.4-µm pore inserts of 24-well transwell plates 
in 200 µl of mixture medium (1:1 THP-1 cell culture medium and osteogenic medium), 
with 800 µl mixture medium containing 2×104 MSCs added to the bottom of the well. 
Medium was changed on day 3, day 7 and then twice a week. After 2 weeks and 4 
weeks, MSCs were stained with Alizarin Red or quantified by calcium test. In parallel 
samples, MSCs were collected for DNA content and ALP activity test and stained with 
ALP dyes after 7, 14, and 28 days. Additionally, medium from each group was collected 
at days 3, 7, 14, and 28 for protein analysis and MSCs were homogenized with 350 µl 
lysis buffer and then stored at -80°C for RT-PCR.
4.2 DNA content of MSCs
Cell proliferation for MSCs was assessed using the PicoGreen DNA quantification assay 
kit, (Invitrogen, Waltham, USA). Cell layers were washed with PBS twice, after which 1 
ml MilliQ water was added. Following two freeze-thaw cycles, samples were used for 
DNA quantification according to the instructions of the manufacturer.
4.3 ALP activity of MSCs
The ALP activity was measured using the same samples as used for cellular DNA content. 
A p-nitrophenyl phosphate (4-NP) method was adapted as developed previously [16]. 
ALP activity results were normalized for DNA (expressed as nmol 4-NP/ng DNA/h). In 
addition, 2 parallel samples from each group were fixed with 4% paraformaldehyde and 
then histochemically stained in methanol using the Leukocyte Alkaline Phosphatase Kit 
(Sigma-Aldrich, St. Louis, USA) per the manufacturer’s protocol.
4.4 Mineralization of MSCs
The calcium content for indirect co-cultures was quantified with the same method as 
described for direct co-cultures. In parallel, 2 samples from each group were fixed in 4% 
paraformaldehyde at indicated time points and then stained with 1 ml/well alizarin red 
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solution for 15 min at room temperature using an osteogenesis quantification kit (EMD 
Millipore, Billerica USA). Stained samples were then photographed with a microscope 
(Keyence International, Mechelen, Belgium).
4.5 Osteogenic gene expression of MSCs
mRNA of cells was extracted using the RNeasy Mini Kit (Qiagen, Valencia, USA) per the 
manufacturer’s protocol. After isolation, RNA was quantified using a Nanodrop ND1000 
Spectrophotometer (Thermo Scientific, Hudson, USA). cDNA was generated from 1 µg 
of RNA using the SuperScript III reverse transcription kit (Invitrogen, Waltham, USA). 
For the RT-PCR reaction, 2 µl cDNA, 12.5 µl Mastermix (Life Technologies, Waltham, 
USA) and 3 µl primer mix with specific forward and reverse primers (Table S1) and 7.5 
µl RNAse free water was mixed. PCR reactions were performed and monitored using 
an ABI Prism 7700 Sequence Detection System (Perkin-Elmer/Applied Biosystems, 
Rotkreuz, Switzerland). The level of gene expression was calculated via the ∆∆Ct 
method [20]. Four independent samples were used for each gene of interest.
5. Osteogenic factors involved in macrophage and MSC interaction
5.1 Protein quantification of osteogenic factors
Medium collected from indirect co-culture at indicated time points and conditioned 
medium from polarized macrophages were used for BMP-2 and OSM ELISAs following 
the manufacturer’s instructions. Colorimetric changes were measured using a multi-
mode spectrophotometer (Biotek, Winooski, USA).
5.2 Gene expression of osteogenic factors in MSCs and polarized macrophages
MSCs and different types of macrophages were homogenized with lysis buffer 
at indicated time points and mRNA was isolated as described above. RT-PCR was 
conducted with the same protocol and gene expression of BMP-2, OSM and OSMR 
were quantified using primers listed in Table S1.
6. Statistical analysis
Data are expressed as the mean and standard deviation (± SD). Statistical analysis was 
performed by GraphPad Prism version 5 (GraphPad software, San Diego, USA) using one-
way analysis of variance (ANOVA) with Dunnett post-test where multiple results were 
compared against a control, or with Bonferroni’s test for multiple comparisons. Two-
way ANOVA with Bonferroni’s test was performed where two independent variables 
were present. Probability (p) values of p < 0.05 were considered statistically significant.
Results
1. Characterization of polarized macrophages
THP-1 monocytes were activated with PMA to generate M0 macrophages, which made 
the cells adherent to plastic. M0 macrophages were further polarized into M1 and 
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M2 macrophages in the presence of the appropriate cytokines (Figure 1a). Cytokine 
secretion profiles for TNF-α, TGF-β, and IL-10 depended on macrophage subtype 
(Figure 1b). Significantly higher TNF-α secretion was observed for M1 macrophages 
(565.74 ± 17.58 ng/ml) compared to M0 macrophages (3.52 ± 1.55 ng/ml; P < 0.001) and 
M2 macrophages (3.06 ± 0.74 ng/ml; P < 0.001). In contrast, significantly higher TGF-β 
secretion was observed for M2 macrophages (499.32 ± 69.48 ng/ml) compared to M0 
macrophages (193.56 ± 68.74 ng/ml; P < 0.001) and M1 macrophages (151.69 ± 66.49 
ng/ml; P < 0.001). Similarly, IL-10 secretion was significantly higher for M2 macrophages 
(0.82 ± 0.06 ng/ml) compared to both M0 macrophages (0.28 ± 0.20 ng/ml; P < 0.01) 
and M1 macrophages (0.35 ± 0.14 ng/ml; P < 0.01).
Immunostaining for macrophage subtype markers showed mixed populations of M1 
and M2 macrophages after polarization procedures (Figure 1c, d & e). M1 polarization 
showed macrophages with positive staining for the M1 marker, CCR7, and slightly 
less positive staining for the M2 marker, CD36. In contrast, M2 macrophages showed 
enhanced positive staining for CD36 and less positive staining for CCR7. Quantification 
of the fluorescent signal from macrophage polarization marker immunoreactions 
showed obvious differences between the three macrophage phenotypes (Figure 1f). 
CCR7 was significantly higher expressed in M1 macrophages (29.44 ± 3.55; P < 0.05), 
compared to M0 (7.96 ± 0.57) and M2 macrophages (14.27 ± 3.61). In contrast, CD36 
was significantly higher expressed in M2 macrophages (40.94 ± 5.81) compared to M0 
(12.70 ± 1.22) and M1 macrophages (17.72 ± 3.05).
2. Direct co-culture of macrophages and MSCs
Experiments were performed with MSCs isolated from three different donors. As similar 
results were obtained from these experiments, the results below mainly describe the 
data from donor 3 as representative experiment.
2.1 Cell distribution
After 4 weeks of direct co-culture, pan-macrophage staining (CD68) combined with 
nuclear staining
(DAPI) showed a homogeneous distribution of both cell types (Figure 2a). Although 
an equal number of macrophages were initially seeded for the co-cultures, higher 
numbers of M0 macrophages (592 ± 101/mm2; P < 0.05) were observed during the 
co-culture compared to both M1 (368 ± 45/mm2) and M2 (351 ± 27/mm2) macrophages 
with MSCs (Figure 2b & c). Simultaneously, MSCs co-cultured with M0 (681 ± 57/mm2) 
and M2 (418 ± 13/mm2) macrophages showed significantly higher number compared to 
MSCs monoculture (327 ± 17/mm2; P < 0.05), while MSCs number decreased with M1 
macrophages (204 ± 22/mm2; P < 0.05).
2.2 Mineralization
Calcium content measurements were used to determine the mineralization capacity of 
MSCs co-cultured with macrophages and MSCs monoculture controls. Different ratios 
of MSCs to macrophages and two co-culture methods, namely direct co-culture and
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Figure 1. The polarization method and cytokine expression of M0, M1 and M2 macrophages derived 
from THP-1 monocytes. The schematic figure shows the differentiation of monocytes into polarized 
macrophages and their morphological appearance (a). TNF-α, TGF-β and IL-10 production in M0, M1 and 
M2 macrophages conditioned medium were assessed by ELISA (b). M0 (C), M1 (d) & M2 (e) macrophages 
were stained with M1-marker CCR7 (red), M2-marker CD36 (green) and DAPI (blue), respectively. The 
relative fluorescence intensity of CCR7 and CD36 were quantified by ImageJ (f). Statistical analysis was 
performed by One-Way ANOVA with Bonferroni’s test. * p < 0.05; ** p < 0.01, *** p < 0.001.
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indirect co-culture by using transwell system, were used here to investigate this 
effect (Figure 3a). The calcium content from direct co-cultures showed macrophage 
subtype-dependent promoting effects on MSCs, irrespective of donors (Figure 3b). 
Taking donors 3 for example, M0 macrophages decreased the mineralization of 
co-cultured MSCs to around 40 µg/ml, irrespective of the macrophage to MSC ratio. 
M1 macrophages, however, showed different effects on the mineralization of MSCs 
depending on their ratio. M1 macrophages and MSCs at a ratio of 1:1 also enhanced 
the mineralization (72.75 ± 4.06 µg/ml) compared to MSCs controls (63.26 ± 1.77 µg/
ml; P < 0.01), while this effect was not obvious for the ratios 1:4 and 4:1. In contrast, M2 
macrophages significantly increased the mineralization of co-cultured MSCs, and this 
effect was proportional to the ratio of macrophages to MSCs. M2 macrophages to MSCs 
at 4:1 and 1:1 ratios reached significantly higher mineralization of 146.84 ± 12.31 µg/ml 
and 131.38 ± 10.94 µg/ml respectively, compared to MSCs monoculture (63.26 ± 1.77 
µg/ml; P < 0.001). At a ratio of 1:4, M2 macrophages reached a similar mineralization 
level (68.01 ± 6.59 µg/ml) compared to MSC monoculture (p > 0.05).
3. Indirect co-culture of macrophages and MSCs
Experiments were performed with MSCs isolated from three different donors. As 
similar results were obtained from these experiments, the data below describe the 
data of donor  3 as representative experiment. More data from donor 1 and donor 2 
was showed in Supplementary Figure S1.
3.1 Cell proliferation of MSCs
DNA content of co-cultured MSCs was assessed to study effects of different types of 
macrophages on the growth of MSCs during co-culture. As shown in Figure 4a, after 7 
days, all of three types of macrophages increased the cell number of MSCs, with the 
effect of M2 macrophages on MSC proliferation being the highest (913.93 ± 334.15 ng/
ml; P < 0.001), followed by MSCs with M1 macrophages (585.49 ± 74.20 ng/ml; P < 0.05) 
and M0 macrophages (547.22 ± 27.90 ng/ml; P < 0.05) compared to MSC monoculture 
(229.44 ± 21.42 ng/ml). After 14 days, although DNA content was increased in all 
groups, no difference was observed between MSC monoculture and co-cultures with 
macrophages. However, on day 28, M2 macrophages still significantly stimulated the 
growth of co- cultured MSCs (614.27 ± 36.53 ng/ml) compared to MSC monoculture 
(454.29 ± 26.63 ng/ml; P < 0.05) and MSCs with M1 macrophages (453.85 ± 27.04 ng/
ml; P < 0.05).
3.2 ALP activity of MSCs
The activity of alkaline phosphatase in co-cultured MSCs was assessed as a marker of 
osteo genic differentiation. Generally, the level of endogenous ALP activity increased 
and peaked around 14 days and then decreased for all experimental groups (Figure 4b 
& c). In view of different macrophage subtype effects, the co-culture of MSCs with M0 
and M1 macro phages increased ALP activity to 0.42 ± 0.07 nmol/ng DNA/h and 0.54 ± 
0.08 nmol/ng DNA/h,respectively, measured at day 7, compared to MSC monoculture
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Figure 2. Immunostaining of different types of macrophages (MΦ) co-cultured with MSCs. MSCs were 
monocultured or co-cultured with M0, M1 and M2 macrophages (1:4 ratio) for 4 weeks and stained with 
DAPI (blue) and pan-macrophage marker CD68 (green) (a). The number of macrophages and MSCs was 
counted based on shape of nuclei (b) and quantified (c).White arrow indicates the MSC while yellow arrow 
indicates the macrophage. Statistical analysis was performed by One-Way ANOVA with Bonferroni’s test. 
N= 4, * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 3. Mineralization of MSCs directly co-cultured with M0, M1 and M2 macrophages. The schematic 
diagram shows the set-up of MSCs monoculture, direct co-culture (at different ratios) or indirect co-culture 
(at ratio of 1:4) with M0, M1 and M2 macrophages respectively (a). Mineralization capacity of monoculture 
and direct co-culture from 3 donors was assessed by calcium content after 4 weeks in osteogenic medium 
(b). Statistical significance relative to controls (MSCs monoculture) and between groups was determined 
by Two-Way ANOVA with Bonferroni’s test correction, N = 5, * * p < 0.01, *** p < 0.001. Asterisks placed 
directly on the columns indicate significant differences from the MSCs control.
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Figure 4. Cell proliferation and ALP activity of MSCs indirectly co-cultured with M0, M1 and M2 
macrophages. MSCs were monocultured and indirectly co-cultured with three types of macrophages 
and their proliferation was determined by DNA content assay (a) and their osteogenic differentiation was 
determined by ALP-activity assay (b) and ALP staining (c). Statistical analysis was performed by One-Way 
ANOVA with Dunnett post-test. N= 4, * p < 0.05, ** p < 0.01, *** p < 0.001.
(0.11 ± 0.02 nmol/ng DNA/h; P < 0.001) and with M2 macrophages (0.09 ± 0.01 nmol/ng 
DNA/h; P < 0.001) (Figure 4b). However, after 14 days, M2 (2.85 ± 0.38 nmol/ng DNA/h; 
P < 0.001) and M1 macrophages (2.28 ± 0.30 nmol/ng DNA/h; P < 0.05) significantly 
increased the ALP activity in co-cultured MSCs. In contrast, MSCs co-cultured with 
M0 macrophages showed significantly less ALP activity (1.43 ± 0.09 nmol/ng DNA/h; 
P < 0.01) compared to MSCs monoculture. After 28 days, MSCs co-cultured with M0 
and M1 macrophages showed similar ALP activity compared to MSC monoculture. In 
contrast, MSCs co-cultured with M2 macrophages (2.16 ± 0.32 nmol/ng DNA/h) still 
had a significantly higher ALP activity compared to all other experimental groups (P < 
0.001; Figure 4b & c).
3.3 Mineralization of MSCs
In indirect co-cultures using a transwell system (Figure 3a), MSCs co-cultured with 
M2 macrophages attained the apparent highest mineralization compared to other 
experimental groups, based on alizarin red staining. In contrast, the effect from M0 
and M1 macrophages on the mineralization of MSCs was not obvious compared to MSC 
monoculture (Figure 5a & b). Quantitatively, 27.3 ± 3.26 µg/ml calcium was obtained 
after 2 weeks of indirect co-culture of M2 macrophages and MSCs (donor 3), which 
obtained similar levels (p > 0.05) as the other experimental groups (less than 20 µg/ml; 
Figure 5c). After 4 weeks indirect co-culture, the calcium content of MSCs co-cultured 
with M2 macrophages reached 120.55 ± 10.09 µg/ml compared to MSC monoculture 
(71.30 ± 17.11 µg/ml; P < 0.001),MSCs with M0 (48.46 ± 16.70 µg/ml; P < 0.001) and M1 
macrophages (67.03 ± 18.39 µg/ml; P < 0.001) (Figure 5d).
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Figure 5. Mineralization of MSCs indirectly co-cultured with M0, M1 and M2 macrophages. MSCs 
monocultured or indirectly co-cultured with macrophages at a ratio of 1:4 were stained with alizarin red 
after 2 weeks (a) and 4 weeks (b), respectively. Calcium content of MSCs (3 different donors) monocultured 
or indirectly co-cultured with three types of macrophages in the osteogenic medium was determined after 
2 weeks (c) and 4 weeks (d), respectively. Statistical analysis was performed by One-Way ANOVA with 
Dunnett post-test. N= 5, * p < 0.05, ** p < 0.01, *** p < 0.001.
3.4 Gene expression of osteogenic markers of MSCs in indirect co-culture
Osteogenic differentiation of MSCs occurs along with an increase in the expression 
of osteogenesis-related genes, which were examined by RT-PCR analysis. After 3 days 
co-culture, the gene expression levels of runt-related transcription factor 2 (Runx2), 
collagen I, ALP, and osteocalcin (OCN) were 2~3 times increased in MSCs indirectly 
co-cultured with M1 macrophages, in comparison to MSC monoculture (P < 0.001). M0 
macrophages increased the expression of two osteogenic markers (Runx 2 and OCN), 
but to a lesser extent (P < 0.05). For co-cultures with M2 macrophages, this stimulating 
effect was not observed on day 3 (Figure 6a).
On day 7, MSCs along with M0 and M1 macrophages inhibited the gene expression of 
Runx2, OCN and bone sialoprotein II (BSP II) (P < 0.001). By contrast, all osteogenesis-
related genes, except for ALP, showed enhanced expression in MSCs co-cultured with 
M2 macrophages (Figure 6b).
After 14 days, Runx2, ALP and OCN, were still more highly expressed in MSCs co-cultured 
with either M1 or M2 macrophages, compared to MSC monoculture (P < 0.05). Notably, 
BSP II expression was significantly enhanced (approximately 10-fold) for MSCs with M2 
macrophages (P < 0.001), but not for MSCs co-cultured with M0 or M1 macrophages (P 
> 0.05) (Figure 6c).
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4. Osteogenic factors involved in macrophage and MSC interaction
Two osteogenesis-related soluble proteins, OSM and BMP-2, were analyzed in the 
co-culture medium to evaluate potential involvement in the effects of macrophages 
on the osteogenic induction of MSCs (Figure 7). Higher concentrations of OSM were 
found in the co-culture medium from M0-MSCs (15.02 ± 4.06 pg/ml) and M1-MSCs 
(17.63± 3.09 pg/ml) on day 3 compared to MSC monoculture (2.11 ± 1.52 pg/ml; P 
< 0.01) and M2-MSCs (4.01 ± 2.39 pg/ml; P < 0.01) (Figure 7a). We further assessed 
OSM gene expression and protein secretion in three types of macrophages and their 
corresponding conditioned medium. M0 and M1 macrophages expressed almost 
twice to four times more OSM than M2 macrophages at the gene level (Figure 7b). 
Secretion of OSM was also higher at the protein level in the conditioned medium of 
M1 macrophages (14.38 ± 3.42 pg/ml) compared to M2 macrophages (6.20 ± 3.06 pg/
ml; P < 0.001) (Figure 7c). The expression of the receptor of OSM (OSMR) was found 
to be enhanced in MSCs co-cultured with M0 (around 2-fold) and M1 macrophages 
(around 7-fold) after 3 days and 2-fold enhanced with M0 and M1 macrophages 
after 7 days (Figure 7d) compared to MSC monoculture controls and MSCs with M2 
macrophages.
Figure 6. Gene expression of osteogenic markers by 
MSCs indirectly co-cultured with M0, M1 and M2 
macrophages. MSCs were indirectly co-cultured with 
three types of macrophages and their key osteogenic 
gene expression was determined by RT-PCR after 3 
days (a), 7 days (b) and 14 days (c). Statistical analysis 
was performed by One-Way ANOVA with Dunnett 
post-test. N= 4, * p < 0.05, ** p < 0.01, *** p < 0.001.
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Figure 7. Secretion of key osteogenesis-related proteins in MSCs monoculture, MSCs and macrophages 
indirect co-cultures and macrophages conditioned medium. OSM secretion in macrophages and MSCs 
co-culture medium was assessed by ELISA (a). OSM gene expression of M0, M1 and M2 macrophages 
was determined by RT-PCR (b) and its protein secretion in conditioned medium was determined by ELISA 
(c). OSM receptor (OSMR) gene expression in MSCs was determined by RT-PCR (d). BMP-2 secretion in 
macrophages and MSCs co-culture medium was assessed by ELISA (e). BMP-2 gene expression of M0, 
M1 and M2 macrophages was determined by RT-PCR (f) and its protein secretion in conditioned medium 
was determined by ELISA (g). BMP-2 gene expression in MSCs was determined by RT-PCR (h). One-Way 
ANOVA with Bonferroni’s correction was performed for comparison of OSM and BMP-2 gene expression 
and protein secretion between different types of macrophages. One-Way ANOVA with Dunnett post-test 
correction was performed for comparison of OSM and BMP-2 concentration, OSMR and BMP-2 gene 
expression in MSCs. N= 4, * p < 0.05, ** p < 0.01, *** p < 0.001.
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Regarding BMP-2, higher concentrations of BMP-2 in M2 macrophages and MSC 
co-culture medium were observed after 7 days (1209.85 ± 156.74 pg/ml) and 14 days 
(497.88 ± 61.80 pg/ml) compared to conditioned medium from MSC monoculture 
(748.03 ± 66.49 pg/ml at day 7 (P < 0.001) and 247.52 ± 19.95 pg/ml at day 14 (P < 0.05), 
respectively) (Figure 7e). No significant differences were observed regarding BMP-2 
secretion in conditioned medium between different phenotypes of macrophages, even 
though significantly higher BMP-2 gene expression in M2 macrophages was observed 
(Figure 7f & g). BMP-2 expression in macrophage-MSC co-culture showed significantly 
higher values (around 4-fold) with M2 macrophages on day 7 and day 14 compared to 
MSC monoculture (Figure 7h).
Discussion
The bone healing process after injury involves interactions of multiple cell types, 
including osteoprogenitor cells, such as MSCs, and inflammatory cells, such as 
monocytes/macrophages. Although this interaction has been indicated to be critical 
for bone formation and related to a macrophage phenotype switch, the mechanisms 
involved still remain unclear. In the present study, we generated and characterized 
three types of macrophages and demonstrated their differential effects on the 
behavior of MSCs. M2 macrophages increased the mineralization of co-cultured MSCs, 
and this effect was proportional to the ratio of macrophages to MSCs. In contrast, M0 
and M1 macrophages showed opposite effects at certain ratios. Furthermore, several 
potential osteogenic factors were proved to be involved in interaction between diverse 
macrophage subtypes and MSCs, which stimulated their osteogenic differentiation.
Macrophage phenotypes ranging from M0 to M1 and M2 were generated and 
characterized before co-culture. The selected cytokine secretion profiles (TNF-α, TGF-β, 
and IL-10), which were previously shown to discriminate M0, M1, and M2 macrophages 
[19], demonstrated the successful polarization of different types of macrophages. 
However, unambiguous classification of macrophage phenotypes is problematic due to 
non-specific staining of different types of macrophages for M1 (CCR7) and M2 (CD36) 
markers. The quantification of relative fluorescence intensity facilitated the assignment 
of markers toward M1 or M2 predominance and provided an additional method to 
interpret macrophage subtypes. With this macrophage subtype characterization, we 
initiated macrophage/MSC co-cultures, during which macrophages were shown to 
influence MSC behavior and vice versa. As a result of these dynamics, fluctuations in 
macrophage subtypes can occur during co-culture, and hence maintenance of the 
condition at cell seeding over the course of 4 weeks cell culture is unlikely. Consequently, 
the pan-macrophage marker, CD68, was used to assess the distribution and viability of 
seeded macrophages due to the difficulty of using specific markers for different subtypes 
of macrophages. A larger number of macrophages were observed for M0 macrophages 
and MSCs in direct co-culture after 4 weeks. Additionally, different proliferation rate 
and osteogenic behavior of MSCs were found with three types of macrophages in direct 
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and indirect co-cultures. These findings indicate dynamic interactions between MSCs 
and different types of macrophages over the co-culture period.
M2 macrophages were shown to promote osteogenic differentiation of MSCs isolated 
from three different donors, evidenced by the significantly higher mineralization 
capacity compared to MSC monoculture, both in direct and indirect co-cultures. 
This finding corroborates data from previous studies, which indicated that M2 
macrophages stimulate the mineralization capacity of MSCs [21-25]. However, several 
pieces of contrasting data on M1 macrophage effects on MSC mineralization have 
been reported [26, 27]. This discrepancy probably relates to experimental design 
differences. For instance, these previous studies did not use actual co-cultures 
but macrophage-conditioned medium for the culture of MSCs. Consequently, the 
dynamic bi-directional cellular interactions between MSCs and macrophages were 
not operative. Furthermore, characterization of macrophages was not reported in 
some studies to insure certain subtype. Finally, the used cells for co-culture studies 
were dissimilar from several perspectives influencing mineralization, including MSC 
differentiation status (i.e. osteoprogenitors versus mature osteoblasts), origin (i.e. 
adipose tissue versus bone marrow) [28] and donor characteristics [29], monocytes/
macrophage characteristics (e.g. CD16 surface marker expression) [30], and co-culture 
cell ratios [31]. This study used THP-1 monocytes activated by PMA and then polarized 
by LPS and IFN γ or IL4 and IL13 to reflect the M0, M1 and M2 macrophages that may 
occur during the bone healing in vivo. As an immortalized human cell line, THP-1 cells 
are characterized to retain all necessary markers and morphologic features to be 
qualified as a monocyte cell population [32]. Under certain microenvironments, they 
can undergo differentiation and polarization into functional, mature macrophages. A 
cell line is needed here to address multivariate research questions that require large 
numbers of cells and also for high reproducibility of results, which was not practical 
and ideal for primary monocytes isolated from peripheral blood. In addition, two-
dimensional co-culture was utilized in the present study to simplify the experimental 
complexity. A three-dimensional co-culture is undergoing to more closely mimic the 
real cell-cell interaction microenvironment. In the following study, an ectopic and an 
orthotopic in vivo model will be conducted as well to assess the clinical relevance of 
our findings in the context of bone formation and bone repair capacity. The ratio of M2 
macrophages to MSCs in the direct co-culture showed a correlation with the extent 
of mineralization, and an imbalance in favor of M2 macrophages even significantly 
increased mineralization compared to MSC monoculture controls. In our preliminary 
experiments (data not shown), a 10:1 ratio of M2 macrophages to MSCs showed 
significantly lower mineralization compared to MSC monoculture controls. Given 
our experimental set-up for direct co-cultures with equal numbers of MSCs for all 
experimental groups, this ratio-dependency suggests an optimally effective (in vitro) 
cytokine secretion profile. In addition, it is worthy of notice that M1 macrophages with 
MSCs at the ratio of 1:1 slightly promoted the mineralization capacity of MSCs as well. 
During this co-culture process, all types of macrophages promoted the proliferation of 
MSCs in the first week. M0 and M2 macrophages showed this beneficial effect even 
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after 4 weeks. On the other hand, M0 and M1 macrophages significantly promoted 
the osteogenic differentiation of co-cultured MSCs in the early and middle stage of 
osteogenesis, evidenced by high ALP activity and high gene expression of early-stage 
osteogenic markers such as Runx2, ALP, Col I at the early time points. In contrast, M2 
macrophages showed delayed stimulatory effects on the osteogenic gene expression 
profile of co-cultured MSCs, with a 10-fold increased expression of BSP II on day 14. 
This finding corroborates the results of Omar et al. and Loi et.al, who showed that 
pro-inflammatory macrophages could promote the early osteogenic differentiation 
of bone marrow derived MSCs and this effect was further enhanced by macrophage 
phenotype modulation from M1 to M2 via IL-4 treatment 72 hours after seeding [27, 
33]. Considering these findings, it could be speculated that an optimized timing of 
M1 and M2 macrophage appearance exists to achieve the maximum osteogenesis of 
co-cultured MSCs. This hypothesis was also postulated by other researchers, but needs 
further investigation [5, 10, 22].
A vital role of soluble factors in the osteoinductive effects of M2 macrophages on MSCs 
was found because the calcium content from indirect co-culture (120.55 ± 10.09 µg/
ml) was comparable to that from MSC and M2 macrophages direct co-culture (146.84 
± 12.31 µg/ml) at the same ratio. BMP-2 and OSM are most likely stimulatory molecular 
candidates based on previous studies [21, 24, 26, 31, 34]. Several studies have found 
that monocytes/macrophages enhanced osteogenic differentiation of MSCs in a 
manner dependent on an OSM signaling pathway [21, 26, 31]. In this study, M0 and 
M1 macrophages, but not M2 macrophages, were found to express and secrete higher 
OSM levels at the early time points to drive the osteogenic differentiation of co-cultured 
MSCs through the OSM-OSMR signaling pathway. On the other hand, higher BMP-2 
secretion was observed only for MSC and M2 macrophage co-cultures, whereas BMP-2 
secretion in the three types of macrophages was not significantly different. We further 
confirmed the increased endogenous BMP-2 secretion of MSCs when co-cultured 
with M2 macrophages. Two studies also proved monocytes/macrophages acting via 
exosomes or soluble factors on MSCs to induce autologous BMP-2 production [33, 34]. 
This finding, however, was contradictory to few previous report, which demonstrated 
the beneficial effect of exogenous BMP-2 [24, 35]. However, it needs to be emphasized 
that only conditioned medium was used and endogenous BMP-2 from MSCs was not 
tested in these studies. Nonetheless, in the present study, the possibility that BMP-2 
expression in M2 macrophages was enhanced when co-cultured with MSCs cannot be 
excluded.
In the present study, all macrophage subtypes promoted the osteogenic differentiation 
of MSCs, albeit to a different extent and at different stages during co-culture. This 
finding challenges the traditional knowledge about macrophages and inflammation, in 
which macrophages were generally considered to adversely affect the bone healing 
process. Since at an organismal physiological level inflammatory signals resulting from 
bone tissue injury or surgery, and the implanted biomaterial mediate the differentiation 
of monocytes into different types of macrophages, our findings provide new impetus 
for the future design of supporting scaffolds and cell selection for treatment of bone 
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defects. For instance, hydrophilic nanostructured surfaces have been shown to drive 
M2 macrophage polarization and improve osseointegration [36], and enhancement of 
M2 phenotype in bone defects further improved bone healing [37]. Furthermore, MSCs, 
irrespective of their origin, have been indicated to function as immunomodulators to 
macrophages beyond their differentiation potential in tissue regeneration [38, 39]. 
Their effect on bone regeneration through immunoregulation mechanisms is worthy 
to be investigated in the future.
Conclusion
This work systematically studied the effects of different macrophage subtypes on the 
osteogenic differentiation of adipose tissue MSCs. We found that M2 macrophages 
had a beneficial effect on ADMSCs mineralization by promoting their proliferation 
and osteogenic differentiation. In contrast, this enhanced mineralization effect was 
not observed for ADMSCS co-cultured with M0 and M1 macrophages at certain 
ratios, although both of them were able to promote the early osteogenic process 
Furthermore, indirect co-cultures demonstrated that the stimulatory effect was 
mediated by soluble factors, in which autocrine BMP-2 and OSM osteogenic factors 
were involved. Our findings not only elucidate the critical role of macrophages in 
the osteogenic differentiation process of osteoprogenitor cells, but also provide 
important considerations for the implementation of macrophage-osteoprogenitor cell 
interactions in the development of bone regenerative treatments.
PSM 20180528 Proefschrift Yang Zhang BW.indd   64 13-06-18   17:55
Macrophage type modulates osteogenic differentiation of adipose tissue MSCs 
65
Ch
ap
te
r 3
References
[1] O. Johnell, J. Kanis, An estimate of the worldwide prevalence and disability associated with 
osteoporotic fractures, Osteoporosis international 17(12) (2006) 1726-1733.
[2] J. Ma, S.K. Both, F. Yang, F. Cui, J. Pan, G.J. Meijer, J.A. Jansen, J. van den Beucken, Concise review: 
cell-based strategies in bone tissue engineering and regenerative medicine, Stem Cells Transl Med 
3(1) (2014) 98-107.
[3] R. Dimitriou, E. Tsiridis, P.V. Giannoudis, Current concepts of molecular aspects of bone healing, Injury 
36(12) (2005) 1392-1404.
[4] H. Takayanagi, Osteoimmunology: shared mechanisms and crosstalk between the immune and bone 
systems, Nature Reviews Immunology 7(4) (2007) 292-304.
[5] C. Schlundt, H. Schell, S.B. Goodman, G. Vunjak-Novakovic, G.N. Duda, K. Schmidt-Bleek, Immune 
modulation as a therapeutic strategy in bone regeneration, Journal of experimental orthopaedics 
2(1) (2015) 1.
[6] S.W. Cho, F.N. Soki, A.J. Koh, M.R. Eber, P. Entezami, S.I. Park, N. van Rooijen, L.K. McCauley, Osteal 
macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone 
in bone, Proceedings of the National Academy of Sciences 111(4) (2014) 1545-1550.
[7] K.J. Lavine, S. Epelman, K. Uchida, K.J. Weber, C.G. Nichols, J.D. Schilling, D.M. Ornitz, G.J. Randolph, 
D.L. Mann, Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and 
remodeling in the neonatal and adult heart, Proceedings of the National Academy of Sciences 111(45) 
(2014) 16029-16034.
[8] R. Hardy, M. Cooper, Bone loss in inflammatory disorders, Journal of Endocrinology 201(3) (2009) 
309-320.
[9] K.A. Alexander, M.K. Chang, E.R. Maylin, T. Kohler, R. Müller, A.C. Wu, N. Van Rooijen, M.J. Sweet, D.A. 
Hume, L.J. Raggatt, Osteal macrophages promote in vivo intramembranous bone healing in a mouse 
tibial injury model, Journal of bone and mineral research 26(7) (2011) 1517-1532.
[10] A.C. Wu, L.J. Raggatt, K.A. Alexander, A.R. Pettit, Unraveling macrophage contributions to bone 
repair, BoneKEy reports 2 (2013).
[11] J. Glynne Andrew, S.M. Andrew, A.J. Freemont, D.R. Marsh, Inflammatory cells in normal human 
fracture healing, Acta Orthopaedica 65(4) (1994) 462-466.
[12] S. Gordon, Alternative activation of macrophages, Nature reviews immunology 3(1) (2003) 23-35.
[13] E. Zajac, B. Schweighofer, T.A. Kupriyanova, A. Juncker-Jensen, P. Minder, J.P. Quigley, E.I. Deryugina, 
Angiogenic capacity of M1-and M2-polarized macrophages is determined by the levels of TIMP-1 
complexed with their secreted proMMP-9, Blood 122(25) (2013) 4054-4067.
[14] R. Tasso, V. Ulivi, D. Reverberi, C. Lo Sicco, F. Descalzi, R. Cancedda, In vivo implanted bone marrow-
derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an 
ectopic bone regenerative niche, Stem cells and development 22(24) (2013) 3178-3191.
[15] X. Wu, W. Xu, X. Feng, Y. He, X. Liu, Y. Gao, S. Yang, Z. Shao, C. Yang, Z. Ye, TNF-a mediated inflammatory 
macrophage polarization contributes to the pathogenesis of steroid-induced osteonecrosis in mice, 
International journal of immunopathology and pharmacology 28(3) (2015) 351-361.
[16] J. Ma, J.J. Beucken, S.K. Both, H.J. Prins, M.N. Helder, F. Yang, J.A. Jansen, Osteogenic capacity of 
human BM-MSCs, AT-MSCs and their co-cultures using HUVECs in FBS and PL supplemented media, 
Journal of tissue engineering and regenerative medicine  (2013).
[17] A. Hayrapetyan, M. Bongio, S.C. Leeuwenburgh, J.A. Jansen, J.J. van den Beucken, Effect of Nano-HA/
Collagen Composite Hydrogels on Osteogenic Behavior of Mesenchymal Stromal Cells, Stem Cell 
Reviews and Reports  (2016) 1-13.
[18] D.A. Stewart, Y. Yang, L. Makowski, M.A. Troester, Basal-like breast cancer cells induce phenotypic 
and genomic changes in macrophages, Molecular Cancer Research 10(6) (2012) 727-738.
[19] D.O. Freytes, J.W. Kang, I. Marcos-Campos, G. Vunjak-Novakovic, Macrophages modulate the viability 
and growth of human mesenchymal stem cells, Journal of cellular biochemistry 114(1) (2013) 220-229.
[20] T.D. Schmittgen, K.J. Livak, Analyzing real-time PCR data by the comparative CT method, Nature 
protocols 3(6) (2008) 1101-1108.
PSM 20180528 Proefschrift Yang Zhang BW.indd   65 13-06-18   17:55
Chapter 3
66
[21] T.J. Fernandes, J.M. Hodge, P.P. Singh, D.G. Eeles, F.M. Collier, I. Holten, P.R. Ebeling, G.C. Nicholson, 
J.M. Quinn, Cord blood-derived macrophage-lineage cells rapidly stimulate osteoblastic maturation 
in mesenchymal stem cells in a glycoprotein-130 dependent manner, PloS one 8(9) (2013) e73266. 
1-e73266. 13.
[22] N.J. Horwood, Macrophage Polarization and Bone Formation: A review, Clinical reviews in allergy & 
immunology  (2015) 1-8.
[23] Z. Chen, X. Mao, L. Tan, T. Friis, C. Wu, R. Crawford, Y. Xiao, Osteoimmunomodulatory properties of 
magnesium scaffolds coated with β-tricalcium phosphate, Biomaterials 35(30) (2014) 8553-8565.
[24] Z. Chen, C. Wu, W. Gu, T. Klein, R. Crawford, Y. Xiao, Osteogenic differentiation of bone marrow MSCs 
by β-tricalcium phosphate stimulating macrophages via BMP2 signalling pathway, Biomaterials 35(5) 
(2014) 1507-1518.
[25] L. Gong, Y. Zhao, Y. Zhang, Z. Ruan, The Macrophage Polarization Regulates MSC Osteoblast 
Differentiation in vitro, Annals of Clinical & Laboratory Science 46(1) (2016) 65-71.
[26] P. Guihard, Y. Danger, B. Brounais, E. David, R. Brion, J. Delecrin, C.D. Richards, S. Chevalier, F. 
Rédini, D. Heymann, Induction of osteogenesis in mesenchymal stem cells by activated monocytes/
macrophages depends on oncostatin M signaling, Stem cells 30(4) (2012) 762-772.
[27] F. Loi, L.A. Córdova, R. Zhang, J. Pajarinen, T.-h. Lin, S.B. Goodman, Z. Yao, The effects of 
immunomodulation by macrophage subsets on osteogenesis in vitro, Stem cell research & therapy 
7(1) (2016) 1.
[28] E. Ivanova-Todorova, I. Bochev, M. Mourdjeva, R. Dimitrov, D. Bukarev, S. Kyurkchiev, P. Tivchev, 
I. Altunkova, D.S. Kyurkchiev, Adipose tissue-derived mesenchymal stem cells are more potent 
suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem 
cells, Immunology letters 126(1) (2009) 37-42.
[29] L.W. Wu, Y.L. Wang, J.M. Christensen, S. Khalifian, S. Schneeberger, G. Raimondi, D.S. Cooney, W.A. 
Lee, G. Brandacher, Donor age negatively affects the immunoregulatory properties of both adipose 
and bone marrow derived mesenchymal stem cells, Transplant immunology 30(4) (2014) 122-127.
[30] V. Nicolaidou, A. Cope, N. Horwood, Monocytes control mesenchymal stem cell differentation 
towards osteoblasts, Bone 44 (2009) S48.
[31] V. Nicolaidou, M.M. Wong, A.N. Redpath, A. Ersek, D.F. Baban, L.M. Williams, A.P. Cope, N.J. Horwood, 
Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast 
formation, PloS one 7(7) (2012) e39871.
[32] S. Tsuchiya, Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, K. Tada, Induction of maturation 
in cultured human monocytic leukemia cells by a phorbol diester, Cancer research 42(4) (1982) 
1530-1536.
[33] O.M. Omar, C. Granéli, K. Ekström, C. Karlsson, A. Johansson, J. Lausmaa, C.L. Wexell, P. Thomsen, The 
stimulation of an osteogenic response by classical monocyte activation, Biomaterials 32(32) (2011) 
8190-8204.
[34] K. Ekström, O. Omar, C. Granéli, X. Wang, F. Vazirisani, P. Thomsen, Monocyte exosomes stimulate the 
osteogenic gene expression of mesenchymal stem cells, PloS one 8(9) (2013) e75227.
[35] R. Pirraco, R. Reis, A. Marques, Effect of monocytes/macrophages on the early osteogenic 
differentiation of hBMSCs, Journal of tissue engineering and regenerative medicine 7(5) (2013) 
392-400.
[36] Q.-L. Ma, L.-Z. Zhao, R.-R. Liu, B.-Q. Jin, W. Song, Y. Wang, Y.-S. Zhang, L.-H. Chen, Y.-M. Zhang, Impro-
ved implant osseointegration of a nanostructured titanium surface via mediation of macrophage 
polarization, Biomaterials 35(37) (2014) 9853-9867.
[37] C. Schlundt, T. El Khassawna, A. Serra, A. Dienelt, S. Wendler, H. Schell, N. van Rooijen, A. Radbruch, 
R. Lucius, S. Hartmann, Macrophages in bone fracture healing: Their essential role in endochondral 
ossification, Bone  (2015).
[38] M.D. Swartzlander, A.K. Blakney, L.D. Amer, K.D. Hankenson, T.R. Kyriakides, S.J. Bryant, 
Immunomodulation by mesenchymal stem cells combats the foreign body response to cell-laden 
synthetic hydrogels, Biomaterials 41 (2015) 79-88.
[39] A.J. Nauta, W.E. Fibbe, Immunomodulatory properties of mesenchymal stromal cells, Blood 110(10) 
(2007) 3499-3506.
PSM 20180528 Proefschrift Yang Zhang BW.indd   66 13-06-18   17:55
Macrophage type modulates osteogenic differentiation of adipose tissue MSCs 
67
Ch
ap
te
r 3
PSM 20180528 Proefschrift Yang Zhang BW.indd   67 13-06-18   17:55
PSM 20180528 Proefschrift Yang Zhang BW.indd   68 13-06-18   17:55
Chapter 4
Toward intra-operative preparation of 
cell-based constructs for bone regeneration
Yang Zhang, Eline C Grosfeld, Winston A Camargo, Hongbo Tang, 
Angela MP Magri, Jeroen JJP van den Beucken
Submitted
PSM 20180528 Proefschrift Yang Zhang BW.indd   69 13-06-18   17:55
Chapter 4
70
Introduction
Bone tissue engineering and regenerative medicine concepts have been proposed and 
conducted for decades to meet the increasing need for bone regenerative therapies 
in clinics and to overcome the limitations of allografts and autografts [1, 2]. In view 
of the use of cell-based constructs, mesenchymal stromal cells (MSCs) [3] have been 
mostly used as an autologous cell source to boost the bone regeneration process. 
Generally, these procedures involved bone marrow isolation, MSC expansion in vitro, 
MSC seeding on a scaffold material and priming osteogenic differentiation in vitro, and 
finally implantation of MSC-based constructs into the bone defect of the patient [4]. 
This conventional approach has severe drawbacks regarding tissue harvest via bone 
marrow aspiration [5], for which an alternative in the form of liposuction has become 
available after the first reports on the existence of MSCs within adipose tissue with 
osteogenic differentiation capacities [6, 7]. The advantages of adipose tissue as a 
source for MSCs include the easy access via liposuction/-aspiration, high cell yield, and 
rapid in vitro expansion [4].
Although recent work has clearly demonstrated the feasibility and efficacy of using 
human adipose tissue MSCs to generate cell-based constructs that promote bone 
formation in pre-clinical animal studies [8, 9], this approach still is limited for clinical 
applications due to the disadvantages of the generation process. To generate MSC-
based constructs, the harvested heterogeneous cell population from fat tissue, known 
as stromal vascular fraction (SVF), requires purification and expansion in vitro to obtain 
sufficiently high cell numbers of MSCs, which is generally performed via gradient 
centrifugation, cell selection based on plastic adherence, and prolonged cell culture 
in a specific medium. All these in vitro procedures are time-consuming, costly, prone 
to decreases in cell bone forming capacity due to passaging, and risk of contamination 
and mix-up [10]. In addition, inconvenience from two surgical procedures, for 
respectively cell harvest and construct implantation, is an obstacle as well. In order 
to attain simplicity, practicality, and cost-efficiency, the manufacturing process of cell-
based constructs should ideally be compatible with the timeline of a single surgical 
procedure. In this perspective, tissue harvest, cell isolation, cell seeding onto a scaffold 
and subsequent implantation of a construct should occur within a few hours in an intra-
operative manner, without ex vivo cell culture.
SVF, the primary isolate from a lipoaspirate, is a heterogeneous mixture of stromal 
cells, endothelial cells, pericytes, lymphocytes, mast cells, and pre-adipocytes [7, 11, 
12]. Recent work has already demonstrated the feasibility of using this SVF for a one-
step surgical approach to generate cell-based constructs and showed formation of 
bone tissue and vascular structures upon implantation in femoral factures and calvarial 
defects in rats [13, 14]. From preparation to implantation, this process can be finalized 
in several hours and has shown superior bone formation compared to cell-free scaffolds 
after 8 and 12 weeks. To date, however, no scientific data report on the performance of 
SVF-based constructs compared to MSC-based constructs.
PSM 20180528 Proefschrift Yang Zhang BW.indd   70 13-06-18   17:55
Toward intra-operative preparation of cell-based constructs for bone regeneration 
71
Ch
ap
te
r 4
Upon implantation of cell-based constructs via a surgical procedure, circulating peripheral 
blood monocytes are recruited to the injury site and differentiate into activated 
macrophages participating in the bone healing [15, 16]. Activated macrophages are 
further transformed into polarized macrophages of either the M1 (pro-inflammatory) 
or M2 (pro-tissue repair) type depending on the environmental cues [17]. In that role, 
they affect the behavior of other cells by secreting factors with chemotactic, mitogenic 
and/or morphogenic activity to respectively attract other cells, stimulate cells to 
proliferate and/or induce cells to undergo differentiation [17]. This concept is currently 
being extended to generate a prevascular network in engineered bone constructs to 
accelerate vascularization and increase cell survival upon implantation of cell-based 
constructs [18-20]. Furthermore, several studies have shown that monocytes stimulate 
the osteogenic differentiation of adipose tissue MSCs [21, 22]. This observation justifies 
further translational research on the applicability of co-culture strategies using these 
two types of ‘easy access cells’, i.e. SVF and monocytes, to intra-operatively prepare 
bone constructs with superior osteogenic potential.
Here, we isolated both SVF and ADMSCs and prepared ADMSC-based constructs in the 
conventional manner (i.e. within vitro expansion culture) as well as SVF-based constructs 
in an intra-operative manner by combining either cell type with ceramic granulate, 
after which we comparatively evaluated their bone regenerative performance in a 
rat femoral condyle bone defect model. Additionally, we added human monocytes to 
these constructs to analyze potential beneficial effects on bone regeneration. We firstly 
evaluated the cellular interaction of human SVF and ADMSCs with human monocytes 
in vitro. To demonstrate feasibility and efficacy of the intra-operatively available 
constructs, we then comparatively treated bone defects with these constructs and 
evaluated bone regeneration histologically and histomorphometrically. 
Materials and methods
1. Human cell isolation and culture
Human subcutaneous adipose tissue was obtained in the form of a fat patch from 
the Department of Plastic Surgery (Radboudumc) after ethical approval (Commissie 
Mensgebonden Onderzoek; dossier number #3252) and informed consent. The 
adipose tissue was excised into pieces and then minced in a 0.1% collagenase type II 
(Mannheim, Germany) solution with 1% bovine serum albumin (BSA, Sigma, St. Louis, 
USA) for 1 hour at 37°C under shaking conditions, as described previously [23]. After 
centrifugation at 600g for 10 min at room temperature, the supernatant together with 
the fat layer was discarded. The resulting cell pellet was washed twice with phosphate 
buffered solution (PBS; Gibco, Merelbeke, Belgium) with subsequent filtration through 
a polypropylene membrane with a pore size of 100 µm. After centrifugation, the cell 
pellet was suspended in proliferation medium, consisting of α-MEM (Gibco, Merelbeke, 
Belgium) containing 10% fetal bovine serum (FBS; Gibco, Carlsbad, USA). Red blood 
cells were lysed by incubation for 2 min in a solution of 7.49 g/L NH4Cl (2.06 g/L Tris 
Base, pH 7.2). Following centrifugation, the deposited cell aggregates were denoted as 
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SVF, suspended in proliferation medium, and counted using a Neubauer chamber. This 
SVF was either frozen as 3× 106 cells per tube in the liquid nitrogen or used for further 
culturing to obtain a homogeneous population of ADMSCs.
For culturing, SVF containing 3× 106 cells was plated in 75 cm2 tissue culture flasks 
(Greiner Bio-one, Frickenhausen, Germany) in proliferation medium supplemented 
with 1 ng/ml of bFGF (Sigma-Aldrich, St. Louis, USA). Cells were grown in a humidified 
incubator at 37°C in an atmosphere of 5% CO2. Two days after seeding, the adherent cells 
were thoroughly rinsed with PBS to remove non-adherent cells from the culture. In this 
way, a homogeneous population of ADMSCs was obtained. When reaching around 80% 
confluency, cells were detached with 0.05% trypsin in 0.5mM EDTA (Sigma-Aldrich, St. 
Louis, USA) and were passaged. SVF and ADMSCs were characterized for surface marker 
expression by flow cytometry for the mesenchymal markers CD73 (APC-conjugated, 
BD Bioscience), CD90 (PE-Cy5-conjugated, BD Bioscience), CD105 (PE-conjugated, 
BD Bioscience, Franklin Lakes, USA), and negatively against CD45 (PE-conjugated, BD 
Bioscience). Osteogenic differentiation capacity of ADMSCs was confirmed by 4-week 
cultures in osteogenic medium (proliferation medium supplemented with 10 nM 
dexamethasone, 100 µM ascorbic acid, and 10 mM β-glycerophosphate).
The human monocytic cell line THP-1 was purchased from the American Type Culture 
Collection (ATCC; Manassas, USA) and cultured in RPMI-1640 medium (Gibco, Carlsbad, 
USA) supplemented with 10% FBS.
2. Scaffold for constructs preparation
Tricalcium phosphate (β-TCP) granules were kindly provided by Cam Bioceramics 
(Leiden, the Netherlands). Pore sizes of TCP granules varied from 500 µm - 2 mm 
and the granules had an overall porosity of 84%. After sterilization by gamma 
irradiation (SynergyHealth, Ede, the Netherlands), 11 mg (total volume around 21 mm3 
corresponding to the bone defect size for in vivo experimental work) of these granules 
per sample were placed into individual wells of a non-adherent well plate.
3. Procedure for construct preparation
Before construct preparation, 3 × 106 SVF cells in the liquid nitrogen were unfrozen 
and suspended in 300 µl proliferation medium to be loaded onto TCP granule. This 
group named as SVF groups. Purified ADMSCs from SVF were expanded in proliferation 
medium with bFGF as described above. Osteogenic medium was applied for ADMSCs 
3 days before preparation. 1 × 106 ADMSCs suspended in 300 µl proliferation medium 
were then loaded onto the same scaffold and nominated as ADMSCs group. All wells 
were then supplemented with 300 µl proliferation medium and incubated at 37 °C for 
2 hours. Non-attached cells were collected and loaded onto granules again every hour. 
Cell attachment was confirmed through 4’, 6-diamidino-2-phenylindole (DAPI) staining 
and was quantified by DNA content to ascertain the comparable number of attached 
cells. After 2h incubation, 1 × 106 monocytes suspended in 200 µl proliferation medium 
were added to the SVF or ADMSCs constructs to make SVF+MO and ADMSCs+MO 
group. Same constructs for animal study were achieved by directly adding monocytes 
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to the defect sites during the surgery. TCP granules supplemented with the same 
amount of proliferation medium or 1 × 106 monocytes only were set as control and MO 
group respectively (Figure. 1A). Then all constructs were ready either for in vitro study 
or for implantation. 
4. In vitro assessment
4.1 cell adhesion and viability on constructs 
Cell attachment and cellular morphology on constructs were checked before 
implantation by identifying nuclei and actin of attached cells. The scaffolds were 
incubated in 20 µM Alexa Fluor® 568 Phalloidin (Thermofisher Scientific, Breda, 
Netherlands) for 15 min and in 300 nM DAPI stain for 5 min and then quantified with 
a Zeiss AxioPlan immunofluorescence microscope (Carl Zeiss Microimaging GmbH, 
Gottingen, Germany). Additionally, cell viability was assessed using a LIVE/DEAD® 
viability/cytotoxicity kit for mammalian cells (Invitrogen, Gaithersburg, MD, USA) 
according to the manufacturer instructions.
4.2 cell proliferation and osteogenic differentiation on constructs
 Constructs from above 6 groups were cultured in osteogenic medium up to 4 weeks. 
After washing with PBS once, constructs were placed in 1 ml MilliQ and subjected 
to two cycles of freezing and thawing. Cell proliferation was evaluated by assessing 
the DNA content using a DNA quantification kit (Invitrogen, Carlsbad, CA) according 
to manufacturer’s instructions. Osteogenic differentiation of all constructs was 
analyzed by quantification of alkaline phosphatase (ALP) activity of cell lysates using a 
4-nitrophenyl phosphate based method [23] after 1, 2 and 4 weeks of culture. To test 
mineralization, same type and number of cells without TCP granules were seeded in 
24-wells cell culture plates. After 4 weeks, mineralization was evaluated by deposit 
calcium as described earlier [23].
4.3 effect of SVF or ADMSCs on macrophages polarization
To assess the effect of SVF or ADMSCs on macrophages polarization, 1 × 106 ADMSCs 
or 3 × 106 SVF were seeded on 11 mg TCP granules for 2 h as described above. These 
cell-loaded constructs and TCP granules were then transferred into 0.4-mm-pore size 
Corning transwell inserts (Sigma-Aldrich, Zwijndrecht, the Netherlands) and placed into 
the 24-well plates where 1 × 106 THP-1 monocytes were seeded with 250 nM PMA 
(monocytes were activated into macrophages) for 48 hours in advance. Co-cultures 
were incubated for another 48 h. Wells supplemented with 100 ng/ml LPS (Sigma-
Aldrich, St Louis, MO, USA) and 30 ng/ml IFN-g (Sigma-Aldrich, St Louis, MO, USA) or 
20 ng/ml IL-4 (Sigma-Aldrich, St Louis, MO, USA) and 20 ng/ml IL-13 (Sigma-Aldrich, St 
Louis, MO, USA) were set as control. The secreted TNF-α and TGF-β in the supernatants 
were evaluated using ELISA kits (e-Bioscience, San Diego, CA, USA) according to the 
manufacturer’s instructions.
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5. Animal surgery
The study was approved by the Centrale Commissie Dierproeven (CCD; project 2015-
137), national guidelines for animal care and welfare were obeyed, conforming to the 
ARRIVE guidelines. A total of 48 nude rats (Crl:NIH-Foxn1rnu, Charles River) weighing 
between 250g and 300g were used in the present study. All rats were pre-medicated 
with an intramuscular injection (5 mg/kg) of carprofen. General anesthesia with nitrous 
oxide, oxygen and isoflurane were applied during the surgery. Bone defects were 
surgically created (3 mm diameter, 3 mm depth) bilaterally in the femoral condyles using 
a 3-mm trephine burr (Hager & Meisinger GmbH, Neuss, Germany) at low rational speed. 
The implants were randomly placed into defects and the soft tissue incision was closed 
with superficial sutures. In all cases, the transplantation was performed within 4 hours. 
After surgery, 150 mg/kg buprenorphine (Temgesic, Schering-plough, Amstelveen, 
the Netherlands) was subcutaneously given for 2 days to reduce postoperative pain. 
2 rats died in the surgery. 4 and 10 weeks after implantation, 46 rats were sacrificed 
by inhalation of CO2. The constructs with surrounding tissue were harvested and fixed 
in a 4% formalin buffer for 48 hours. One sample from each group was randomly 
selected and then dehydrated and embedded in paraffin for histochemistry and 
immunohistochemistry process. The rest of samples were randomly distributed, 
dehydrated and embedded in polymethyl methacrylate (PMMA) for the histological 
process.
6. Histological and histomorphometric analysis
After fixation, certain specimens were dehydrated in a graded series of ethanol and 
embedded in PMMA without decalcification. Specimens were sectioned longitudinally 
(335 um thick) using a diamond saw (Leica Microsystems SP 1600, Nussloch, Germany). 
Three sections representative of the center of the defect and subcutaneous sample 
from each specimen were then stained with methylene blue/basic fuchsin to evaluate 
new bone formation. Stained samples were further photographed with Zeiss Imager 
Z1 microscope equipped with the Axiocam camera using AxioVision 4.8 software. 
After that, the bone formation percentage (BF) was determined in stained sections 
using an automated image-analysis system (Leica Qwin Proimage analysis system, 
Wetzlar, Germany) which recognize bone tissue based on different RGB values from 
highly magnified images. Minor manual corrections were made to ensure the precise 
selection of newly formed bone in the defects. The percentage of new bone formation 
was measured by normalized to initial defect area measured from the cross-section.
7. Immunohistochemical and histochemical staining
After fixation, one sample from each group was decalcified in an EDTA solution, 
dehydrated in a series of alcohol and embedded in paraffin. The specimens were sec-
tioned in at a thickness of 5 µm and stained with hematoxylin and eosin for conventional, 
qualitative bright field light microscopy analysis. Sections were further stained with 
Masson’s trichrome and observed by light microscopy as well. For immunostaining, 
paraffin sections were rehydrated in serials of ethanol and antigen was retrieved in 
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sodium citrate buffer (PH 6.0) at 70°C for 10 min. Subsequently, slides were blocked 
with 10% normal donkey serum (NDS) and then incubated with the primary antibody 
overnight at 4°C. Slides were then treated with a biotin-conjugated secondary antibody 
(Chemicon, Temecula, USA) for 1h at room temperature, followed by counterstaining 
with hematoxylin. Negative controls using 2% NDS instead of the primary antibody 
were generated in parallel to ensure that the staining was specific. Finally, the sections 
were dehydrated and mounted. Stained sections were photographed with the same 
Zeiss Imager Z1 microscope. To detect human cells in the constructs implanted in rats, 
immunostaining was performed using human specific anti-mitochondria antibody 
(EMD Millipore, No. MAB1273, Amsterdam-Zuidoost; diluted 1:200) as protocol 
indicated. Human and rat skin sections were used as positive and negative controls, 
respectively. The presence of human origin macrophages was assessed by using human 
specific mouse anti-human CD68 (Dako, Leuven, Belgium; diluted 1:200). For blood 
vessel staining, monoclonal anti-actin, α-smooth muscle antibody (α-SMA, Sigma-
Aldrich, No. A2547, Billerica, USA; diluted 1:128,000) were performed. For Tartrate-
resistant acid phosphatase (TRAP) staining, sections were deparaffinized, rinsed in 
PBS and incubated with a solution containing 50 mM sodium acetate (pH 5.2), 0.15% 
Naphtol-AS-TR-phosphate, 50 mM sodium tartrate, and 0.1% Fast Red T.R. (Sigma-
Aldrich Chemie Gmbh, Taufkirchen, Germany) for 30 - 40 min at room temperature. 
Subsequently, the sections were rinsed in PBS and counterstained.
8. Statistical analysis
Data are presented as means ± standard deviations (SD). Statistical analysis was 
performed using a one-way ANOVA with Graphpad Prism 5 software. When ANOVA 
indicated a significant difference between different groups, Tukey Post-hoc Multiple 
Comparisons were performed. The unpaired test was used to compare the calcium 
content between SVF and ADMSCs. P values < 0.05 were regarded as significant.
Results
1. Comparative characterization of human ADMSCs and SVF
After regular digestion, filtration and centrifugation steps of a fat patch, we obtained 
260 × 106 SVF cells from 400 ml lipoaspirate. To obtain purified ADMSCs, we seeded 
6 × 106 SVF cells per tissue culture flask for cell selection based on adherence and 
culture with proliferation medium. To characterize the SVF population, we performed 
cytofluorimetric analysis in comparison with conventionally purified ADMSCs. The 
analysis of stromal cell markers (CD73, CD90, and CD105) showed consistent presence 
of stromal cells in SVF and stromal cells took up around 1/3 of the SVF population 
(Figure S1).
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Figure 1. Construction of intraoperative preparation and conventional strategy based bone grafts. (A) 
Cell number used for each construct preparation. (B) Schematic structure of the experimental design. PM, 
proliferation medium; OM, osteogenic medium; EPCs, endothelial progenitor cells; ECs, endothelial cells; 
MCs, mast cells; HPSCs, hematopoietic stem/progenitor cells. (C) Time line toward to the intraoperative 
preparation of cell-based bone grafts. These constructs can be made within 4 hours. Cell attachment was 
confirmed by DAPI staining. Monocytes were added to the defect sites when SVF-based constructs were 
loaded into femoral defects (yellow dashed circle).
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2. Preparation of constructs and viability assessment
To prepare SVF constructs, we seeded 3 × 106 SVF cells on 21 mm3 TCP granules and 
incubated these in proliferation medium for 2 hours to allow for cell attachment. 
Similarly, we seeded 1 × 106 ADMSCs similarly on TCP granules to obtain a comparable 
number of stromal cells on each construct. Subsequently, we added 1 × 106 monocytes 
to the SVF and ADMSC constructs in the wells in vitro or to the constructs in the 
defects in vivo (Figure 1A). Based on the design, from the isolation of SVF cells and 
peripheral blood monocytes till implantation of SVF-based constructs with monocytes, 
this procedure can be performed within 4 hours (Figure 1B & C). In contrast, the 
conventional ADMSC-based approach takes at least 10 days. To assess cell attachment 
to the prepared constructs, we performed nuclei and actin staining. Cells showed 
homogeneous distribution over the surface of granules (Figure S2). Cell viability after 
2h in vitro incubation demonstrated that the majority of cells attached to the scaffold 
were viable, without apparent differences in dead cells between the experimental 
groups (Figure S2).
3. Monocytes promote osteogenic differentiation of SVF and ADMSCs
To study cellular behavior upon effect of cell-cell interactions between monocytes 
and SVF or ADMSCs, we cultured cell-loaded constructs in osteogenic medium for 
up to 4 weeks and assessed cell proliferation (DNA content; Figure 2A), osteogenic 
differentiation (ALP-activity; Figure 2B), and mineralization (calcium assay; Figure 2C). 
SVF and ADMSCs cultures showed similar cell proliferation profiles. In contrast, cultures 
containing monocytes showed a significantly increased proliferation. Additionally, 
whilst monocyte monocultures did not show ALP-activity, monocytes slightly increased 
ALP- activity in co-cultures with either SVF or ADMSCs. Monocytes further significantly 
increased mineralization in co-cultures with either SVF (~2-fold) or ADMSCs (~1.5-fold) 
compared to SVF and ADMSCs monocultures, respectively.
4. SVF cells and ADMSCs induce distinct polarization of monocytes/macrophages
In parallel with our experiments focused on the effect of monocyte addition to 
either SVF or ADMSC cultures, we oppositely focused on effects of SVF or ADMSCs 
on monocytes activation and polarization. Therefore, we set up an in vitro culture 
model [24, 25] and analyzed macrophage polarization via cytokine expression profiles 
of the pro-inflammatory M1 macrophage cytokine TNF-α and the pro-wound healing 
M2 macrophage cytokine TGF-β (Figure 3A), using conventional induction into M1 
macrophage polarization via LPS+IFN-γ and into M2 macrophage polarization via 
IL-4+IL-13 stimulation as controls. TCP granules used as cell carrier material in our 
experiments induced polarization into a pro-inflammatory M1 macrophage, while SVF 
and ADMSCs induced macrophage polarization toward the pro-wound healing M2 
type (Figure 3B & C). The ratio TGF-β/ TNF-α (Figure 3D) clearly shows the overall M2 
macrophage polarization stimulation, particularly by SVF.
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5. Cell-based constructs enhance early bone healing
To assess the bone regeneration capacity, we implanted control, MO, SVF, SVF+MO, 
ADMSCs, and ADMSCs+MO constructs (n ≥ 7 for each group) into rat femoral defects 
(3 mm in diameter, 2.8 mm in depth) and evaluated bone regeneration histologically 
and histomorphometically after 4 and 10 weeks. Methylene blue/basic fuchsin staining 
(Figure 4A) displayed substantial amounts of newly formed bone at the defect margins 
Figure 2. In vitro cell behavior of SVF and ADMSCs 
upon co-culture with monocytes. (A) Cell 
proliferation quantified by DNA content (n = 4; *** 
< 0.001, ns, no significant difference). (B) Osteogenic 
differentiation of SVF, ADMSCs monoculture or co-
culture with monocytes quantified by ALP activity 
(n = 4; * < 0.05; *** < 0.001). (C) Cell mineralization 
after 4 weeks quantified by calcium content (n = 4; * 
< 0.05; *** < 0.001).
Figure 3. In vitro cell behavior of 
monocytes upon co-culture with 
SVF or ADMSCs. (A) Schematic 
diagram of SVF and ADMSCs 
indirectly co-cultured with 
macrophages by a transwell. (B) 
Quantification of pro-inflammatory 
cytokine TNF-α in the co-culture 
medium (n = 6; ** p < 0.01; *** < 
0.001). (C) Quantification of anti-
inflammatory cytokine TGF-β in 
the co-culture medium (n = 6; ** 
p < 0.01; *** < 0.001). (D) Ratio 
of TGF-β/TNF-α (n = 6; ** p < 
0.01). LPS and IFN-γ induced M1 
macrophages and IL-4 and IL-13 
induced M2 macrophages were set 
as control respectively.
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in between the voids of TCP granules in all SVF and ADMSC constructs after 4 weeks, 
irrespective of monocyte addition. In contrast, control and MO constructs showed 
limited amounts of newly formed bone. Histomorphometrically, SVF (34.5 ± 8.6%) 
showed similar amounts of new bone formation to ADMSCs (27.1 ± 6.0%; P < 0.05), 
both of which regenerated approximately 3 times more bone compared to control and 
MO (Figure 4B).
We further assessed the contribution of SVF and ADMSCs to bone formation using 
specific anti-human mitochondrial staining to detect human cells (i.e. SVF, ADMSCs and 
monocytes) in the bone defect (Figure 4C and Figure S3). SVF and SVF+MO constructs 
clearly showed the presence of human cells in the vicinity of the TCP granulate and 
newly formed bone, but not within the newly formed bone. This positive staining for 
human cells originated from SVF, as we observed no positive staining for the human 
monocyte/macrophage marker CD68 (Figure S4) nor for the osteoclastic marker TRAP 
(Figure S5). In contrast, ADMSCs and ADMSCs+MO constructs showed no human cells 
within any of the histological sections.
Figure 4. Overview of histology and histomorphometric after 4 weeks implantation in a rat femoral 
condyle bone defect. (A) Representative histological sections (methylene blue/basic fuchsin); (blue 
dashed circle indicates original bone defect, black arrow indicates TCP granulate, white arrow indicates 
newly-formed bone; scale bar = 500 µm). (B) Histomorphometric analysis of bone area (BA) within the 
original defect (n = 7 or 8; *p < 0.05; ** < 0.01). (C) Immunostaining for anti-human mitochondria (top 
panels; yellow arrows indicate positive staining) and anti-alpha SMA (bottom panels; green arrows indicate 
positive staining; bar = 500 µm).
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With vascularization as an essential part of bone formation [26, 27], we used α-SMA 
staining to evaluate blood vessel formation. SVF and ADMSCs constructs showed 
apparently larger vessel-like structures compared to control and MO constructs, which 
suggests beneficial effects of SVF and ADMSCs on the vascularization of implanted 
constructs (Figure 4C).
6. SVF constructs show complete bone defect healing
At 10 weeks post implantation, SVF constructs (w/- MO) exhibited complete healing of 
the defect site with newly formed bone present throughout the entire defect area (Figure 
5A). In contrast, ADMSCs (w/- MO) showed substantial bone ingrowth centripetally 
from the original defect edge toward the defect center without presence of newly 
formed bone in the center. Control and MO constructs still showed large defect areas 
containing fibrous connective tissue with only sparse bone formation at the edge of 
the original defect. Residual TCP granulate was still present in non-healing defects and 
integrated with new bone in SVF and ADMSCs constructs. Quantitative analysis of new 
bone formation by histomorphometry (Figure 5B) revealed superior amounts of newly 
Figure 5. Overview of histology and histomorphometric after 10 weeks implantation in a rat femoral 
condyle bone defect. (A) Representative histological sections (methylene blue/basic fuchsin); (blue 
dashed circle indicates original bone defect, black arrow indicates TCP granulate, white arrow indicates 
newly-formed bone; scale bar = 500 µm). (B) Histomorphometric analysis of bone area (BA) within the 
original defect (n = 7 to 8; *p < 0.05; ** < 0.01). (C) Immunostaining for anti-human mitochondria (top 
panels) and anti-alpha SMA (bottom panels; green arrows indicate positive staining; bar = 500 µm).
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form bone for SVF and SVF+MO constructs (64.9 ± 9.1% and 66.3 ± 6.0%, respectively) 
compared to ADMSCs (45.4 ± 3.7%; P < 0.05), ADMSCs+MO (55.2 ± 10.6%; P < 0.05), MO 
(17.3 ± 8.0%; p < 0.01), and control (17.2 ± 9.0%; p < 0.01) constructs. Further, ADMSC 
and ADMSC+MO constructs showed significantly higher bone formation compared to 
MO (p < 0.01) and control constructs (p < 0.01).
Anti-human mitochondrial staining to detect cells of human origin demonstrated 
absence of human cells for any type of implanted construct after 10 weeks (Figure 5C). 
Based on α-SMA staining to assess vascularization, constructs with SVF or ADMSCs 
apparently gained more organized and elongated vessel-like structures (Figure 5C). 
Different to our observations after 4 weeks of implantation, osteoclastic activity was 
abundantly present in all defects containing cell-based constructs and only to a limited 
extent in control constructs (Figure S5).
Discussion
 
Cell-based bone tissue engineering, especially with the application of adipose tissue 
derived MSCs, represents an appealing alternative for the current best practice 
treatments using auto-/allografts for bone regeneration. This approach, however, 
is challenged by complex, impractical and expensive in vitro cell handling. Aiming to 
circumvent these, we followed an intra-operative approach based on stromal vascular 
fraction from fat tissue, as described recently [13, 14, 28]. However, the efficacy of 
this intra-operative approach has not been directly compared to conventional ADMSC-
based method. As another type of ‘easy access’ cells with potential stimulatory effects 
on wound healing and stromal cell differentiation [21, 22], we explored the addition of 
monocytes to both ADMSC- and SVF-based constructs both in vitro and in vivo using a 
rat femoral condyle bone defect model.
SVF is reported to be a heterogeneous mixture of MSCs, endothelial progenitor cells, 
pericytes, mast cells, pre-adipocytes, and other cell types [7, 12]. From flow cytometry 
and in vitro cell culture results, we proved that MSCs take up around 1/3 of the whole 
SVF population, which corroborates previous reports [29-31]. Consequently, we 
prepared constructs containing 3 million SVF cells or 1 million purified ADMSCs to 
compare their osteogenic potential in vitro and bone regeneration capacity in vivo. 
In vitro mineralization demonstrated a similar osteogenic potential between SVF and 
ADMSCs. In contrast, although both SVF and ADMSCs improved bone defect healing 
compared to cell-free controls, data from our in vivo work demonstrated superiority 
of SVF-based constructs over ADMSC-based constructs regarding bone regenerative 
capacity. This difference between in vitro and in vivo results suggests that in vitro 
osteogenic differentiation capacity is not predictive for in vivo bone healing capacity. 
The synergetic effect of endothelial progenitor cells and pericytes contained in SVF 
probably plays an important role in the superiority of SVF-based bone healing [30, 32]. 
An important observation, likely related to the superior bone regeneration for SVF and 
SVF+MO constructs, is the prolonged presence of SVF cells in the bone defect region 
compared to ADMSCs.
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Speculating about the mechanism of SVF- and ADMSCs-based bone regeneration, our 
results and those of others [33] indicate that direct differentiation of grafted cells into 
bone forming osteoblasts or eventually embedded osteocytes seems very unlikely. 
Further, it has been postulated that the grafted cells provide osteoinductive signals 
or act as a source of trophic factors to modulate microenvironments [34-36]. Here, 
we did not observe grafted human cells within the newly formed bone, ruling out the 
mechanism of direct differentiation of SVF or ADMSCs into bone forming osteoblasts 
or osteocytes. Consequently, we speculate that SVF and ADMSCs exerted a certain 
paracrine effect on surrounding host cells to stimulate bone regeneration. The exact 
paracrine factors secreted by these implanted cells responsible for bone healing are 
largely unknown yet due to the complexity of in vivo conditions. Still, few pioneering 
reports indicated several possible roles of grafted cells, such as promoting progenitor 
cells migration [15, 16], benefiting vascularization [34, 37] and modulating immune 
response [38-40], to stimulate bone formation. In this study, SVF and ADMSCs 
activated and polarized monocytes/macrophages into anti-inflammatory phenotype as 
proved in in vitro co-culture experiment, which correspondingly led to more profound 
vascularization and bone formation compared to constructs without SVF and ADMSCs 
in vivo. The coincidence of superior immunoregulatory effect and more remarkable 
bone regeneration capacity by grafted SVF warrants further investigations into the 
mechanisms underlying the immunoregulatory capacity of grafted cells in bone healing.
Once a bone fracture occurs, circulating monocytes travel to the injured sites within 
several hours, become activated macrophages and contribute to various aspects of 
the healing process [41, 42]. Due to their reported beneficial effects on osteogenic 
differentiation [21, 22] and the fact that monocytes are easily accessible via a venous 
puncture, the concept of harnessing the power of monocytes/macrophages for 
bone tissue engineering has been proposed by several researchers [19, 38], but has 
never been applied for cell-based bone regeneration. Our study also confirmed their 
beneficial effects on in vitro osteogenic differentiation, evidenced by significantly 
higher ALP-activity and mineralization in co-cultures with SVF or ADMSCs. Interestingly, 
monocytes exerted a more obvious effect on SVF compared to ADMSCs, which 
indicates the different cell status (undifferentiated and differentiated), cell components 
(heterogeneous and homogenous), and cell-cell interaction of SVF compared to 
ADMSCs. Nonetheless, in our orthotopic animal model, we did not observe this 
favorable effect on bone regeneration following monocyte addition. As we did not 
observe specific immunostaining for human monocytes/macrophages in any of our 
histological sections (Figure S3), this might be explained by the short duration of 
exogenously added monocytes present in the defects, the relatively limited half-live of 
this cell life, and less adhesive properties compared to stromal cells [43, 44].
Our study also has several limitations. First, we used human monocytes from a cell line 
rather than human primary monocytes considering the experimental feasibility and 
reproducibility. Although THP-1 has been proven as an ideal research cell culture model 
for primary monocytes [45], further studies are needed to analyze the behavior of SVF 
and ADMSCs co-cultured with primary monocytes. Secondly, SVF- and ADMSC-based 
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constructs enhanced bone formation after 4 weeks, which suggests that the seeded 
cells function in the early post-implantation stage. Therefore, observation of host 
response (i.e. cell infiltration, vascularization and macrophage phenotype) at earlier 
time points would likely provide more clarity on the potential immunoregulatory role 
of grafted cells in bone healing. In addition, due to the component similarity and close 
distribution between TCP and newly formed bone, it is not practical to use regular 
X-ray or Micro CT to provide additional information on bone mineralization and defect 
healing. The advanced technology such as Nano CT and contrast reagents can be 
applied in the future study to analyze new bone formation in real-time.
Compared to simply focusing on outcome of cell-based bone tissue engineering in most 
studies, our study put more emphasis on viewing their potential for clinical applications. 
Since both SVF and monocytes are easily accessible and isolated during the surgical 
procedure itself and can be isolated via standard procedures, this strategy meets the 
requirements of “good manufacturing practice” and “during the same visit” defined 
by the concept of intraoperative preparation, making this approach more feasible for 
clinical applications and permissible from a regulatory perspective. In addition, an 
intra-operative method likely reduces the high-cost associated to ex vivo cell expansion 
and its safety was confirmed in various clinical applications [13, 46]. Although further 
experiments are needed, for instance to precisely define the composition of SVF and 
to apply this approach in more bone defect models, this ‘easy access cells’ based intra-
operative approach and its superior bone regenerative capacity will greatly innovate 
the concept, design, and development of cell-based bone tissue engineering and 
regenerative medicine.
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Introduction
Implants for the replacement and fixation after bony fractures have become a general 
treatment modality in the current dental and mainly orthopedic clinic, respectively. 
Generally, these bone implants are made from metallic materials that allow to withstand 
mechanical forces. Among the metallic materials used for bone implant preparation, 
titanium (Ti) presents excellent biocompatibility and high mechanical strength [1, 
2]. Also, from the biological perspective, orthopedic Ti implants can be improved by 
combining different surface modifications [3]. In view of this, research efforts have 
focused on the effect of surface modifications for implant surfaces to promote implant 
integration within the native bone tissue [2, 4-6].
The nature of these surface modifications can be categorized as either physical (e.g. 
roughness or topography) or chemical (e.g. coatings). In this way, titanium implants 
coated with different physiochemical properties can stimulate the osseointegration 
ability, directly affecting the performance and clinical success of the implant [3]. In this 
context, calcium phosphate ceramics (CaPs) are the appealing group of materials for the 
deposition of coatings for bone implants. Many studies have shown that CaP coatings, 
particularly those based on hydroxyapatite (HA), β-tricalciumphosphate (β-TCP), or 
combinations thereof, provide a favorable microenvironment for the interaction of 
the implant surface with the bone tissue, allowing an accelerated and more effective 
integration of such implants in the surrounding bone tissue [7-9].
Upon implantation, any biomaterial induces a cascade of events initiated by the 
activation of platelets and inflammatory cells (e.g. macrophages and foreign body giant 
cells) [10-13].Within this cascade of events, the challenge for the biomedical engineering 
field is to optimize the initial inflammatory events toward an effective regenerative 
phase, and hence achieve an improved performance of biomedical devices [10, 14]. In 
the initial inflammatory events, platelets play an active role in the immunological and 
inflammatory aspect of tissue healing in normal hemostasis as well as in host defense. 
Platelets can be directly involved in the inflammatory response by the production 
and release of several inflammatory mediators, including a variety of cytokines and 
chemokines. Platelet activation results in stimulation of various leukocytes, including 
macrophages [15]. Beside platelets, macrophages also contribute to tissue homeostasis 
by clearance of injured host components and to defense against infection. Once out of 
the circulation and in the tissue at a wounded site, macrophages can acquire different 
morphologies and functionalities in response to pathogens and local environment 
stimuli. Two major macrophage subpopulations have been defined in vitro, designated 
as either classically activated macrophages (M1) or alternatively activated macrophages 
(M2) [16]. Classically activated M1 induced by lipopolysaccharide (LPS), interferon 
(IFN)-γ or tumor necrosis factor alpha (TNF) are associated with the first phases of 
acute inflammation. This macrophage subtype is characterized by the secretion of 
pro-inflammatory cytokines, Tumor necrosis factor-α (TNF-α), inducible nitric oxide 
synthase (iNOS or NOS2), reactive oxygen species (ROS), reactive nitrogen intermediates 
(RNI), promotion of Th1 responses, and strong microbicidal and tumoricidal activity 
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[17]. In contrast, alternatively activated M2 macrophages are characterized by 
increased phagocytic activity, high expression of scavenging, mannose and galactose 
receptors, production of ornithine and polyamines through the arginase pathway, a 
distinct chemokine repertoire (e.g., CCL17, CCL18 and CCL22) and an IL-12lo, IL-10hi, IL-1, 
decoyRhiIL,1RAhi phenotype [18].
The role of implant surface properties in the initial phase after implantation is largely 
unknown. However, it is generally accepted that the physical-chemical properties of 
a biomaterial surface (e.g. microporosity, surface roughness, coating chemistry and 
solubility), the inflammatory response evoked in the tissue (i.e. platelet adhesion and 
activation and inflammatory responses), the design and size of the medical device, 
and the anatomical site in which it will be inserted [8, 13, 19] are major determinants 
for implant success. There is a vast amount of evidence that CaP biomaterials with 
osteogenic properties have enormous potential in bone healing, reducing the chances 
of complications and time to repair. Urquia Edreira et al. [20] evaluated the effect of 
CaP sputter-coatings with different phase composition in an in vitro and in vivo study. 
Their data demonstrated that the differences in physico-chemical properties of the 
coatings affect both in vitro and in vivo results. One of the CaPs, the hydroxyapatite 
(HA), has been widely used to improve the bioactivity and osseointegration of metallic 
implants since it is an osteoconductive material capable of enhancing the bond with the 
surrounding bone tissue [21]. Several studies show positive effects on osseointegration 
of HA-coated metallic implants [21-23]. In addition, β-TCP is another widely used CaP 
that has osteoconductivite properties to be used as a coating for Ti implants. Several 
studies demonstrated greater ability to form new bone after being implanted in the 
body [24-26].
Although several studies have shown the effects of HA and TCP as coatings of metallic 
implants, the initial response of blood-born components (i.e. platelets and monocytes/
macrophages) are largely neglected by many researchers evaluating bone response 
after implantation of a biomaterial. Consequently, we here evaluated biomaterial 
surface property effects on the response of blood-born components that account 
for the initial biological cascade of events following implantation. We used in vitro 
experiments with human platelets and monocytes/macrophages to investigate (i) 
platelet adhesion, and (ii) monocyte/macrophage morphology, proliferation, cytokine 
secretion and polarization, using either unmodified or CaP-coated Ti discs. We 
hypothesized that CaP-coated discs (HA or β-TCP) would alter the initial response of 
blood-born components and platelet adhesion and macrophage secretion/polarization 
in favor of wound healing. 
Materials and methods
1. Material preparation and characterization
Commercially available pure Ti discs (99.9 wt% Ti, thickness 1.5 mm, diameter 12 mm) 
were Al2O3 grit-blasted before deposition. The target materials used in the deposition 
process for the coating were hydroxyapatite (HA; Ca10(PO4)6(OH)2) granulated powder 
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obtained from CAMCERAM® (CAM Bioceramics, Leiden, the Netherlands; low 
porous granules 500-1000µm) and β-tricalcium phosphate (β-TCP; Ca3(PO4)2) (CAM 
Bioceramics, Leiden, the Netherlands). The solubility product constant (Ksp) of HA and 
TCP is 10-116.8 mol/L and 10-28.9 mol/L respectively. As a control, Ti discs and Thermanox 
coverslip (Diameter: 13 mm; thickness: 0.2 mm; use with a 24-well multi-dish; Thermo 
Scientific Nunc®) were used. The coatings for this study were deposited using RF 
magnetron sputtering equipment (Edwards High Vacuum ESM 100 system, Crawford, 
England) as described previously [20, 27-29]. Before deposition, the discs were cleaned 
ultrasonically in acetone and propanol to remove impurities. Subsequently, the discs 
were placed on a rotating holder and the coating deposition process with HA and β-TCP 
were initiated (sputtered target: HA and β-TCP; distance between target and implants: 
80 mm; power: 400W; working gas: Argon; pressure: 5.0 x 10-3; treatment time: 10 
hours for HA deposition and 13 hours to (β-TCP deposition). After sputtering, the discs 
received a heat-treatment of 15s in air at final heating temperature of up to 600oC 
using an infrared furnace (Quad Ellipse Chamber, Model E4- 10-P, Research, MN) [20]. 
Infrared irradiation was carried out under pure argon flow as described by Yoshinari et 
al. [30].
2. Surface analysis
Ti discs, HA and β-TCP coated discs were morphologically inspected by field emission 
scanning electron microscopy (FE-SEM; JEOL 6310, Nieuw-Vennep, the Netherlands). 
Additionally, thickness and roughness of the coatings (quadruplicate samples, n=4) 
were measured using a Universal Surface Tester (UST®, Würzburg, Germany).
3. Physico-chemical characterization and stability of the coatings
The crystal structure of each specimen was determined by X-ray diffraction (XRD, 
Phillips, PW3710, Eindhoven, the Netherlands) using CuKα radiation (power: 40 kV; 
current: 30 mA). In addition, infrared spectra of the coatings were obtained by a 
reflection Fourier transform infrared spectrometer (FTIR, Perkin Elmer, Spectrum Two, 
Groningen, the Netherlands).
For analyzing coatings stability, discs (triplicate samples; n=3) were placed in 4 mL of 
Milli-Q water and incubated at 37oC in a water bath on a shaker table (70 rpm) for 4 
weeks. After 7, 14, 21 and 28 days of incubation, MilliQ water was refreshed completely 
and used for the calcium assay based on orthocresolphtalein complexone (OCPC). At 
the end of the experimental period, the coated discs were incubated overnight in 1 
ml 0.5 N acetic acid on a shaker table to dissolve remaining calcium phosphate on the 
discs. For analysis, 300 µl working reagent was added to 10 µl sample or standard in 
a 96 wells plate. The well plates were incubated for 10 min at room temperature. The 
absorbance was measured using a microplate spectrophotometer at 570 nm (Bio-Tech 
Instruments, Winooski, VT, USA). The total calcium content within the coatings (µg/
cm2) was determined by cumulating total calcium release and remaining calcium on the 
discs, normalized for disc surface area.
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4. Platelet experiments
Human platelet-rich plasma (hPRP) was obtained from Sanquin (Nijmegen, the 
Netherlands) with cell counts of 4-5 x 108 platelets/mL. Platelets counts were obtained 
with a particle count and size analyzer according to the instructions of the manufacturer 
(Beckman Coulter, Z2, Florida, USA).
The experimental discs (quadruplicate samples; n=4) were placed in 24-well plates with 
custom-made Teflon molds surrounding each disc and a cylindrical volume above the 
disc (1 ml volume) as described previously [31]. These molds restrict platelet adherence 
to only the disc surface. A platelet solution containing 200 µl of the freshly prepared 
PRP and EDTA solution with a final concentration of 10 mm EDTA (Sigma, MO, USA) was 
added to each well containing one disc. Thereafter, the well plate was centrifuged at 
150g for 10 minutes to achieve platelet adherence to the disc surface.
After centrifugation, the 24-well plates were incubated at 37oC on a horizontal shaker 
(70 rpm) for 30 minutes. After that, the experimental discs were washed with PBS in 
order to remove non-adherent platelets and prepared for (qualitative) SEM examination 
of adherent platelets as well as (quantitative) lactate dehydrogenase (LDH) activity.
4.1 Scanning electron microscopy of platelets
SEM (JEOL 6310, Nieuw-Vennep, the Netherlands) was used for qualitative analysis of 
adherent platelets. After 3 hours of incubation, platelets were washed twice with PBS 
and subsequently fixed for 15 min in 2% glutaraldehyde in 0.1M sodium cacodylate 
buffered solution. Then, samples were rinsed twice with cacodylate buffered solution 
and dehydrated using a graded series of ethanol. Finally, samples were dried with 
tetramethylsilane. The samples were sputter-coated with gold prior to SEM examination.
4.2 Platelet adhesion
The quantification of platelet adherence was determined using a photospectrometric 
measurement based on kinetic determination of lactate dehydrogenase (LDH) activity 
[7, 32, 33]. Adherent platelets were lysed by adding 200 µL of 1% Triton buffer (Triton 
X-100, Sigma) to each well. The wells were incubated for 3 hours at room temperature. 
After the incubation, 100 µL of each lysate was collected and mixed with 100 µL of 
reaction solution (LDH measurement kit, Roche Life Science, Almere, the Netherlands). 
Per manufacturer’s instructions, LDH-activity was determined by recording absorbance 
at 490 nm.
5. Monocytes/macrophage experiments
The human monocytic cell line (THP-1; ATCC, LGC Standards GmbH, Germany) was 
cultured in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 
10% fetal bovine serum, 100 U/ml penicillin and streptomycin at 37oC in a 5% CO2 
and 95% atmospheric air. THP-1 cells were activated into macrophages by 50 ng/ml 
phorbol-12-myristate-13-acetate (PMA) as previously reported [34]. 1 x 105 cells/cm2 
were seeded on the experimental discs in culture medium (quadruplicate samples; n = 
4) and cultured for 1, 4 and 7 days.
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5.1 Morphological analysis
Cell morphology was assessed by SEM (JEOL 6310, Nieuw-Vennep, the Netherlands). 
After 1, 4 and 7 days, the cells were washed twice with PBS and subsequently fixed 
for 15 min in 2% glutaraldehyde in 0.1M sodium cacodylate buffered solution. Then, 
samples were rinsed twice with cacodylate buffered solution and dehydrated using a 
graded series of ethanol. Finally, samples were dried with tetramethylsilane and sputter 
coated with gold prior to SEM analysis.
5.2 Cellular DNA content
After day 1, 4 and 7 of cell culture, total DNA content was determined to obtain 
information about cellular proliferation. Cellular DNA content was measured using 
QuantifluorTM dsDNA System (Promega Benelux BV, Leiden, the Netherlands) according 
to the instructions of the manufacturer. Medium was removed and the cell layer was 
washed twice with PBS, after which 1 mL of MilliQ was added to each well and the 
samples were stored at -80oC until further use. For the standard curve, serial dilutions 
of dsDNA stock were prepared to final concentrations of 0-2000 ng/mL. Next, 100 µL 
of each sample and 100 µL freshly made 1x QuantifluorTM dye working solution were 
added to a 96-wells plate in duplicate. The plates were incubated at room temperature 
in the dark for 5 min, after which the fluorescence excitation/emission at 480/520 nm 
was read.
5.3 Cytokine measurements by ELISA
The secretion of Tumor Necrosis Factor-alpha (TNF-α) and Transforming Growth 
Factor-beta (TGF-β) was measured in the cell culture media. After 1, 4 and 7 days of 
culture, the culture medium was aspired and stored frozen at -80oC until analysis. 
The concentrations of TNF-α (pro-inflammatory) and TGF-β (pro-wound healing) 
were determined using ELISA kits (Bioscience, USA), according to the manufacturer’s 
instructions. Relative values of cytokine secretion were obtained by normalization to 
DNA quantification data (i.e. results are expressed as pg/mL/ng DNA content).
5.4 Macrophage polarization assessment
For immunostaining, THP-1 was cultured on the experimental discs for 1, 4 and 7 days. 
After that, the cells were fixed with 500 uL of 3.7% paraformaldehyde (PFA) for 10 min 
at room temperature and blocked with 500 uL of 1% bovine serum albumin (BSA) during 
15 min. After blocking, the discs were incubated with primary antibodies CCR7 (M1 
macro phage marker; Abcam, Cambridge MA, USA) and CD36 (M2 macrophage marker; 
Biolegend, San Diego CA, USA) overnight at 4o C. The sections were washed three 
times with PBS, incubated for 1 h with Alexa-Fluor 488 or 568 secondary antibodies 
and then incubated with DAPI (nucleus; Thermo Fisher Scientific, Waltham MA, USA) 
for 5 min. Microscopy images were obtained using a fluorescent microscope equipped 
with a digital camera (Carl Zeiss, Göttingen, Germany). The exposure time of each light 
channel was kept the same for all samples. The relative intensity of each fluorescence 
after images collection was analyzed using ImageJ (U.S. National Institutes of Health, 
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Bethesda, USA). The values of red (Alexa-568) and green (Alexa-488) fluorescence of 
each sample were further normalized to the value of blue fluorescence (DAPI).
5.5 Quantitative PCR
Quantitative PCR (qPCR) was performed to detect the macrophage polarization 
markers indoleamine 2,3-dioxygenase (INDO) (M1); CXCL11 (M1); MCR-1 (M2) and 
CCL13 (M2). Total RNA was isolated from the cells using TRIzol reagent (Invitrogen, 
Darmstadt, Germany) according to the manufacturer’s instructions. In brief, after 
removing the culture medium, 1 mL TRIzol reagent was added to each well. The cell 
extract was mixed vigorously with 0.2 mL of chloroform and centrifuged at 12.000 g 
for 15 min at 4°C. The aqueous phase of the sample was collected and mixed with 0.5 
mL of 100% isopropanol. After incubation at room temperature for 10 min, the extract 
was centrifuged and then washed with 75% ethanol. Successively, the RNA pellet was 
dissolved in RNase-free water and concentration and purity was determined using the 
NanoDrop (ND-2000; Thermo Scientific, Waltham MA, USA). 
For real-time PCR, total RNA (1 ug) was applied as template for cDNA synthesis using 
the iScript cDNA synthesis kit (Bio-Rad, Veenendaal, the Netherlands) following the 
manufacturer’s instructions. The cDNA samples were subjected to quantitative real 
time polymerase chain reaction (qRT-PCR) using a BIORAD CFX96 real-time system.
Oligonucleotide primers were designed for human β-actin, INDO; CXCL11; MCR-1 and 
CCL13 (Table 1). All real-time primers were initially tested against standards and a 
standard curve was generated. The optimized PCR conditions were: initial denaturation 
at 94°C for 10 min, followed by 40 cycles consisting of denaturation at 94°C for 15 s, 
annealing at 60°C for 1 min, and extension at 72°C for 60 s. Negative control reactions 
with no template (deionized water) were also included in each run. For each gene, 
all samples were amplified simultaneously in duplicate in one assay run. Analyses of 
relative gene expression were performed using the 2-∆∆CT method. Human β-actin was 
used as a housekeeping gene to normalize gene expression data.
6. Statistical analysis
Data are presented as mean ± standard deviation of the mean. The normality of all 
variables was verified using the Shapiro-Wilk W-test. For coating thickness and 
roughness analysis, Student’s t-tests were used. For the multiple analyses of variables 
that exhibited normal distribution (i.e. cytokine secretion; macrophage proliferation, 
polarization and gene expression), comparisons among the groups were made using 
one-way analysis of variance (ANOVA) with a post-hoc Tukey Multiple Comparisons test. 
For variables that exhibited non-normal distribution (i.e. roughness analysis, coating 
stability, platelet adhesion, and monocyte/macrophage proliferation), Kruskal Wallis 
tests were used with post-hoc Dunn tests. GraphPad Prism version 6.01 (Software 
Mackiev, Boston, MA, United States) was used to perform statistical analysis. Values of 
p < 0.05 were considered statistically significant.
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Results
1. Material preparati on and characterizati on
1.1. Surface analysis
SEM was used to morphologically examine the topography of the diff erent material 
surfaces. SEM results of Thermanox, grit-blasted Ti, HA, and β-TCP are depicted in 
Figure 1. Thermanox showed a smooth appearance, whereas grit-blasted Ti, Ti-HA, and 
Ti-β-TCP exhibited apparent roughness (Figure 1A).
Table 2 depicts the results of thickness and roughness analyses of grit-blasted Ti, HA, 
and Ti-β-TCP. The average thickness of HA and β-TCP coati ngs was 1.423 ± 0.229 µm 
and 1.688 ± 0.130 µm, respecti vely (p>0.05). The roughness of grit-blasted Ti, Ti-HA, 
and Ti-β-TCP was similar with average Ra values of 2.598 ± 0.074 µm, 2.425 ± 0.049 µm, 
and 2.538 ± 0.092 µm, respecti vely (p>0.05).
Figure 1. Surface characterizati on of diff erent surfaces. (A) SEM micrographs of Thermanox, grit-blasted 
Ti, Ti-HA and Ti-β-TCP surfaces; (B) X-ray diff racti on spectra of grit-blasted Ti and as-deposited and heat 
treated Ti-HA and Ti-β-TCP coati ngs; (C) Fourier transforms infrared spectra of as-deposited and heat 
treated Ti-HA and Ti-β-TCP.
PSM 20180528 Proefschrift Yang Zhang BW.indd   96 13-06-18   17:55
Biomaterial property effects on platelets and macrophages: an in vitro study 
97
Ch
ap
te
r 5
1.2. Physico-Chemical Characterization
Figure 1B shows the XRD patterns of grit-blasted Ti, HA and β-TCP (as-deposited and 
with heat treatment). The XRD patterns of grit-blasted Ti showed characteristic titanium 
peaks at 35.04o, 38.40o and 40.10o (ICDD 5-682). The XRD pattern of as-deposited HA 
showed 2 characteristic peaks at 25.9o and 32o that can be attributed to apatite. The 
XRD patterns of as-deposited β-TCP presented peaks (26o, 32o, 34o) with low intensity. 
However, heat treatment increased the intensity of peaks in the XRD pattern at 34o and 
49o for HA (ICDD 9-0432) and 26o, 32o, 34o for β-TCP (ICDD 9-169). These results indicate 
that heat treatment evoked a more crystalline structure in the ceramic coatings.
These findings were confirmed by FTIR spectra of HA and β-TCP as-deposited and after 
heat treatment (Figure 1C). HA coating showed bands at 575, 670, 970, 1050 and 1090 
cm-1 (stretching and bending motion of phosphate) [20]. These P-O bonds of calcium 
phosphate appear sharper after heat treatment. Furthermore, the β-TCP coating 
spectrum presented bands in the same regions as HA coatings (575, 670, 970, 1050 
and 1090 cm-1) characteristics of stretching and bending motion of phosphate[20]. 
After heat treatment can be observed sharper bands revealing that this treatment 
was effective to make the coating more crystalline. Therefore, both spectrum showed 
similar characteristic absorption bands at 500-650 cm-1 (P-O bending) and 900-1200 
cm-1 (P-O stretching), which increased after heat treatment and match with crystalline 
structure of HA and β-TCP.
Table 1 Primers sequence for each gene analyzed in the present study.
Gene Forward primer Reverse primer
β-actin CATCACCATTGGCAATGAGC CGATCCACACGGAGTACTTG
INDO CCTGAGGAGCTACCATCTGC TCAGTGCCTCCAGTTCCTTT
CXCL11 AGTCCTGGAAAAGAGCATCT TCACCCACCTTTCATCCTTC
MCR-1 GGTTTATGGAGCAGGTGGAA AAACTTGAACGGGAATGCAC
CCL13 ATCTCCTTGCAGAGGCTGAA ACTTCTCCTTTGGGTCAGCA
Table 2 Coating thickness and roughness.
Experimental group Coating thickness (µm) Roughness (µm)
Thermanox _ _
Grit-blasted Ti _ 2.598 ± 0.074
Ti-HA 1.423 ± 0.229 2.425 ± 0.049
Ti-β-TCP 1.688 ± 0.130 2.538 ± 0.092
1.3 Coating stability
Table 3 shows the total amount of calcium on the surface of the coated discs (µg/
cm2). Ti-HA and Ti-β-TCP coatings showed similar calcium amounts within the coating 
of 177.12 ± 14.47 µg/cm2 (as-deposited Ti-HA), 191.67 ± 14.70 µg/cm2 (heat-treated 
Ti-HA), 186.80 ± 6.82 µg/cm2 (as-deposited Ti-β-TCP), and 182.06 ± 24.97 µg/cm2 (heat-
treated Ti-β-TCP). Figure 2A presents cumulative calcium release from the Ti-HA and 
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Ti-β-TCP coatings after 7, 14, 21 and 28 days incubation in MilliQ. Cumulative calcium 
release was significantly higher for Ti-β-TCP coatings compared to Ti-HA coatings 
after 7 days (p=0.036) and after 21 days (p=0.037). No significant differences between 
as-deposited and heat treated coatings were observed, irrespective of CaP coating 
type (p>0.05). After 28 days, the calcium remaining on the discs was measured (Figure 
2B). Calcium remaining for Ti-HA heat (130.73 µg/cm2) was higher when compared to 
Ti-β-TCP heat (58.15 µg/cm2) (p=0.011).
2. Platelet activation
2.1 Platelet morphology
Qualitative analyses of platelet adhesion and morphology were performed with 
SEM (Figure 3A). On Thermanox, numbers of platelets with spherical shape and 
some platelets with changes in their shape (development of tiny pseudopodia) were 
observed. On grit-blasted Ti, Ti-HA and Ti-β-TCP, the platelets were more difficult to 
identify because of the roughness of the discs. However, on grit-blasted Ti, Ti-HA and 
Ti- β-TCP, the appearance of adherent platelets was similar, showing spherical platelets 
spread and aggregated on the disc surface.
Figure 2. Calcium release of calcium phosphate coatings. (A) Calcium release from as-deposited 
and heat-treated Ti-HA and Ti-β-TCP coatings over a 28-day incubation period in MilliQ water (n=3). 
* p = 0.036, Ti-β-TCP heat vs. Ti-HA heat; ≠ p = 0.037, Ti-β-TCP heat vs. Ti-HA heat. (B) Calcium remaining 
on the coated discs after 28 days in MilliQ water soaking experiment for as-deposited and heat treated HA 
and β-TCP coatings (n=3). * p = 0.011.
2.2 Platelet adhesion (LDH-activity assay)
Quantitative analysis of platelets adhesion based on LDH-activity assay (Figure 3B) 
showed a significant increase in platelet adherence to grit-blasted Ti (p=0.0024), Ti-HA 
(p=0.0007) and Ti-β-TCP (p=0.0011) compared to Thermanox (p=0.0024, 0.0007 and 
0.0011, respectively).
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platelets on Thermanox, grit-blasted Ti, Ti-HA, and Ti-β-TCP. Yellow arrows indicate the platelets; (B) LDH-
activity assay for platelets adhered to Thermanox, grit-blasted Ti, Ti-HA, and Ti-β-TCP (n=4). * p=0.00011, 
Thermanox vs. Ti- β-TCP; # p=0.0007, Thermanox vs. Ti-HA; θ p=0.0024, Thermanox vs. grit-blasted Ti.
3. Macrophage polarization
3.1 Cell morphology
Morphology of macrophages after 1, 4 and 7 days of culture on the different 
experimental surfaces was observed (Figure 4). Spherical macrophages were observed 
at the first day on Thermanox. Interestingly, after four and seven days morphological 
changes were observed in the form of prolongations. In contrast, macrophages showed 
a faster transition to a flattened morphology on rough surfaces of grit-blasted Ti, Ti-HA 
and Ti- β-TCP.
3.2 Cell proliferation
The DNA content of macrophages seeded on the different experimental substrates 
after culture periods of 1, 4 and 7 days are presented in Figure 5A. Both grit-blasted 
Ti and Thermanox showed an increase in DNA content values from day 1 to day 4, and 
a decrease thereafter to day 7. In contrast, Ti-HA and Ti-β-TCP showed similar DNA 
content values over time, both of which were significantly lower compared to those of 
grit-blasted Ti and Thermanox.
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Figure 4. Macrophage morphology cultured on different surfaces. (A) Scanning electron microscopy 
images of macrophages cultivated on Thermanox, grit-blasted Ti, Ti-HA, and Ti-β-TCP after 1, 4 and 7 
days of cultivation. Yellow arrows indicate macrophages (original magnification: 1000x; scale bar: 50 µm).
Figure 5. Macrophage proliferation and cytokine secretion cultured on different surfaces. (A) DNA 
content of macrophages cultured on Thermanox, grit-blasted Ti, Ti-HA, and Ti-β-TCP. Results represent 
mean ± SD (n = 4). * p<0.05; ** p<0.01 and *** p<0.001; (B) TNF-α and (C) TGF-β secretion of macrophages 
after 1, 4 and 7 days of culture on Thermanox, grit-blasted Ti, Ti-HA and Ti-β-TCP. Results represent mean 
± SD of four experimental groups (n = 4). *p<0.05; **p<0.01 and ***p<0.0001.
3.3 Cytokine secretion
Secretion levels for the cytokines TNF-α and TGF-β are presented in Figure 5B and 
C. After 1 day, TNF-α secretion was significantly higher for Ti-β-TCP compared to 
Thermanox (p=0.008). After 4 days, Ti-HA showed significantly higher secretion of 
TNF-α compared to Thermanox (p=0.0318). At day 7, both Ti-HA (0.178 pg/mL/ng DNA) 
and Ti-β-TCP (0.422 pg/mL/ng DNA content) showed an increased TNF-α secretion 
compared to Day 1 and Day 4. Additionally, in this period, both Ti-HA and Ti-β-TCP 
showed a significantly higher secretion of TNF-α compared to Thermanox (p=0.019) 
and grit-blasted Ti (p=0.019).
TGF-β levels (Figure 5C) showed no statistically significant differences during the first 
4 days of macrophages culture (range: 0.006– 0.156 pg/mL/ng DNA content). At day 
7, Ti-HA showed a significantly higher secretion of TGF- β levels (0.920 pg/mL/ng DNA 
content) compared to Thermanox (0.377 pg/mL/ng DNA content) (p=0.014), grit-blas-
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ted Ti (0.313 pg/mL/ng DNA content) (p=0.011) and Ti-β-TCP (0.456 pg/mL/ng DNA 
content) (p=0.046).
3.4 Macrophage polarization on experimental surfaces
Representative fluorescent images of the experimental groups at their corresponding 
time points are shown in Figure 6. The images demonstrated that all surfaces presented 
the M1 (CCR7) and M2 (CD36) macrophages markers across all time points. The images 
also suggest that grit-blasted Ti, Ti-HA and Ti-β-TCP are effective at maintaining the 
CD36 staining (M2 macrophages) especially after 4 days. 
Quantification of the immunofluorescent staining was performed. Figures 7A, B and 
C shows the immunostaining for CCR7 and CD36 after 1, 4 and 7 days. After 1 day, M1 
macrophage marker CCR7, can be observed a decreased of labeling in the Ti and an 
increase in the labeling in the HA (Figure 7A). No significant differences were observed 
between the Thermanox and Ti-β-TCP in this experimental period. For CD36, an 
increase of immunostaining was observed in the grit-blasted Ti, Ti-HA and Ti-β-TCP 
compared to Thermanox (Figure 7A). On day 4, no statistically significant was observed 
for CCR7 between the groups analyzed. For CD36, similar results were observed the 
analysis after 1 day, with increased immunostaining for CD36 in the Ti, Ti-HA and Ti-β-
TCP groups when compared to Thermanox (Figure 7B). Finally, as shown in Figure 7C, 
CCR7 and CD36 immunostaining labeling in all groups after 7 days. For CCR7, can be 
observed an increase in the Ti-HA compared to Thermanox and grit-blasted Ti and Ti-β-
TCP. The lowest values for the CCR7 immunostaining were observed in Thermanox. No 
significant differences were observed between the grit-blasted Ti and Ti-β-TCP in this 
experimental period. For CD36, the grit-blasted grit-blasted Ti and Ti-HA demonstrated 
the higher values of immunostaining compared to Thermanox and Ti-β-TCP.
3.5 Quantitative PCR
The macrophage polarization was also assessed by RT-PCR, in which INDO and CXCL11 
were considered as M1 macrophage markers and MCR-1 and CCL13 were considered 
as M2 macrophage markers. After 1 day, grit-blasted Ti, Ti-HA and Ti-β-TCP showed 
more obvious biological activity compared to Thermanox controls, which promoted 
both M1 macrophage and M2 macrophage polarization process, evidenced by higher 
INDO, CXCL11, MCR-1 and CCL13 gene expression. Amongst these, Ti and Ti-HA 
showed significantly higher M1 and M2 macrophage marker expression than β-TCP 
(Figure 7D). After 4 days, grit-blasted Ti, Ti-HA and Ti-β-TCP still showed more obvious 
biological activity compared to Thermanox controls as the trend on day 1.  However, 
the difference is that significantly higher expression of INDO, CXCL11, MCR-1 and CCL13 
in the Ti-β-TCP was found compared to grit-blasted Ti. Still, Ti-HA displayed the highest 
INDO, CXCL11, MCR-1 and CCL13 gene expression in the Ti-HA (Figure 7E). 
After 7 days, intriguingly, Ti-β-TCP significantly enhanced the M1 macrophage polari-
zation, evidenced by INDO and CCL11 gene expression and decreased M2 macrophage 
gene expression MCR-1 and CCL13 compared to Ti-HA and grit-blasted Ti and Thermanox 
controls (Figure 7F). 
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Figure 7. Specific gene expression of macrophage cultured on different surfaces. Quantitative 
immunostaining for CCR7 (M1-marker) and CD36 (M2-marker) for macrophages cultured on Thermanox, 
grit-blasted Ti, Ti-HA, and Ti-β-TCP disc after cultures of 1 day (A), 4 days (B) and 7 days (C) (n=4). Quantitative 
PCR for INDO and CXCL11 (M1-markers) and MCR-1 and CCL13 (M2-markers) for macrophages cultured on 
Thermanox, grit-blasted Ti, Ti-HA, and Ti-β-TCP disc after cultures of 1 day (D), 4 days (E) and 7 days (F) 
(n=4). *p<0.05; **p<0.01 and ***p<0.0001.
Figure 6. Immunostaining of macrophage cultured on different surfaces. Immunostaining for DAPI 
(nuclei), CCR7 (M1-marker), CD36 (M2-marker) and merged images for macrophages cultured on grit-
blasted Ti, Ti-HA, and Ti-β-TCP disc after cultures of  1 (A), 4 (B) and 7 (C) days.
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Discussion
Dental and orthopedic bone implants should provide a complete host tissue integration 
and moreover, prevent an exacerbated immune response. Upon implantation, such 
biomaterial devices can activate many cells, and hence the secretion of cytokines and 
factors by members of the hematological and immune system [10-12]. This activation 
is the initial step for bone healing, and hence represents a challenge for the medical 
field in terms of modulating this foreign body response toward functional performance 
of implanted biomaterials [10, 14]. Here, we evaluated bone implant surface effects on 
the response of blood-born components that account for the initial biological cascade 
of events following implantation, using in vitro experiments with human platelets and 
macrophages. The characterization of the different coatings showed that the heat 
treatment was effective in increasing coating crystallinity, but not coating stability. For 
platelets, higher numbers of adherent platelets were observed for grit-blasted Ti, Ti-HA 
and Ti-β-TCP compared to Thermanox. Macrophage experiments showed decreased cell 
proliferation on CaP-coated Ti-discs (Ti-HA and Ti-β-TCP) compared to Thermanox and 
grit-blasted Ti. However, the coated CaP seems more biological active than Thermanox, 
proved by upregulated pro-inflammatory and anti-inflammatory cytokine secretion, 
M1/M2 macrophage marker and M1/M2 macrophage gene expression. Additionally, 
Ti-β-TCP demonstrated a more pro-inflammatory function than Ti-HA.
In this study, two calcium phosphate ceramics (CaPs) were used as a coating, the HA 
and β-TCP. These coatings are considered a class of bioactive materials, which have 
properties that affect the adhesion and proliferation of immune and bone cells and 
induce bone formation [8, 20].  HA is an osteoconductive biomaterial similar to natural 
bone mineral both from a chemical and a structural point of view [35, 36]. In contrast, 
β-TCP is a biomaterial used in biomedical applications mainly due to its mechanical 
performance, chemical stability, solubility and reabsorption rate [20, 36]. These CaP 
biomaterials were used to provide the Ti discs a thin coating deposition using the RF 
sputtering , which has been shown to be useful to control ceramic coating properties 
and the adhesion between the substrate and the coating [30, 37, 38] besides to 
permit a uniform and continuous deposition coatings [20, 27]. After the sputtering, 
the discs were heat treated in an infrared furnace. This treatment is a necessary post-
annealing treatment to crystallize the coating. Yoshinari et al. [30] demonstrated that 
the heat treatment with infrared radiation around 600o was the best treatment for RF 
magnetron sputtered coatings, which was used in this study [30]. The physical-chemical 
characterization analyzed by XRD and FTIR of the CaP coatings used in this study 
showed that the heat treatment was able to increase the crystallinity of the coatings. 
The physical-chemical characteristics of CaPs coatings and their link with the Ti discs is 
crucial for the first host body response and can affect the success of the implantation. 
Many studies on bone implants, however, neglect the importance of physicochemical 
characteristics such as dissolution, crystallinity, corrosion among others and how they 
alter the microenvironment around the implant. 
Platelets play an active role in the immunological and inflammatory aspect of tissue 
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healing in normal hemostasis as well as in host defense. Platelets can be directly involved 
in the inflammatory response by the production and release of several inflammatory 
mediators, including a variety of cytokines and chemokines. Furthermore, the ions 
and/or particles release as calcium release can affect the behavior of the platelets and 
macrophages [7]. In this study, the calcium assay showed that the β-TCP coatings can 
permit more calcium release and transform the microenvironment around the implant. 
It is known that the release of calcium ions plays an essential role in several steps of the 
bone repair process, from platelet activation to biomineralization and bone remodeling 
[39]. In the process of osseointegration of implants, calcium establishes electrostatic 
bridges between the surface of the implant and several proteins, modifying them and 
allowing a better integration of the bone tissue with the implant. In addition, after 
implantation, the platelets need to be activated to perform their functions properly 
[40]. In this context, calcium participates in the binding of platelet membrane 
phospholipids to Factor Xa and Factor IXa, which are necessary for the tenase and 
prothrombinase complexes, which convert prothrombin to thrombin (Factor IIa), 
polymerizing fibrin [39, 40]. Thus, calcium actively participates in platelet adherence 
and activation and exocytosis of their granules to perform its function. In addition, 
platelets secrete cytokines, generated from platelets in contact especially with 
calcium ions (Ca) in the surface can upregulate neutrophil activation and consequently 
stimulate osteogenic cell proliferation in vivo [7]. Kikuchi et al. [7] observed that the 
Ca and phosphate (PO4-) in the coatings surface can increase the microtopographical 
complexity resulting in an increase in the platelets activation levels. The findings of this 
work demonstrated that there was no significant difference between Ti-HA and Ti-β 
-TCP groups on platelet adherence in the discs. It is known that platelets adherence and 
activation generally occur at the same time when contact with materials and they are 
closely combined. Additionally, platelet activation results in stimulation and behavior 
of various leukocytes, including macrophages [15]. 
Beside platelets, the other important immune cells as to macrophages migrate to the 
local of the implantation site and produce many chemokines, cytokines and growth 
factors to play an important tissue remodeling response after an injury or a host 
defense. In the present study, a significant decrease in the DNA content of macrophages 
when in contact with CaP coated discs was observed. Besides macrophage adhesion, 
macrophage polarization has been proved to play crucial roles in bone-implant 
interaction and further its osseointegration [41]. 
Therefore, we investigated effects of different surface chemical properties on 
macrophage polarization by assessing M1/M2 macrophage cytokine secretion, marker 
gene expression based on our previous work [42] . We demonstrated a significantly 
upregulated pro-inflammatory and anti-inflammatory cytokine secretion and marker 
gene expression of macrophages on HA and β-TCP coatings. This hybrid macrophage 
phenotype with simultaneously M1 and M2 markers was also reported in previous data 
[13] . However, its action of mode and functions in in vivo performance remains to be 
decoded. Furthermore, HA induced an earlier M1 macrophage polarization than β-TCP 
since M1 macrophage markers CCR7 and CXCL11 and CCR7 immunostaining showed 
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higher expression than those on β-TCP after 1 and 4 days.  During this time period, 
M2 macrophage polarization was also enhanced on HA coated discs. However, after 7 
days, β-TCP showed more obvious M1 macrophage polarization than HA. These results 
can be attributed to the over-physiological calcium content in the medium. From the 
clinical review, HA coating is superior than β-TCP since it is more biological bioactive 
and macrophages around HA will be converted into M2 macrophages after 7 days, 
which is beneficial for the ending of inflammation and tissue remodeling. 
Conclusion
This study demonstrated that the biomaterial surface property of HA and β-TCP 
coatings induce different responses to blood-born components that account for 
the initial biological cascade of events following implantation. Grit-blasted Ti, Ti-HA 
and Ti-β-TCP did not display significant difference for platelet adhesion. However, 
for macrophages, both types of coatings (Ti-HA and Ti-β-TCP) decreased more than 
twice of macrophage proliferation compared to grit-blasted Ti. Furthermore, Ti-β-
TCP significantly upregulated pro-inflammatory cytokine TNF-α secretion while Ti-HA 
significantly upregulated anti-inflammatory cytokine TGF-β secretion after 7 days of 
macrophages culture on these surfaces. Immunostaining and gene expression of M1/
M2 macrophages further revealed a hybrid macrophage phenotype with simultaneous 
M1 and M2 markers induced by Ti-HA and Ti-β-TCP compared to grit-blasted Ti. In 
addition, Ti-HA induced an earlier M1 macrophage polarization and earlier M1-M2 
macrophage transformation compared to Ti-TCP. Further studies are required to verify 
the clinical significance of our findings and evaluate effects of biomaterial surface 
properties on multiple cell types in suitable in vitro coculture models and in vivo models 
with appropriate post-implantation time points.
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Introduction
Different metals and metallic alloys have been utilized as dental and orthopedic 
implant materials, because of their acclaimed mechanical strength, stability, and 
biocompatibility. In particular, titanium implants with a surface roughness (e.g. as 
created by grit-blasting and acid etching) or a bioceramic coating are widely used to 
favor the bone response based on many years’ clinical experience [1]. In a systematic 
review, smooth and minimally rough surfaces (Ra < 0.5 µm) were demonstrated to 
show less bone formation and bone-implant contact than rougher surfaces while 
moderately rough surfaces (Ra 1 ~ 2 µm) showed more bone formation and bone-
implant contact than excessively rough surfaces (Ra > 2 µm) [2]. Thereafter, implant 
surfaces with roughness value between 1 and 1.5 µm were indicated as the optimal 
surface to achieve superior bone formation [3, 4]. On the other hand, ceramic coatings, 
such as hydroxyapatite (HA) layer, also show enhanced and favored initial bone response 
and bone ingrowth compared to uncoated implants [5]. These findings suggest the 
importance of implant surface properties to orchestrate the bone healing process in 
the close vicinity of metallic implants. Due to the increase of patients with unfavorable 
bone healing conditions such as diabetes and osteoporosis, more knowledge about the 
healing mechanism is required to optimize implant surface properties for the safe and 
predictable installation of implants in such patients.
Given that osteoblasts play a major role in the osseointegration process, the majority 
of previous studies focused on the response of mesenchymal cell types to titanium 
implants. Inconsistencies between in vitro and in vivo data regarding effects of a physical 
or chemical surface on the osteogenic differentiation and bone healing capacity, 
however, are commonly found [6, 7], which emphasizes the need to unravel further 
the mechanisms that govern the capacity of material surface properties to mediate 
osseointegration.
When a bone implant is installed, a proteinaceous layer is immediately adsorbed on the 
implant surface and a blood clot is formed. Subsequently, inflammatory cells including 
peripheral monocytes that give rise to macrophages and multinucleated cells populate 
the blood clot and simultaneously elicit an inflammatory response. Then, this blood clot 
remodels, neovascularization occurs and at later times, induction and commitment of 
osteogenic precursors is achieved [8]. During this process, bone healing cannot occur 
or is significantly reduced without the presence of inflammation or with extravagant 
inflammation [9, 10]. As monocytes/macrophages are one of the main cell types associated 
with the inflammatory response around implants and they secrete various cytokines and 
growth factors relevant for the differentiation of mesenchymal cells (MSCs), it can be 
hypothesized that monocytes/macrophages play an important role in the final outcome 
of the bone healing process. Consequently, some researchers have proposed the novel 
concept of “osteoimmunomodulation”, which refers to the modulation of bone immune 
response by implant materials [11]. This concept implies that macrophages exert either 
inhibitory or stimulatory effects on osteogenesis due to the heterogeneity and plasticity 
of macrophages, which are governed by implant surface properties.
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Indeed, recent studies pinpointed the versatility of the macrophage phenotype, 
classically activated M1 types and alternatively activated M2 types [12]. M1 macrophages 
predominantly secrete pro-inflammatory cytokines (e.g. TNF-α, interleukin-1β (IL-1β) and 
IL-6) involved in chronic inflammation as well as in recruitment of polymorphonuclear 
neutrophils. In contrast, M2 macrophages predominantly secrete anti-inflammatory 
mediators (e.g. TGF-β, IL-10, and IL-1ra) to promote the resolution of inflammation and 
benefit tissue regeneration [12]. M2 macrophages also support the migration, growth, 
and osteogenic differentiation of MSCs [13]. Recent work has shown that prolonged 
M1 polarization can lead to the perpetuation of chronic inflammation, which results 
in eventual osteolytic loosening of implants [14]. In contrast, an effective and timely 
switch toward M2 macrophage phenotype can result in an osteogenesis-enhancing and 
tissue remodeling cytokine secretion profile and subsequent osseointegration [15, 16]. 
Thus, engineering a microenvironment around implanted devices that would convert 
macrophages to a more M2 phenotype seems a promising approach to attenuate adverse 
immune reactions and improve the bone formation around enossal implants [17, 18].
The effect of material roughness and CaP coatings on macrophage activation 
and cytokine secretion has been studied in several previous studies [19-22]. The 
majority of these investigations, however, considered macrophages as conventional 
inflammatory cells and consequently to avoid the macrophage-material interaction. 
The newly identified pro-healing characteristic of macrophages is lack of consideration. 
Additionally, murine macrophages rather than human macrophages were commonly 
used in these reported data. Although macrophages from mouse and human share 
some common characteristics, an apparent difference in their proliferation, spreading 
and cytokine secretion has been demonstrated, especially when assessing effects of 
surface physical characteristics on cell behaviors [23, 24]. Furthermore, amongst these 
studies, effects of smooth surface and (a certain of) rough surface on macrophage 
secretion of inflammatory cytokines were compared, while comparison of different 
degrees of roughness were rarely reported and the combined effect of roughness and 
HA coating was not depicted. Therefore, the current study aimed to assess the effect 
of titanium surfaces provided with a series of roughness and with/without HA coating 
on adherent human monocyte/macrophage behaviors. Specifically, macrophage 
polarization into M1/M2 phenotype was examined by quantification of secreted pro- 
and anti-inflammatory cytokines, cytokine gene expression, and immunostaining. M1/
M2 macrophages conventionally induced with specific cytokines on glass slides were 
set as controls. We hypothesized that both physical (roughness) and chemical (HA 
coating) characteristics would influence human macrophage adhesion and polarization 
on titanium surface.
Materials and methods
1. Preparation of titanium surfaces
Commercially pure titanium disks (Purity > 99.9 wt%; diameter 12 mm; thickness 1.5 
mm; Ti) were purchased from Machinefabriek G Janssen, the Netherlands. Disks were 
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sandblasted with 50 µm, 110 µm and 250 µm Al2O3 particles for 30 seconds from a 
distance of approximately 10 mm to obtain titanium surfaces with low roughness (Ti-
LR), medium roughness (Ti-MR) and high roughness (Ti-HR), respectively. After that, all 
disks were subjected to ultrasonic cleaning in four successive baths of 10% nitric acid 
solution, acetone, ethanol, deionized distilled water for 10 min in each bath. Ti-MR 
disks were then provided with a 0.3 µm thick hydroxyapatite (HA) (Ca10(PO4)6(OH)2; 
TiHA-MR) coating using radiofrequency (RF) magnetron sputtering and subjected to 
heat treatment (600 °C) as previously reported [25]. Glass slides (diameter 13 mm) 
were commercially obtained from VWR, Germany and were used as control substrates. 
All samples were then autoclaved, dried at 370C and ready for characterization and cell 
culture.
2. Surface characterization of titanium surfaces
The different surfaces were characterized for morphology, surface roughness, wetta-
bility, and crystal structure. The morphology of these surfaces was characterized with 
scanning electron microscopy (SEM; Zeiss, Germany). The crystalline phase of the 
deposited HA coating was analyzed by X-ray diffraction (XRD; Phillips PW3710, the 
Netherlands) as described previously [25]. The surface profile and roughness of the 
titanium disks were measured using a Universal Surface Tester (UST) (Innowep GmbH, 
Germany) and a surface topography scanner (Proscan 2100, Scantron, Germany) under 
the ISO standards settings for scanning (ISO 4288-1996). The 2D Roughness Average 
(Ra), the arithmetic average of the 3D roughness (Sa), the average space between the 
irregularities (Scx) parameter were used as a previously reported method to numerically 
characterize the surface roughness [26]. All samples were measured for water contact 
angles using Surface Tension (Biolin scientific, Finland) equipped with a digital camera 
and image analysis software.
3. Culture of human THP-1 monocytic cells
Human THP-1 cells (ATCC, USA) were cultured in suspension in RPMI 1640 medium 
(Gibco, USA) supplemented with 10% heat-inactivated fetal bovine serum (Sigma-
Aldrich, USA) and incubated at 37°C, 5% CO2 in a 95% humidified atmosphere. The cell 
density was kept at 0.2 ~ 1.2 × 106 cells/ml.
4. Cell seeding
All disks were put in 24-well non-adherent plates (Greiner-one, Germany) before cell 
seeding. 5 × 105 monocytes suspended in 1 ml medium were added to the different 
surfaces in each well with phorbol myristate acetate (PMA; Sigma-Aldrich, USA) at 
a concentration of 50 ng/ml. M0, M1 and M2 phenotype controls were prepared by 
unstimulating macrophages on glass for M0, stimulation with 240 ng/mL LPS (Sigma-
Aldrich, USA) and 20 ng/ml INF-γ (Sigma-Aldrich, USA) for M1, or stimulation with 20 
ng/mL IL-4 (Sigma-Aldrich, USA) and 20 ng/ml IL-13 (Sigma-Aldrich, USA) for M2 as 
previously developed [13]. The plates were incubated for different time periods until 
analyses.
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5. Cell adhesion
Macrophages were cultured for 2 and 4 days. The medium was changed every 2 days. 
The supernatant was stored for cytokine quantification. Cell monolayers were then 
washed twice with PBS, immersed in 1 ml MilliQ and went through two freeze and thaw 
cycles. DNA content was quantified in cell lysates using the Quant-iTTM PicoGreen 
dsDNA Assay Kit (Life Technologies, the Netherlands) per the manufacturer’s protocol.
6. Cytokine secretion
The supernatant from all wells was harvested after 2 and 4 days of incubation. The 
media were aspirated and transferred to Eppendorf tubes and centrifuged at 400 g 
for 5 min. TNF-α, IL1-β, TGF-β (eBioscience, USA) and CXCL18 (R&D Systems, USA) 
ELISA analyses were performed using commercially available kits with a multi-mode 
spectrophotometer (Biotek, USA).
7. RT-PCR for gene expression analysis
After 2 days of culture, wells were washed twice with PBS and total RNA was isolated 
using the RNeasy Mini Kit (Qiagen, Valencia, CA). RNA quality and quantity were 
assessed using a Nanodrop ND-1000 Spectrometer (Thermo Scientific). A total of 
800 ng RNA was transcribed to cDNA using TaqMan Reverse Transcription kit (Applied 
Biosystems). RT-PCR reactions of INDO, CXCL11, MCR-1, CCL13 were performed using 
Fast SYBR Green Master Mix Kit (Applied Biosystems, CA, USA) by Applied Biosystems 
PRISM 7500 sequence amplification system with the primers listed in Table 1. Each 
PCR reaction consisted of 1 µl of the cDNA as template, 2 µl (10 pmol) of forward 
and reverse primers, 12.5µl Mastermix, and 9.5µl RNAnase-free water. Thermal cycle 
conditions consisted of denaturation at 95 ºC for 40 s, annealing at 60 ºC for 1 min. 
After 40 cycles, the reaction was completed with a final extension step at 72 ºC for 
5 min. The expression of target genes was normalized to the relative abundance of 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Fold induction was calculated 
using the 2-ΔΔCt method.
Table 1. Primer sequence used for RT-PCR in the present study. 
Target gene Forward primer Reverse primer
GAPDH CTCTGCTCCTCCTGTTCGACA ACGACCAAATCCGTTGACTC
INDO CCTGAGGAGCTACCATCTGC TCAGTGCCTCCAGTTCCTTT
CXCL11 AGTCCTGGAAAAGAGCATCT TCACCCACCTTTCATCCTTC
MCR-1 GGTTTATGGAGCAGGTGGAA AAACTTGAACGGGAATGCAC
CCL13 ATCTCCTTGCAGAGGCTGAA ACTTCTCCTTTGGGTCAGCA
8. Immunostaining for macrophage phenotype markers
After 3 days, all samples were washed twice with phosphate-buffered saline (PBS) and 
fixed with 4% paraformaldehyde. Cells were permeabilized with 0.5% Triton X-100 
diluted in PBS for 5 min and then incubated with 1% BSA in PBS for 20 min. After that, 
cells were incubated with rabbit anti-human CCR7 (1:2000; abcam, No. ab32527) and 
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mouse anti-human CD36 (1:200; Biolegend, No.336202) primary antibodies in 1% BSA 
in PBS at 4 ºC overnight. After washing twice with PBS, Alexa Fluor-546 donkey anti-
rabbit IgG, Alexa Fluor-488 goat anti-mouse IgG (all Life Technologies, USA) secondary 
antibodies diluted in 1% BSA in PBS were added and incubated with cells at room 
temperature for 2 h. The wells were washed twice with PBS and nuclei was then stained 
with 5 µg/ml 4, 6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich). Samples were then 
mounted with the mounting medium and fluorescent images were acquired using an 
inverted fluorescence microscope (Zeiss AxioCam MRc5, Germany). Each fluorescence 
was kept on the same exposure time for all samples and images were further analyzed 
using ImageJ software (NIH, USA). The values of red (Alexa-568) and green (Alexa-488) 
fluorescence of each sample were quantified and further normalized to the value of 
blue fluorescence (DAPI) to measure the relative fluoresce intensity.
9. Statistical analysis
Experiments were performed twice with consistent results. Presented data are 
from one experiment. All data were expressed as mean values ± standard deviation. 
Statistical analysis was performed using Prism Software (GraphPad, USA) via one-way-
ANOVA followed by a Tukey’s Multiple Comparison Test. A Student’s t-test was used for 
comparing TiMR and TiHA-MR. Results were considered significant at p < 0.05.
Results
1. Surface characterization
The surface morphology of as-received smooth, sandblasted rough, and HA-coated 
titanium disks was characterized by SEM, together with the glass substrate (Figure 
1A). Glass slides exhibited a smooth surface. In contrast, as-received Ti discs showed 
a typical concentric pattern due to use of a milling machine during their production, 
while sandblasted titanium surfaces showed crack structures and blasting scars. XRD 
patterns of the HA coating displayed a peak at 2θ = 26o and 32o, indicating the presence 
of HA on top of TiHA-MR surface (Figure 1B). When the 2D surface profile is tested by 
UST, glass surfaces showed a smooth line and as-received Ti discs showed a slightly 
fluctuant line. The fluctuating extent of this line gradually increased for Ti-LR, Ti-MR, 
and Ti-HR while TiMR-HA displayed a similar extent as TiMR (Figure 1C). With further 
characterization of the surfaces with a 3D surface scanner, glass displayed a smooth 
surface and the similar concentric pattern was observed in as-received titanium 
surfaces. In contrast, the rest surfaces displayed varying degrees of ragged surfaces 
and irregular space between peaks (Figure 1D).
The quantitative roughness measurements showed glass slides a smooth surface (Ra 
= 0.02 µm; Sa = 0.02 µm), while titanium disks showed a gradually increasing surface 
roughness ranging from Ra = 0.20 µm; Sa = 0.33 µm for Ti to Ra = 2.60 µm; Sa = 4.12 
µm for Ti-HR (Figure 2A). Ti-MR and 
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Figure 1. Preparation of glass, titanium surfaces with different roughness with or without HA coating. 
The morphology of glass control and different titanium surfaces prepared in this study were observed with 
SEM (A; the scale bar is 20 µm). XRD patterns of the HA coatings displayed the typical peak of HA at 2θ = 
26o and 32o, which are indicated by arrowheads (B). The surface profile was further assessed with UST (C) 
and Surface Scanner (D).
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TiHA-MR displayed no significant difference in 2D surface roughness (Ra = 1.36 µm 
and 1.41 µm respectively; Figure 2B). However, the 3D surface roughness of TiHA-MR 
(Sa = 2.59 µm) is lower than Ti-MR (Sa = 2.91 µm). Water contact angle (WCA) data for 
the different surface are shown in Figure 2B. Glass surface showed WCA at 55° while 
all other titanium surfaces showed WCA ranging from 70° to 80°, indicating moderate 
hydrophilicity of these surfaces. Differences in titanium surface roughness and with/
without HA coating did not significantly alter the surface hydrophilicity after the 
autoclave sterilization.
2. Macrophage adhesion
The adhesion of PMA activated macrophages to the different sandblasted surfaces 
was significantly lower compared to smooth Ti after 2 days of culture. In contrast, 
macrophage adhesion to amongst these rough surfaces did not display significantly 
difference. In contrast, TiHA-MR significantly increased macrophage adhesion 
compared to Ti-MR (Figure 3A). After 4 days, total cell adhesion values revealed a 
reduction compared to day 2 and were similar for all experimental surfaces, except 
for TiHA-MR which displayed significantly higher macrophage adhesion compared to 
Ti-MR (Figure 3B).
3. Pro- and anti-inflammatory cytokine secretion
To assess the effect of roughness and HA coating on macrophage polarization, we 
investigated the secretion of pro- and anti- inflammatory mediators (Figure 4). 
Macrophage responses elicited by all titanium surfaces appeared to be predominantly 
anti-inflammatory because the cytokine secretion profile was relatively more similar to 
that of M2 macrophages on glass controls, showing low amounts of typical inflammatory 
mediators (TNF-α and IL-1β) and high amounts of anti-inflammatory cytokines (TGF-β 
and CCL18). Specifically, after 2 days, TNF-α secreted by macrophages cultured on the 
Ti-LR and Ti-MR surface decreased significantly compared to Ti surfaces and Ti-HR. 
Macrophages cultured on HA coated surfaces, in contrast, significantly increased 
TNF-α secretion compared to Ti-MR surfaces (Figure 4A). Additionally, macrophages on 
all rough titanium surfaces showed significantly lower levels of IL-1β compared to those 
cultured on Ti. In contrast, IL-1β secreted by the macrophages cultured on HA coated 
surfaces increased significantly compared with Ti-MR surfaces (Figure 4B). In view of 
anti-inflammatory cytokines, CCL18 and TGF-β secretion were greatly increased on 
all rough surface compared to Ti, in particular on Ti-MR (Figure 4C & D). Increased 
secretion of CCL18 was found on TiHA-MR compared to Ti-MR, but not of TGF-β.
A similar trend was observed after 4 days of culture, when the level of TNF-α secretion 
was significantly lower on Ti-LR and Ti-MR compared to Ti and Ti-HR. The presence of the 
HA coating significantly increased TNF-α secretion on Ti-MR compared to day 2 (Figure 
4E). Further, secretion of the inflammatory cytokine IL-1β significantly decreased at day 
4 compared to that at day 2. Only on TiHA-MR a significantly increased IL-1β secretion 
was observed compared to TiMR (Figure 4F). In view of anti-inflammatory cytokines, 
significantly increased levels of CCL18 secretion were detected on all rough surfaces 
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compared to the smooth Ti surface. The presence of an HA coating also significantly 
promoted CCL18 secretion compared to Ti-MR (Figure 4G). Regarding TGF-β secretion 
at day 4, its level was significantly higher on Ti-LR and Ti-MR surfaces than on Ti and 
Ti-HR. Further, TiHA-MR induced significantly higher TGF-β secretion compared to 
Ti-MR (Figure 4H).
4. Pro- and anti-inflammatory cytokine gene expression
To further investigate macrophage polarizing nature on surfaces with different roughness 
and HA coating, we performed gene expression analysis of selected marker genes, 
consisting of M1 macrophage markers (INDO, CXCL11) and M2 macrophage markers 
(MCR-1 and CCL13). All titanium surfaces showed extremely low pro-inflammatory 
markers gene expression compared to M1 macrophages and similar anti-inflammatory 
markers gene expression as M2 macrophages (Figure 5). Rough surfaces, especially 
Ti-LR and Ti-MR, significantly downregulated M1 macrophage surface markers INDO 
and CXCL11 compared to Ti and Ti-HR (Figure 5A & B). In contrast, the presence of 
Figure 3. DNA quantification of THP-1 derived macrophages cultured on glass and different titanium 
surfaces for 2 days (A; n=4) and 4 days (B; n=4) respectively. A significant difference between Ti, TiLR, 
TiMR and TiHR was indicated by a & b (p < 0.05). Groups with different letters are significantly different 
and groups sharing the same letter are not significantly different. A significant difference between TiMR 
and TiHA-MR was indicated by ** (p < 0.05) and *** (p < 0.001).
Figure 2. Characterization of surface roughness and wettability of glass and different titanium surfaces. 
2D Roughness Average (Ra), 3D roughness Average (Sa), and average space between the irregularities 
(Scx) were quantified by Universal Surface Tester and Surface Scanner (A; n=4). The wettability of different 
surfaces were tested by water contact angle (WCA) after the sterilization by autoclave (C; n=4). 
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an HA coating significantly increased the expression of both these markers compared 
to Ti-MR (Figure 5A & B). Additionally, the relative mRNA expression levels of MCR-1 
and CCL13 were significantly increased for macrophages cultured on Ti-LR and Ti-MR 
compared to Ti and Ti-HR (Figure 5C & D). The presence of an HA coating induced a 
macrophage polarization tendency toward the M2 phenotype, but without a significant 
difference compared to Ti-MR (Figure 5C & D).
Figure 4. Quantification of pro-inflammatory cytokines TNF-α (A & E; n=4) and IL-1β (B & F; n=4) and 
anti-inflammatory cytokines CCL18 (C & G; n=4) and TGF-β (D & H; n=4) in supernatant harvested 
from THP-1 derived macrophages cultured on glass and different titanium surfaces for 2 days and 4 
days respectively. A significant difference between Ti, TiLR, TiMR and TiHR was indicated by a, b & c (p < 
0.05). Groups with different letters are significantly different and groups sharing the same letter are not 
significantly different. A significant difference between TiMR and TiHA-MR was indicated by * (p < 0.01), 
** (p < 0.05), *** (p < 0.001) and ns (no significant difference).
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5. M1 and M2 macrophage immunostaining
To further determine macrophage phenotype upon culture on the surfaces with 
different roughness and HA coating, macrophages were stained with M1 macrophage 
surface marker CCR7 and M2 macrophage surface marker CD36, respectively. Control 
macrophage phenotypes M0, M1 and M2 all showed some expression of CCR7 and 
CD36 (Figure 6A), which correlates with previous reports about the unexclusiveness of 
markers for M1 and M2 human macrophages [13]. However, M1 macrophages showed 
relatively higher CCR7 expression, while M2 macrophages showed relatively higher CD36 
expression (Figure 6B). Upon culture on surfaces with different roughness, relatively 
higher CCR7 expression was observed on Ti and TiHA-MR surfaces, followed by Ti-MR, 
Ti-HR. The least CCR7 positive signal was found on the Ti-LR surface. In contrast, CD36 
positive signal intensity appeared considerably more on Ti-LR, Ti-MR than on Ti and 
TiHR. In addition, TiHA-MR surfaces displayed significantly higher intensity than Ti-MR 
(Figure 6C).
Figure 5. Quantitative RT-PCR analysis of the levels of M1/M2 macrophage marker genes in THP-1 
derived macrophages on the glass and different titanium surfaces after 2 days of culture. INDO and 
CXCL11 mRNA expression levels represent for surface marker genes of the M1 phenotype (A & B; n = 
4). MCR-1 and CCL13 mRNA expression levels represent for surface marker genes of the M2 phenotype 
(C & D; n = 4). A significant difference between Ti, TiLR, TiMR and TiHR was indicated by a, b, c & d (p < 
0.05). Groups with different letters are significantly different and groups sharing the same letter are not 
significantly different. A significant difference between TiMR and TiHA-MR was indicated by *** (p < 0.001) 
and ns (no significant difference).
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Figure 6. THP-1 cells were activated and cultured on glass and different titanium surfaces for 3 days, 
then (A) stained with CCR7 (M1 phenotype; red), CD36 (M1 phenotype; green), and nucleus (DAPI, blue). 
The scale bar is 50 µm. The relative fluorescence intensity was quantified by ImageJ and analyzed by 
Graphpad prism (B & C; n =3). A significant difference between Ti, TiLR, TiMR and TiHR was indicated by 
a, b & c (p < 0.05). Groups with different letters are significantly different and groups sharing the same 
letter are not significantly different. A significant difference between TiMR and TiHA-MR was indicated by 
* (p < 0.01) and ** (p < 0.05).
Discussion
The aim of this study was to investigate the effect of physical and chemical surface 
properties of titanium implants on the function of human macrophages. More specifically, 
this investigation focused on the effect of surface roughness and the presence of a 
HA coating on macrophage adhesion and polarization into different phenotypes in the 
absence of any cytokines, using the human macrophage cell line THP-1 as a model. The 
results demonstrated that roughness did not remarkably affect macrophage adhesion 
while the presence of an HA coating significantly increased macrophage adhesion. 
More notably, low and medium roughness (i.e. Ra=0.51~1.36 µm; Sa=0.66~2.91 µm) 
had more potency to polarize macrophages into the M2 phenotype, while the presence 
of an HA coating increased both M1 and M2 macrophage characteristics. These findings 
prove that macrophage polarization in response to implants are influenced by surface 
physical and chemical properties.
Upon in vivo implantation of a material, macrophage migration and adhesion occur 
after the fibrin clot is formed. The physical and chemical properties of the material 
surface have a direct effect on this event. Previous studies have shown that macrophage 
adhesion to titanium surface was not dependent on surface roughness rather on the 
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chemical properties [20, 27, 28], which correlates with our findings that cell adhesion 
did not display significant difference to different rough surfaces while coated HA 
significantly increased the macrophage adhesion. A slight discrepancy observed in this 
study is an increased macrophage adhesion on smooth Ti surface compared to rough 
surfaces after 2 days, which is likely due to its slightly higher hydrophilicity.
After adhesion to an implant, macrophage polarization in response to microenvironmental 
cues is the main driver orchestrating further physiological processes and ultimately 
bone healing [17, 18]. Although this polarization into M1 or M2 phenotype has been 
widely demonstrated in cell biology [12] and is proposed to be of great importance in 
determining the material suitability and bone healing capacity for metallic implants 
[15, 29], effects of material properties on macrophage polarization are not well 
characterized for human macrophages due to the lack of exclusive markers [13]. Thus, 
using multiple cellular characteristics and cytokine secretion profiles are recommended 
to characterize a macrophage population. Thereafter, cytokine secretion, certain 
gene expression, and surface markers were adopted in the present study to define 
the macrophage phenotype on different surfaces. Low and medium rough titanium 
surfaces (Ra=0.51~1.36 µm; Sa=0.66~2.91 µm) downregulated the secretion and 
gene expression of pro-inflammatory cytokines and upregulated the secretion and 
gene expression of anti-inflammatory markers compared to as-received smooth 
surfaces (Ra=0.20 µm; Sa=0.33 µm), indicating more M2 phenotype induction upon 
macrophage attachment to these surfaces. We further applied the internal comparison 
of effects of different rough surfaces on macrophage behaviors, which was rarely 
reported before. High rough surface (Ra=2.60 µm; Sa=4.11µm) displayed significantly 
upregulated M1-related cytokine secretion including TNF-α, INDO, and CXCL11 and 
downregulated M2-related cytokine secretion including TGF-β, CCL18, MCR-1, and 
CCL13. To sum up, we here revealed the optimal roughness of titanium surface with a 
Ra value from 0.51~ 1.36 µm for M2 macrophage polarization after comparing a series 
of titanium surfaces. Indeed, previous observations from an animal study also showed 
that this range of roughness (1~1.5 µm) leads to superior osseointegration compared to 
a smooth surface and higher roughness [3, 4, 30]. However, whether this improvement 
of osseointegration is directly associated with macrophage phenotype switch in vivo 
needs more pre-clinical and clinical evidence. In addition, TiHA-MR enhanced both 
the secretion of pro- and anti-inflammatory cytokines compared to the Ti-MR surface, 
indicating the complex role of HA with medium roughness on macrophage polarization. 
Above all, these findings demonstrate that the macrophage polarization is strongly 
dependent on the combination of physical (roughness) and chemical (Ti or HA) surface 
properties.
Here, titanium surfaces influence the polarization of macrophages to a different extent. 
However, none of material-induced macrophages fall distinctly into the M1 or M2 
phenotypes as cytokines induced. HA coating even induced a macrophage phenotype 
with both M1 and M2 characteristics. This agrees with recent claims that material-
activated macrophage phenotypes are not identical with conventionally cytokine-
activated states [31-33]. It articulates the complexity of macrophages and indicates the 
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conventional classification into M1 or M2 probably outdated. The phenomenon that a 
decrease of M1 characteristics does not correlate with an increase of M2 characteristics 
and vice versa indicates the distinct signaling pathways of M1 and M2 macrophage 
activation.
The underlying mechanism of surface roughness regulating the polarization of 
macrophages is incompletely understood. Based on studies about roughness with 
other cell types, it is hypothesized to be related to two aspects. The first one is that 
roughness affects protein adsorption, such as complement components, fibrinogen, 
fibronectin and vitronectin and their kinetics, binding strengths, activities, and 
structures. Upon contact, adsorbed proteins may change these properties to be 
recognized by macrophages and further alter macrophage phenotypes [34, 35]. The 
second aspect is regulation of macrophage polarization by the molecules involved in 
focal contact or focal adhesion formation, which in turn is determined by the nature 
of the implant roughness [19, 36]. HA coating influencing macrophage polarization 
is more complicated. It can be attributed to specific HA-absorbing proteins or ions 
released from the HA coatings during macrophage culture or synergetic effects of 
protein adsorption, ions, and medium roughness. Several studies have indicated 
effects of HA on protein adsorption, macrophage cytoskeleton structure and activation 
[37, 38]. Furthermore, Ca2+ as one of the major components released from HA is well 
documented to be involved in certain inflammatory signaling pathways [39, 40]. These 
different signaling pathways probably synergistically resulted in the specific material-
activated phenotype with both M1 and M2 macrophage characteristics. This specific 
phenotype was surprisingly observed reproducibly on other rough implant surfaces 
coated with divalent cations [41]. Additional work is needed to confirm this phenotypic 
change at a functional level.
Conclusion
We here demonstrate that titanium surface modifications via roughness or HA-coating 
affect the polarization of human macrophages into different phenotypes. Rough(er) 
surfaces displayed decreased initial macrophage adhesion and low and medium rough 
surfaces (Ra=0.51~1.36 µm; Sa=0.66~2.91 µm) seems to show more tendency to 
polarize macrophages into M2 phenotype than smooth and high rough surfaces did. 
The presence of an HA-coating elicited a non-typical, hybrid macrophage phenotype 
with both increased pro- and anti-inflammatory cytokine profiles. These results confirm 
that surface roughness and chemistry differentially affect macrophage polarization and 
force macrophages into a specific material-activated state. Knowledge on this surface 
physical and chemical characteristics-induced M1/M2 paradigm might facilitate 
the design of biomaterial surfaces capable of generating desired inflammatory and 
immunological responses. In view of the potential impact of this phenomenon on 
the bone response to endossal implants, more research is necessary to unravel the 
underlying biological mechanisms, which remain elusive.
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Introduction
Bone is a dynamic tissue that undergoes continuous remodeling and can regenerate 
upon tissue damage. This continuous remodeling occurs through a dynamic process of 
breakdown by osteoclasts and rebuilding by osteoblasts. Under normal circumstances, 
more than 97% resorbed bone is precisely replaced in location and amount by new 
bone [1]. This tightly balanced process is referred to as “coupling of bone formation and 
resorption”. Uncoupling occurs when the balance between resorption and formation 
is disrupted, which often leads to pathological situations, such as osteoporosis or 
osteopetrosis. However, uncoupling also occurs under physiological conditions, i.e. 
during skeletal growth, when bone formation exceeds bone resorption. In clinical 
practice, there are often situations, in which major injuries, diseases or birth defects 
cause serious bone damage or large bone defects, which also need the remodeling 
cycle uncoupled in favor of bone formation. Thus far, the majority of studies tried to 
induce bone formation by grafting bone forming cells, such as MSCs and osteoblasts [2]. 
The outcome of these attempts, however, are not consistent, reliable, and satisfactory. 
Also, the mechanism of exogenous MSCs and osteoblasts contributing to bone 
regeneration is controversial to date [3-5]. Furthermore, cost and safety issues behind 
these approaches have been postulated [2]. More advanced strategies to induce new 
bone formation are urgently needed, which are expected to be premised on the basic 
knowledge of the initiation of bone formation.
According to the theory on coupling bone formation and resorption, in bone 
remolding, osteoclasts start to resorb a package of bone due to microtrauma or other 
local inductive phenomena [6]. The resorbed bone matrix releases osteogenic factors, 
such as insulin-like growth factor (IGF) and transforming growth factor (TGF-β), which 
simultaneously induce osteogenic differentiation of surrounding mesenchymal stem 
cells [6]. More recently, it has become clear that osteoclasts, irrespective of their 
bone resorption activity, are able to secrete bone anabolic signals (clastokines) that 
affect the behavior of osteoblasts in vitro [7, 8] and in vivo [9, 10]. To explain these 
observations, several clastokines of interest, including sphingosine 1-phosphate (S1P), 
bone morphogenetic protein 6 (BMP-6), Wnt10b, platelet-derived growth factor-BB 
(PDGF-BB) and collagen triple helix repeat containing 1 (CTHRC1) have been identified 
as regulators of bone formation through complex activities on the osteoblast lineages 
[6]. Amongst these, S1P is well-documented to promote the recruitment, survival, and 
osteogenic differentiation of osteoblast precursors at the site of damaged bone [11, 
12]. Furthermore, another cell-cell interaction between osteoclasts and osteoclast was 
discovered through the EphrinB2-Eph4 signaling pathway [6].
The finding of clastokines changed the conventional understanding of osteoclasts and 
promoted more researchers to investigate the role of osteoclasts in bone formation. 
Colnot et al. recently investigated the time-course of natural bone healing to detect 
reparative osteogenesis. They found osteoclasts appeared as early as day 5 compared 
to bone matrix on day 7. Osteoclast deficiency gives rise to a reduced osteoblast 
population and activity and defective mineralization [13]. When a bone substitute 
PSM 20180528 Proefschrift Yang Zhang BW.indd   130 13-06-18   17:55
Osteoclast-based constructs induce ectopic bone formation 
131
Ch
ap
te
r 7
β-TCP was used to heal rat and rabbit bone defects, the appearance of osteoclasts still 
occurred earlier than that of new bone formation [14, 15]. The attachment and activity 
of osteoclasts functioned not only to resorb substitute material but also as an essential 
preparatory step to be replaced by new bone. Furthermore, local application of 
alendronate reduced the number of osteoclasts on the surface of β-TCP and subsequent 
new bone formation [16]. In MSC-based bone regeneration, a similar finding was 
observed: TRAP and cathepsin K-positive positive-multinucleated cells appeared after 
day 7 and day 14 and directly attached to MSC-based scaffolds. Scaffolds were resorbed 
by osteoclasts and this event promoted ectopic bone formation [4, 17]. Interestingly, 
for osteoinductive materials, which have the capacity to induce ectopic bone formation 
without exogenous growth factor loading or cell grafting, the appearance of a large 
number of active osteoclasts also precedes new bone formation. This phenomenon 
was firstly reported for β-TCP by Kondo et.al [18] and thereafter confirmed by several 
research groups [19, 20]. The osteoinductive capacity was further attributed to the 
submicron-scale surface architecture of the implanted materials and correlated to 
the material capacity to induce osteoclastogenesis [21, 22]. Complete depletion of 
osteoclasts but not macrophages showed to block ectopic bone formation [23, 24], 
while stimulating osteoclastogenesis with EP4 agonist accelerated osteoinduction 
[19]. All these observations suggest that the osteoclastogenesis plays a key role in the 
subsequent cellular events to initiate ectopic bone formation.
In view of suggested anabolic effects of osteoclasts in vitro and a pivotal role in bone 
formation in vivo, we speculated that osteoclasts might have the capacity to initiate 
bone formation. To test this, we prepared osteoclast-based constructs using RAW264.7 
and primary mouse macrophages on commercially available bone substitute material 
and subcutaneously implanted these constructs into mice; BMP-2 loaded and acellular 
bone substitute material served as positive (+Control) and negative controls (-Control), 
respectively. Ectopic bone induction and osteoclast formation were histologically and 
histomorphometrically evaluated.
Materials and Methods
1. Cell isolation and culture
RAW264.7 cells were obtained from China Infrastructure of Cell Line Resources (Beijing, 
China) and cultured in α-MEM supplemented with 10% FBS, 100 U/ml penicillin and 
100 µg/ml streptomycin (RAW proliferation medium).
Primary mouse bone marrow derived-macrophages were isolated as previously 
developed with minor modifications [25]. Briefly, 4-6 week old BALB/c nude mice were 
obtained from Institute of Animal Science of Vital River Co., Ltd., Beijing, China after 
the approval from the local ethical committee (Capital Medical University C4417). After 
euthanasia, the mice were sprayed with 70% ethanol and the femurs were dissected 
using scissors. Muscles connected to the femur bone were removed using plastic gauze 
with Iodine, and then femurs were placed into a polypropylene tube containing RPMI 
1640 medium with 1 ug/ml Fungizone. The bones were sterilized with 70% ethanol in 
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cotton ball in the cell culture hood and washed twice with medium. The bones were 
then cut with scissors and flushed with a syringe filled with RPMI 1640 to extrude bone 
marrow into a 15 mL sterile polypropylene tube. Bone marrow was gently homogenized 
with a pipette and then filtered through a cell strainer. Bone marrow cells were counted 
using a cytometer, centrifuged at 200× g for 5 min and adjusted to the concentration 
of 4 × 106/ml with RPMI 1640 supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/
ml streptomycin (primary proliferation medium). These cells were then transferred to a 
100 × 20 mm petri dish (Corning, China) and incubated at 37°C in a 5% CO2 atmosphere. 
After overnight incubation, non-adherent monocytes were collected and suspended in 
above primary proliferation medium.
2. Osteoclast-based construct preparation
Four experimental groups were used throughout this work:
– -control (acellular constructs)
– +control (BMP-2 loaded constructs)
– OC-R (constructs containing osteoclasts derived from RAW264.7 cell line)
– OC-P (constructs containing osteoclasts derived from primary mouse 
monocytes)
For OCs-R, 3 × 105 RAW264.7 cells were suspended in 2 ml proliferation medium and 
dropped on 0.5 g Bio-Oss granules, which were kept in a 50 ml tube and were pre-treated 
with FBS for 24 hours. The tube was then transferred to a rotation system (hl-2000 
hybrilinker hybridization oven, UVP) at 10 RPM at 37°C for 2 h. After cell attachment, 13 
ml proliferation medium was added to the tube and tilted the tube in the incubator to 
make largest interface of medium and air. The lid of the tube was kept loosen to allow 
for air and oxygen exchange. After one day, 15 ml medium supplemented with 50 ng/
ml RANKL was used to replace the medium. Part of cell-containing granules (around 
10 mm3) were placed in the 24-well plates. When loading RAW264.7 cells onto Bio-
Oss granules, 2 × 103 RAW264.7 cells/cm2 without granules were directly seeded in 
24-well tissue culture plates (2D) and cultured in the presence/absence of RANKL as an 
osteoclastic differentiation control to 3D osteoclast culture onto Bio-Oss granules. The 
constructs and TCP were culture for 5 days until implantation. Medium with cytokines 
was refreshed every 2 days.
For OCs-P, 6 × 106 primary mouse monocytes were suspended in 2 ml proliferation 
medium supplemented with 30 ng/ml M-CSF and dropped onto 0.5 g Bio-Oss granules 
(around 1.5 cm3), which were kept in a 50 ml tube and were pre-treated with FBS for 
24 h to increase cell attachment. Next, the tube was transferred to a rotation system 
(hl-2000 hybrilinker hybridization oven, UVP) at 10 RPM at 37°C for 2 hours. Thereafter, 
13 ml proliferation medium supplemented with 30 ng/ml M-CSF were added to the 
tube and tilted the tube in the incubator and loosed the lip as above. After 2 days, the 
medium was changed to proliferation medium supplemented with 30 ng/ml M-CSF and 
50 ng/ml RANKL. Part of cell-containing granules (around 10 mm3) were placed in the 
24-well tissue culture plates (TCP). When loading monocytes onto Bio-Oss granules, 2 × 
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104 monocytes were seeded in 24-well plates and cultured in the presence of 30 ng/ml 
M-CSF and +/- 50 ng/ml RANKL as an osteoclastic differentiation control as above. The 
constructs and TCP were culture for 6 days until implantation. Medium was changed 
and cytokines were refreshed every 2 days. 
Control constructs were prepared via incubation of 0.5 g Bio-Oss granules in 
proliferation medium supplemented with M-CSF and RANKL (incubation for 6 days; 
-Control) or loading 0.5 g Bio-Oss granules with BMP-2 via an incubation procedure 
(2 ml of BMP-2 solution containing 200 µg BMP-2; incubation for 24 hours; +Control).
3. Osteoclastogenesis quantification in vitro
DNA content and TRAP activity were assessed for evaluation of cell proliferation and 
osteoclastogenesis, respectively. Cell layers or cell-seeded granules were rinsed with PBS 
three times before adding 1 mL of MilliQ and two freeze-thaw cycles (-80°C and room 
temperature). DNA content was measured using Quant-iTTM Picogreen Kit (Invitrogen; 
Breda, the Netherlands) and TRAP-activity was determined using a TRAP assay kit 
(Sigma-Aldrich, the Netherlands) as per the recommendation of the manufacturer. 
TRAP activity was normalized for DNA content and expressed as mM pNP/ng DNA.
4. Animal studies
11 BALB/c nude mice obtained from Institute of Animal Science of Vital River Co., Ltd. 
were used for implantation surgery under the approval form ethical committee (Capital 
Medical University #15JL72). Mice were premeditated by subcutaneous injection of 
zoletil (10 mg/kg; Virbac, France) to reduce operative pain. Mice were immobilized 
and placed in a dorsal position. Two longitudinal incisions were made on each side 
of the vertebral column and four subcutaneous pockets were created using blunt 
dissection. Each animal received one sample of each experimental construct (~40 
mg granules) inserted into the pockets and then the skin was closed using resorbable 
sutures. Six weeks after implantation, animals were euthanized using CO2 suffocation. 
The specimens with the surrounding tissue were retrieved and fixed in 10% neutral 
formalin for 24 h and transferred into 70% ethanol.
5. Histology analysis
Five samples from each group were dehydrated and embedded in poly(methyl-
methacrylate) (PMMA) before cross-sectioning with a diamond saw (10 µm thick 
sections). All sections were stained with methylene blue and basic fushin (MB-BF) as 
described previously [26]. Six samples from each group were decalcified in 10% EDTA, 
dehydrated, and embedded in paraffin before cross-sectioning with a microtome (5 
µm thick sections). All sections were then stained with hematoxylin and eosin (HE) and 
tartrate-resistant acid phosphatase (TRAP).
6. Ectopic bone quantification
All MB-BF sections were imaged with the automated Axio Imager Z1 microscope 
equipped with the AxioCam MRc5 camera and AxioVision 4.8 software (Carl Zeiss 
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Micro Imaging GmbH, Göttingen, Germany). The paraffin sections were photographed 
with the Panoramic Scanner 250 Flash III (3D Histech, Budapest) and Panoramic Viewer 
(3D Histech, Budapest). All sections were then evaluated for the incidence of the new 
bone formation based on the morphology. The area with Bio-Oss materials (M), new 
bone (B), and TRAP-positive stain (T) was selected in a region of interest (ROI; area with 
residual materials and new bone) using ImageJ. The percentage of bone in each sample 
was determined as B% = B*100/(ROI-M). The percentage of TRAP-positive area (T) in 
each sample was similarly determined as T% = T*100/(ROI-M).
7. Statistical analysis 
All data are presented as mean ± standard deviation. One-way analysis of variance 
(ANOVA) with the aid of GraphPad Prism 7 was conducted to compare the means 
among the groups. If the ANOVA was applicable, then a Tukey HSD test was used as 
a post-hoc test. A student’s T-test was performed to compare new bone formation 
between the +control and OC-P constructs. P-values less than 0.05 were considered 
statistically significant.
Results
1. Osteoclasts formed on constructs after osteoclastogenic induction in vitro
We quantified the osteoclastogenesis of RAW264.7 and primary mouse macrophages 
cultured on TCP (2D) and Bio-Oss scaffold (3D) after osteoclastogenic induction by 
assessing TRAP activity (Figure 1). Induction with RANKL significantly increased TRAP 
activity for both primary monocytes and Raw264.7 cells. For cells cultured without 
RANKL, only negligible TRAP activity was measured. Especially for OCs-P constructs, 
the 3D affected the extent of TRAP activity: on Bio-Oss, OCs-P showed the highest 
TRAP activity (5.52±0.85 mM pNP/ng DNA/h), which was approximately twice higher 
than OCs-P on TCP (2.98±0.11 mM pNP/ng DNA/h; p < 0.001) and was almost 10 times 
higher than RAW264.7 cells on TCP and Bio-Oss granules (around 0.6±0.02 mM pNP/
ng DNA/h). 
Figure 1. TRAP activity of induced osteoclasts. RAW264.7 
and primary mouse BM macrophages were cultured in 
tissue culture plates (TCP; 2D) and Bio-Oss granules (Bio-
Oss; 3D) with and with-out osteoclastogenic induction 
factors for 6 days.The TRAP activity of RAW264.7 derived 
osteoclasts (OCs-R) and primary mouse osteoclasts (OCs-P) 
was quantified in the cell lysate (n = 4).
PSM 20180528 Proefschrift Yang Zhang BW.indd   134 13-06-18   17:55
Osteoclast-based constructs induce ectopic bone formation 
135
Ch
ap
te
r 7
Figure 2. In vivo ectopic bone formation. Histological images of MB-BF stained PMMA sections showing 
ectopic bone formation, fibrous tissues and residual materials within the (a) -Control, (c) +Control, (e) 
OCs-R, and (g) OCs-P based constructs after 6 weeks implantation. Images at higher magnification was 
showed for (b)-Ccontrol, (d) +Control, (f) OCs-R, and (h) OCs-P based constructs. Histological images of 
HE stained paraffin sections showing ectopic bone formation, bone marrow, fibrous tissues and residual 
materials within the (i) -Control, (j) +Control, (k) OCs-R, and (l) OCs-P based constructs after 6 weeks 
 implantation. New bone was observed in +Control and OCs-P based constructs. Asterisk indicates residual 
Bio-Oss granules, Black thick arrow indicates the new bone area, blue arrow indicate the osteoid tissue 
and yellow think arrow indicates the bone marrow. Scale bar = 200 µm.
2. Ectopic bone formation is induced by OCs-P
After 6 weeks, typical fibrous tissues attached to the implanted constructs was observed 
in all collected specimens (Figure 2a-l). None of the specimens for -control, +control, 
and OCs-P showed an inflammatory response (Figure 2a, c, g, i, j & l). In contrast, OCs-R 
based constructs showed a severe inflammatory response with massive cell infiltration 
(Figure 2e & k). Newly formed bone, evidenced by typical bone matrix and osteocytes, 
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was reproducibly observed for OCs-P (11 out of 11) and +control constructs (Tab. 1). 
Furthermore, bone marrow tissue was detected in the majority of OCs-P (8 out of 11) 
and +control constructs (10 out of 11; Figure 2j & l). In contrast, few osteoid tissue 
(immature bone) was found in the -control group (3/11). OCs-R based constructs did 
not show any presence of newly formed bone in any region of the implanted area 
(Figure 2e & k).
3. Distinct spatial patterns of new bone formation
New bone was formed both in +Control and OCs-P based constructs (Figure 3a-d). 
However, two major differences between +Control and OCs-P were observed. Firstly, 
in +controls, new bone was mainly formed adjacent to fibrous tissue surrounding the 
total granulate material (Figure 3b & e). In OCs-P constructs, however, bone mainly 
formed adjacent to the granulate material and within the intergranular spaces bridging 
the neighboring granules (Figure 3d & f). Secondly, the interface between new bone 
and the Bio-Oss granules surface in +Control had a clear demarcation line. In contrast, 
new bone formed in OCs-P was mostly closely adjacent to Bio-Oss granule surfaces.
Table 1. The incidence of ectopic bone formation in all constructs after 6 weeks implantation. 
Constructs -Control +control OCs-R OCs-P
Incidence of ectopic bone 0/11 11/11 0/10 11/11
Incidence of bone marrow 0/11 10/11 0/10 8/11
4. Quantitative analysis of new bone formation 
We further quantified the new bone in all MB-BF stained sections, +Control had a 
significantly higher amount of bone formation (4,54% ± 2,20%) than OCs-P (2.32% 
± 1.00%; p = 0.03) (Figure 4a). When this measurement was applied to HE sections 
(Figure 4b; n = 6), +Control (3,73% ± 2,86%) similarly displayed significantly higher bone 
formation than OCs-P constructs (1,32% ± 0,44%; p = 0.0009). 
5. Quantitative analysis of osteoclastic activity
To examine the cellular events of monocyte-macrophage lineage cells, we performed 
TRAP immunohistochemistry staining. TRAP-positive cells were absent in -Control group 
while quite few TRAP-positive multinucleated cells were present in OCs-R specimens. 
In contrast, abundant TRAP-positive multinucleated cells appeared in +Control and 
OCs-P constructs (Figure 5a-d). When further determine the location of TRAP-positive 
area, it was mainly distributed adjacent to residual Bio-Oss granules (Figure 5a, c, e, 
& f). However, part of TRAP-positive area also distributed between fibrous tissue and 
new bone in +Control based constructs (Figure 5e). We further quantified the TRAP-
positive area in these two constructs (Figure 5g; n=6), a significantly higher amount 
of TRAP-stained area was present in +Control constructs (2.27% ± 0.30%) than OCs-P 
constructs (1.12% ± 0.27%; p = 0.003). This value was almost negligible in the OCs-R 
based constructs and -controls. 
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Figure 4. Quantification of 
ectopic bone formation in 
+Control and primary osteoclasts 
based constructs after 6 weeks 
implantation. The percentage 
of newly formed bone per unit 
area of +Control and OCs-P based 
constructs were quantified based 
on (a) MB-BF stained PMMA 
sections (n = 5) and (b) H&E stained 
paraffin sections (n = 6). 
Figure 3. Location of ectopic bone formation in all constructs. Histological images of H&E stained paraffin 
sections showing the position of ectopic bone formation within the (a)-Control, (b)+Control, (c) OCs-R, 
and (d) OCs-P based constructs after 6 weeks implantation. New bone was not observed in any position of 
-control and OCs-R based constructs while a large amount of new bone was observed adjacent to fibrous 
tissue in +Control (b & e) and adjacent to Bio-Oss granules in OCs-P based constructs (c & f). Asterisk 
indicates residual Bio-Oss granules, Black thick arrow indicates the new bone area. Scale bar = 200 µm.
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Figure 5. Osteoclastic activity in all constructs demonstrated by TRAP staining. Representative 
histological images showed TRAP activities (red staining) within the (a) -Control, (b) +Control, (c) OCs-R, 
and (d) OCs-P based constructs after 6 weeks implantation. TRAP-positive signals were identified in 
+Control and OCs-P based constructs. Representative histological images showed different distribution of 
TRAP-positive area in (b & e) +Control and (c & f) and OCs-P based construct. TRAP-positive signals were 
observed mainly adjacent to fibrous tissue and Bio-Oss in +Control (b & e). In contrast, these signals were 
mainly adjacent to Bio-Oss granules in OCs-P based constructs (c & f). TRAP activity was quantified and 
compared in +Control and OCs-P based constructs (n = 6). Asterisk indicates residual Bio-Oss granules, 
Blue arrow head indicates the TRAP-positive area. Scale bar = 200 µm.
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Discussion
Bone remodeling continues to occur throughout lifetime and involves a continuous 
balance between bone formation and bone resorption. However, how new bone 
formation is initiated remains unclear due to this close coupling between bone 
resorption and bone formation. Here, we evaluated the capacity of osteoclasts to induce 
bone formation in a subcutaneous implantation model. Our results demonstrate that 
primary osteoclasts seeded on commercially available, devitalized bovine bone induce 
the initiation of ectopic bone formation. To the best of our knowledge, thus far no 
data have described this phenomenon of osteoinductive capacity for osteoclasts. This 
finding greatly supplements the theory of bone formation in a broader biological context 
and is of utmost importance for the future application of bone tissue engineering and 
regenerative medicine in clinical practice.
Over the past several decades, osteoinductive capacity has been merely ascribed to cells 
with bone forming capacity (e.g. osteoblastic cells [27] and mesenchymal stromal cells 
[3] ), growth factor members of the TGF-b-like superfamily (i.e. BMP-2 [28] and BMP-7 
[29]), as well as few biomaterials (e.g. calcium phosphates [20] and titanium [30]). After 
the finding of adult stem cell presence in the body [31], it was straightforward to assume 
bone marrow-derived MSCs to migrate to bone defect/fracture sites and differentiate 
into osteoblasts, which subsequently form new bone. Based on this hypothesis, MSC-
based approaches have been widely used to directly provide bone-forming cells for the 
treatment of bone defects [2, 32]. However, the pre-clinical and clinical performance of 
this approach has not been proven consistently satisfactory [2, 33]. Further, MSCs have 
recently been found to only slightly or even not directly contribute to the formation of 
bone tissue [3, 4], suggesting other unrevealed modes of action pivotal in the initiation 
of bone formation. Furthermore, the hypothesis of MSCs initiating bone formation is 
contradictory to the findings in the natural bone remodeling process, in which bone 
resorption precedes bone formation [1, 6]. Especially related to the osteoinductive 
capacity of few biomaterials, emerging data suggest a dominant role of osteoclasts 
in the initiation of bone formation [18-23], but thus far no direct evidence has proven 
this concept. Therefore, with the aid of the well-established cell-based approaches 
and osteoclast differentiation methods, we prepared osteoclast-based constructs and 
implanted thes in a subcutaneous model to evaluate the osteoinductive capacity of 
osteoclasts.
The osteoinductive capacity of BMP-2 has been widely demonstrated [34], as well as 
the lack thereof for Bio-Oss granules [35]. Consequently, we used this knowledge to 
include positive and negative controls for osteoinductive capacity in the present study. 
BMP-2 loaded BioOss reproducibly induced bone formation, while bone formation 
was absent for Bio-Oss granules after 6 weeks of subcutaneous implantation in mice. 
Remarkably, bone formation was observed in the primary osteoclasts-based constructs 
with a 100% incidence (11 out of 11 retrieved specimens). This finding is direct proof 
for our hypothesis that osteoclasts can initiate the bone formation process. In contrast, 
osteoinductive capacity was not observed for any of the RAW264. 7-derived osteoclast-
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based constructs (0 out of 9 specimens). Instead of bone formation, these constructs 
induced a severe inflammatory response with massive inflammatory cell infiltration. 
Indeed, macrophages have also been proven crucial for osteogenic differentiation 
of MSCs, both dependent and independent of osteoclasts [36, 37].On the one hand, 
macrophages can directly fuse into osteoclasts upon supplementation of a cytokine 
cocktail and/or a surface microenvironments [38, 39] and regulate differentiation of 
osteoblast progenitor cells by secreting various cytokines known as clastokines [40, 41]. 
On the other hand, macrophages, independent of osteoclasts, can affect osteogenic 
differentiation of osteoblastic cells and further bone formation [36, 42, 43]. However, 
monocytes/macrophages alone cannot initiate ectopic bone formation [44, 45]. As such, 
despite an important role for macrophages (via osteoclastogenesis or inflammation) in 
the initiation of bone formation, osteoclasts seem the decisive cell type responsible for 
initiation of bone formation. Furthermore, the OC-R based constructs failing to induce 
ectopic bone formation was likely ascribed to the extravagant inflammation arising 
from RAW264.7 derived macrophages, which suggests that osteoclast based ectopic 
bone formation is crucially on the surrounding microenvironment such as controlled 
inflammation.
Although both BMP-2 and primary osteoclast-based constructs induced the formation 
of ectopic bone, the spatial pattern and amount of the newly formed bone was distinct. 
For BMP-2, a band of bone was formed at the periphery of the subcutaneous pocket 
as recently demonstrated [46], close to the fibrous tissue, and only limitedly adjacent 
to the Bio-Oss granules. In contrast, primary osteoclasts induced bone formation 
predominantly adjacent to Bio-Oss granules. This discrepancy may indicate a difference 
in the mechanism of initiating bone formation. It is likely that BMP-2 release from 
BioOss leads to entrapment of this growth factor in the fibrous capsule surrounding the 
subcutaneous pocket, which may subsequently induce osteogenic differentiation, and 
hence peripheral bone formation, of osteoprogenitor cells embedded in the nearby 
soft tissue. In contrast, osteoclast-based constructs likely induced bone formation 
through anabolic effects of osteoclasts via paracrine actions adjacent to BioOss 
granules. Furthermore, we observed a significantly higher TRAP activity and higher 
bone formation in BMP-2 constructs than osteoclast based constructs. Consequently, 
we cannot rule out that BMP-2 induced bone formation also follows an osteoclastic 
path, which was suggested in previous work but requires more evidence [47, 48].
Although we firstly demonstrated the finding that osteoclasts are able to initiate bone 
formation, several relevant questions require further investigations:
1) What is the biological mechanism by which osteoclasts initiate ectopic bone 
formation? Based on previous knowledge and our findings, we proposed three potential 
mechanisms: Firstly, Bio-Oss granules as a deproteinized xenograft can release ionic 
species (e.g. Ca2+ and PO4
3-) upon osteoclastic activity that may further promote 
migration and osteogenic differentiation of osteoprogenitor cells [5, 49]. Secondly, 
seeded osteoclasts secrete anabolic factors, including S1P, BMP6, Wnt10b, THRC1, 
which initiate osteoprogenitor cells recruitment and osteogenic differentiation [11]. 
Thirdly, osteoclastic resorption forms a specific topography on granule surfaces during 
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the culture and after implantation, which activates the osteogenesis process [50]. 
Although the third hypothesis is relatively novel, previous work with nano- and micro-
sized material surface features for cultures of osteoprogenitor cells and osteoclasts 
already suggested a material-driven mechanism [51, 52]. Additionally, the possible full 
biological mechanism of osteoclast-induced bone formation may not follow one single 
proposed mechanism, but also a combination of aforementioned possibilities.
2) What is the origin of osteoblastic cells that form bone tissue? It was long thought that 
osteoblasts to form ectopic bone are derived from bone marrow MSCs [53]. This idea 
is being challenged by emerging evidence. Actually, upon a construct implantation, a 
highly vascular connective tissue and capillary sprouting are generally initiated and 
invade the construct [46]. Compelling evidence indicates that pericytes, satellite cells 
or endothelial cells, which locate around the smallest vessels and in the mussels, seem 
to transform into bone-forming cells in response to the microenvironment [54].
3) Following what pathway is the (ectopic) bone formed in osteoclast-based constructs? 
Bone formation can occur via the endochondral or intramembranous pathway. BMP-2 
is well-known to induce bone formation through the intra membranous pathway [55]. 
How the ectopic bone is formed in osteoclast-based constructs remains unknown, 
although no histological signs of cartilaginous tissue were observed. In view of this 
and the temporal similarity of bone formation induced by BMP-2 loaded controls, 
this strongly suggests an intramembranous pathway for bone formation induced by 
osteoclasts.
Here, we demonstrate that osteoclast-based constructs have the capacity to initiate 
bone formation at an ectopic location. This finding is a valuable supplement to the 
existing knowledge on the role of osteoclasts in bone resorption and the coupling of 
bone resorption and formation in bone remodeling. Our findings also suggest powerful 
potential to develop bone regenerative constructs based on osteoclastic activity. One 
strategy is to make osteoclast based bone constructs as we used here. Compared to 
currently developed bone morphogenetic protein based constructs, which have safety 
concerns due to uncontrolled bone formation and other life-threatening side effects 
[56, 57], osteoclasts based constructs can precisely formed bone adjacent to the seeded 
scaffolds. Also, this approach is superior to the conventional MSC-based approach in 
many aspects such as more convenient isolation procedure, less induction time. The 
other strategy is to prepare special scaffold materials which are ready to be resorbed 
by osteoclasts and simultaneously induce bone formation after implantation by 
modulating surface properties. This strategy is more advantageous due to the unlimited 
supply and greatly reduced cost and time when circumnavigating cell expansion and 
differentiation in vitro. For instance, Synthetic carbonate-substituted biomimetic 
hydroxyapatite showed increased osteoclastogenesis and deeper resorption pits from 
osteoclasts in vitro [58] and demonstrated more bone formation compared to pure HA 
scaffold in vivo [59].
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Conclusion
We demonstrated here that primary mouse osteoclast-based constructs have the 
capacity to induce ectopic bone formation. The new bone evoked by osteoclasts 
had less amount and distinct pattern compared to BMP-2 induced new bone, which 
further correlated with the amount and location of host osteoclasts. Although more 
evidence and the mechanism of initiation of bone formation by osteoclasts need to be 
discovered and decoded, our finding greatly innovates the conventional cognition of 
bone formation process and aids the understanding of the cellular basis of this event, 
which can provide valuable information for improving existing treatment approaches 
of bone disease and novel strategies to develop bone substitute to repair damaged 
bone in the clinic.
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Introduction
Metallic biomaterials and devices are widely used in dental, orthopedic, and spinal 
surgery to facilitate replacement and repair of damaged bone due to their robust 
mechanical properties and their ability to integrate into bone (osseointegration) [1, 2]. 
Amongst them, titanium and its alloys have been developed as most common bone 
implant materials and as a model substrate for studying cell and tissue responses to 
biomaterials, because of their clinical relevance, suitable biocompatibility and the 
diverse possibilities for surface modifications [3, 4]. Still, clinical work has reported 
an implant failure incidence of up to 20% [5], the majority of which was caused by 
deficient or poor early bone healing at the bone/implant interface in the early post-
implantation period [6, 7]. Consequently, it is of crucial importance to improve the 
early bone healing of an implant for its long-term performance.
The biomaterial surface properties of an implanted medical device have demonstrated 
to contribute to the host cellular and tissue response and play a significant role in 
determining overall implant success or failure [8, 9]. Therefore, manipulating surface 
physical or chemical properties offers an effective and straightforward strategy to 
improve the biological performance of implant materials. For titanium implants 
installed in bone defects in animal studies, multiple studies have shown superior bone-
to-implant contact and peri-implant bone formation when the surface roughness 
(arithmetical mean deviation of the surface profile, Ra) is between 1-1.5 µm [10]. 
Clinical studies also demonstrated that the osseointegration rate of rough implants 
was significantly higher than that of machined smooth implants [11-13]. To elucidate 
the mechanism responsible for these observations from (pre-) clinical studies, previous 
work has extensively studied how micron and submicron scale roughness contributes 
to osteoblastic cell attachment, spreading and differentiation, in which these cells 
originated from mesenchymal stem cells (MSCs) [14-17]. Remarkably, the other cell 
type involved in bone remodeling and osseointegration, i.e. osteoclasts, have to date 
been largely ignored. Interestingly, osteoclasts have been observed to appear earlier 
than osteoblastic cells around bone implants and seem to initiate the remodeling 
process to form new bone tissue in the peri-implant region [18-20]. Furthermore, the 
preferred roughness of bone implant surfaces, consisting of a combination of micron 
scale roughness created by sandblasting and submicron scale roughness generated by 
acid etching, was found to be strikingly similar to osteoclast resorption pit dimensions 
on bone wafers [21-23]. All this evidence suggests that biomaterial surface roughness 
modulates the behavior of osteoclasts, which further affect the bone formation process.
Osteoclasts are giant multinucleated bone-resorbing cells differentiated from 
precursors of the monocyte/macrophage lineage. Polarized osteoclasts form sealing 
zones, detectable as actin rings and ruffled borders, containing protons and catabolic 
enzymes such as TRAP, to resorb bone [24, 25]. Osteoclast functions, however, have been 
widely recognized not to be limited to their ability to resorb bone only. In the context 
of bone remodeling, osteoclasts also contribute to bone formation by communicating 
with osteoblastic cells in a process called “coupling of the bone formation to resorption” 
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[26]. In this process, osteoclasts locally promote osteoblastic cell recruitment and 
osteogenic differentiation through the secretion of coupling factors, known as 
clastokines, which include sphingosine-1-phosphate (S1P), bone morphogenetic protein 
6 (BMP-6), Wnt10b, collagen triple helix repeat containing 1 (Cthrc1) and complement 
component 3a (C3a) [26, 27]. In contrast, Semaphorin4D (Sema4D), another clastokine 
secreted by osteoclasts, inhibits osteoblastic cell differentiation [28]. Taken together, 
these findings indicate that coupling factors released by osteoclasts play an important 
role in the local regulation of bone formation by influencing recruitment, osteogenic 
differentiation, and activity of osteoblastic cells.
Above all, the combined activity of osteoblastic cells and osteoclasts and their 
bidirectional interactions are relevant for bone remodeling and regeneration. Regar-
ding the chronological order in presence at the site of bone regeneration and the 
stimulatory effects of roughness, we hypothesized that surface roughness influences 
osteoclastogenesis and the behavior of formed osteoclasts in terms of clastokine 
secretion. Subsequently, these secreted clastokines then orchestrate osteoblastic cell 
behavior. To test this hypothesis, we prepared and characterized titanium surfaces 
with a series of roughness ranging from submicron to micron levels and evaluated their 
effects on osteoclast behavior (i.e. morphology, growth, and differentiation) using 
both the murine RAW264.7 cell line and primary mouse macrophages. To evaluate 
the coupling function of surface roughness induced osteoclast effects on osteoblastic 
cell differentiation, murine MC3T3 osteoprogenitor cell line and primary rat bone 
marrow MSCs were cultured in the conditioned medium of these osteoclasts and their 
osteogenic differentiation was evaluated by mineralization and osteogenic marker 
analysis and then correlated with osteoclast parameters.
Materials and methods
1. Materials and reagents
Receptor activator for NF-κB ligand (RANKL) and macrophage colony stimulating factor 
(M-CSF) were purchased from Peprotech (Rocky Hill, USA). Acid Phosphatase Leukocyte 
Kit and acid phosphatase activity assay kit were obtained from Sigma (St. Louis, USA). 
RNA Isolation Kit was obtained from Qiagen (Venlo, Netherlands). ELF97 dye, Alexa 
Fluor 568 labeled phalloidin, 4’, 6-Diamidino-2-Phenylindole (DAPI), mounting medium, 
PicoGreen DNA quantification assay kit, TaqMan Reverse Transcription kit and Fast 
SYBR Green Master Mix Kit were obtained from Thermo Fisher Scientific (Breda, 
Netherlands). Osteogenesis quantification kit was obtained from EMD Millipore 
(Darmstadt, Germany). Minimum Essential Medium α (α-MEM), fetal bovine serum 
(FBS), antibiotics, and Phosphate Buffered Saline (PBS) were obtained from Gibco (Delft, 
Netherlands). Titanium (Ti) disks (1.5 mm in thickness, 12 mm in diameter; 99.9 wt% 
purity) were purchased from Machinefabriek G Janssen (Valkenswaard, Netherlands). 
Glass coverslips with 12 mm diameter were obtained from VWR (Renswoude, 
Netherlands).
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2. Preparation and characterization of titanium (Ti) surfaces
Ti surfaces with different roughness were made through grit blasting with Al2O3 using 
different particle size (50 µm and 250 µm) and pressure (1, 2 bar and 3 bar). Each 
group of disks was consecutively washed with 10% nitric acid, acetone and ethanol 
in and ultrasonic bath for 10 minutes, respectively. The disks were then sterilized by 
autoclaving. The roughness of prepared disks was tested with Universal Surface Tester 
(UST; Innowep GmbH, Germany). Contact angle measurements were obtained using 
Surface Tension (Biolin scientific, Finland) equipped with a digital camera and image 
analysis software. Four disks from each titanium surface were utilized for each test.
3. RAW264.7 derived osteoclasts
RAW264.7 was obtained from Sigma-Aldrich® and cultured in α-MEM supplemented 
with 10% FBS. Cells were seeded at 2 × 103 cells/cm2 and passaged until 80% confluence 
using a plastic scraper (Greiner Bio-One, Netherlands). For osteoclastic differentiation, 2 
× 103 cells/cm2 RAW264.7 were seeded on the surface of titanium disks and glass slides. 
The medium was changed to differentiation medium (α-MEM supplemented with 10% 
FBS supplemented with 50 ng/ml of murine sRANK ligand) after 24h. The medium was 
then refreshed every 2 days. Cells and conditioned medium were collected after 4 days 
of the osteoclasts induction.
4. Mouse bone marrow macrophages derived osteoclasts
Mouse bone marrow mononuclear cells were isolated from 6- to 8-week-old male 
C57Bl/6 mice by flushing femurs and tibia with α-MEM medium supplemented with 0.5 
mg/ml gentamycin and 3 µg/ml fungizone. Cells were cultured in α-MEM containing 
10% FBS and the non-adherent cells were collected after 24h. Cells were then seeded 
in flasks with 30 ng/mL human M-CSF for 2 days. Attached cells were detached and 
seeded on different surfaces at 2 × 104 cells/cm2 and cultured in α-MEM containing 10% 
FBS supplemented with 30 ng/ml M-CSF and 50 ng/ml of murine RANKL for osteoclast 
induction. The medium was then changed every 2 days. Cells and conditioned medium 
were collected after 4 days.
5. Characterization of osteoclasts behaviors on different roughness
5.1 Cell morphology
Macrophage morphology on the tested surfaces was examined by scanning electron 
microscopy (SEM, Jeol SEM6310, Nieuw-Vennep, Netherlands) at indicated time 
points. Cells were fixed with 2% glutaraldehyde in cacodylate buffer, dehydrated in a 
sequential series of ethanol followed by tetramethysilan, coated with gold and then 
observed using SEM.
5.2 TRAP staining
Osteoclasts cultured on different surfaces were fixed with 4% of paraformaldehyde (PFA) 
for 10 mins and stained using Acid Phosphatase Leukocyte Kit per the manufacturer’s 
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instructions. Briefly, 10 ml Acid Phosphatase solution consisting of 9 ml pre-warmed 
MilliQ, 400 µl acetate solution, 100 µl Naphthol AS-BI Phosphoric Acid, 200 µl Tartrate 
Solution and 200 µl Diazotized Fast Garnet GBC was prepared and cells were stained 
with this solution for 20 min at 37°C. TRAP positive multinucleated cells on these 
surfaces were observed using a light microscope (Leica, Germany).
5.3 DNA content
Cell growth on different surfaces was assessed using the PicoGreen DNA quantification 
assay kit. Cell layers were washed twice with PBS, after which 1 ml MilliQ was added. 
Following two freeze-thaw cycles, samples were aspirated several times and used for 
DNA quantification per the instructions of the manufacturer.
5.4 TRAP activity assay
Cell layers were washed twice with PBS, rinsed with 1 ml of MilliQ and lysate with 
two freeze-thaw cycles. TRAP activity was tested using acid phosphatase activity assay 
kit per the manufacturer’s instructions. Briefly, 50 µl sample was mixed with 50 µl 
substrate dissolved in citrate buffer and incubated at 37°C for 30 minutes. The reactions 
were stopped by adding 200 µl of Stop Solution (0.5 N NaOH). A blank control (citrate 
buffer) and standard solutions were made in parallel. The absorption was measured at 
405 nm with a multi-mode spectrophotometer (Biotek, Winooski, USA). The value of 
TRAP activity was then normalized to DNA content.
5.5 Gene expression of osteoclast markers
RNA was isolated from osteoclasts on different surfaces using RNA Isolation Kit per the 
manufacturer’s protocol. Reverse transcription was performed using TaqMan Reverse 
Transcription kit. RT-PCR expression analysis was performed using a Fast SYBR Green 
Master Mix Kit and PRISM 7500 sequence amplification system (Applied Biosystems, 
USA). TRAP, Cathepsin K (CTSK), Receptor activator of nuclear factor kappa-B (RANK), 
Matrix metallopeptidase 9 (MMP-9) were tested with GAPDH as housekeeping gene. 
The primer sets used are shown in Supplementary Table 1. The level of gene expression 
was calculated via the 2-ΔΔCt method. Three independent samples were used for each 
gene of interest.
5.6 ELF97 staining
Samples were washed twice with PBS and fixed with 4% of paraformaldehyde (PFA). 
After fixation, samples were washed twice with PBS. ELF97 dye was diluted 50 times 
with above Acid Phosphatase solution, added to each well and incubated for 15 minutes 
at 37°C in the dark. Samples were then washed twice with PBS and images were taken 
using a microscope (Zeiss AxioCam MRc5; Carl Zeiss Microimaging, Germany).
5.7 Actin and nuclei staining
For actin and nuclei staining, cells were rinsed twice with PBS and then fixed with 
4% PFA in PBS for 10 min. After washing twice, samples were incubated with Alexa 
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Fluor 568 labeled phalloidin and (1:50 dilution) in PBS for 15 mins. After washing with 
PBS, samples were incubated with DAPI (1:500 dilution) for 5 mins and mounted with 
mounting medium. Cells were imaged with a Zeiss microscope. Osteoclast number 
(more than three nuclei), actin ring perimeter, nuclei per osteoclast and osteoclast 
area were quantified using Image J. Cell area was categorized into one of the following 
classes: ≤– 25 × 103 µm2 per cell, 25-50 × 103 µm2 per cell, 50-100 × 103 µm2 per cell, 100-
200 × 103 µm2 per cell, 200-400 × 103 µm2 per cell, ≥ 400 × 103 µm2 per surface. Nuclei 
number of each osteoclast was counted for four disks. If the number of osteoclasts was 
more than 100 per disk, the measurements were performed at random 100 osteoclasts 
on each specimen.
6. Effect of osteoclast medium on osteogenic differentiation of osteoblastic cells
6.1 Mouse osteoprogenitor and rat primary MSCs culture
The mouse osteoblastic precursor cell line MC3T3 was purchased from Sigma-Aldrich®. 
Rat bone marrow-derived MSCs were isolated from 6-week-old male Fischer rats. All 
animal procedures were approved by the Radboud University Nijmegen Animal Ethics 
Committee. Both MC3T3 cells and MSCs were cultured in growth medium (α-MEM 
with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin) at 37°C in humidified 5% 
CO2.
For osteogenic differentiation assays, 2 × 104 cells were seeded in 48 well plates. 
After 24 hours, medium was changed with 1:1 conditioned medium from RAW264.7-
derived osteoclast cultures (for MC3T3 cells) or primary mouse osteoclast cultures (for 
primary MSCs) on Ti disks with different roughness and osteogenic medium (growth 
medium supplemented with 10 nM dexamethasone, 100 µM ascorbic acid, and 10 mM 
β-glycerophosphate). Medium was changed twice per week. These cultures were used 
to obtain samples for alizarin red staining and mineralization quantification and for 
gene expression analysis.
6.2 Alizarin red staining and quantification 
After 14 days, cell layers were washed twice with PBS and then fixed with 4% PFA for 10 
mins and then washed twice with PBS. Cell were then stained with 1 ml/ well alizarin 
red solution for 15 min at room temperature using an osteogenesis quantification 
kit. Stained samples were photographed with a light microscope. The quantification 
of alizarin red of cell layer was conducted based on the protocol. Briefly, cell layers 
were dissolved in 10% acetic acid, vortexed, heated at 85 0C and then centrifuged. 
The supernatant was neutralized and then colorimetric changes were measured at the 
absorbance of 405 nm using a multi-mode spectrophotometer (Biotek, Winooski, USA). 
To reduce the internal errors, alizarin red values from each sample were normalized to 
cells cultured in 1:1 of osteogenic medium and growth medium.
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6.3 Gene expression of osteogenic markers
Osteoprogenitor cells cultured in conditioned medium of osteoclasts for 7 days, RNA 
was isolated, transcribed as aforementioned. Gene expression of RUNX2, Collagen 
I, ALP and osteocalcin (OCN) was analyzed by RT-PCR using the primers listed in 
Supplementary Table 1. GAPDH was used as housekeeping gene and the level of gene 
expression was calculated via the 2-ΔΔCt method. Four independent samples were used 
for each gene of interest.
7. Regression analysis of osteoclast subtype and its anabolic activity
Size of actin ring, number of osteoclasts per cm2, number of nuclei per osteoclast and 
TRAP activity were averaged for each surface roughness group. These values were 
then correlated with the alizarin red value of osteoblastic cells cultured in each type of 
osteoclasts on different surfaces. Scatter diagrams were made with Excel, regression 
analyses were conducted and the most accurate trend lines were displayed based on 
R2 value.
8. Statistical analysis
All experiments were repeated three times and figures showed the representative data 
of a single representative experiment. All results are expressed as the mean ± standard 
deviation (SD) from multiple samples per experimental group (see figure captions for 
exact sample numbers) and P < 0.05 was considered statistically significant. One-way 
analysis of variance (ANOVA) was used for each experiment to compare the means 
among the groups. Where applicable, a Tukey HSD test was used as a post-hoc test.
Results
1. Preparation and characterization of titanium disks with different surface rough-
ness
Four types of titanium disks were prepared with significantly different surface roughness 
(Figure 1); Ra values were 0.24 µm for machined (Ti), 0.81 µm for low roughness (TiLR), 
2.30 µm for medium roughness (TiMR), and 3.63 µm for high roughness (TiHR). Glass 
slides with a smooth surface (Ra = 0.02 µm) served as controls (Figure 1A). To exclude 
effects of surface wettability on cell behavior, contact angles were measured using the 
sessile drop method. All surfaces had a similar wettability value (range: 64° - 84°; Figure 
1A). SEM assessment of the surface morphology showed that control and Ti surfaces 
were apparently smooth. TiLR displayed a low roughness and uniform topography 
compared to TiMR and TiHR, which showed crack structures and blasting scars with a 
higher roughness (Figure 1B).
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Figure 1. Surface characterization of titanium disks with different surface roughness. Machined titanium 
disks were sand-blasted to create different roughness and smooth glass slides were used as control. (A) 
The roughness of glass and different rough titanium surfaces was determined with Universal Surface 
Tester and the contact angle was measured with Surface Tension. (B) The morphology of different rough 
surfaces was observed by SEM. Original magnification for SEM ×500; Scale bar is 10 µm in all panels.
2. Osteoclast morphology on different surface roughness
The morphology of macrophages after osteoclastogenic induction on different surfaces 
was observed with SEM (Figure S1; RAW264.7 macrophages were representatively 
displayed). Both large giant cells and smaller, undifferentiated macrophages were visible 
on all surfaces. Osteoclast morphology was greatly affected by the surface roughness. 
Osteoclasts present on the smooth surfaces of controls and Ti showed a more spread 
shape and more clear cell fusion than cells on rougher surfaces (TiLR, TiMR and TiHR), 
on which cells were smaller and separately distributed.
3. Osteoclast growth and differentiation with different surface roughness
To determine the osteoclastic nature of the formed multinucleated cells, TRAP staining 
was performed. Different sizes and numbers of TRAP-positive cells originating from 
RAW264.7 macrophages were observed on different surfaces (Figure 2A). TRAP-positive 
cells were bigger and present in lower numbers on smoother disks (Ctrl and Ti) than on 
rougher disks. A difference between TiLR, TiMR and TiHR was not obvious. To assess 
cell numbers on these different surfaces, DNA content was measured after 4 days of 
osteoclastogenic induction. DNA content from RAW264.7 cells gradually increased with 
surface roughness. Significantly higher cell growth was observed for rougher surfaces 
(TiMR and TiHR) compared to smoother titanium surfaces (controls, Ti and TiLR; Figure 
2B). Quantitative assessment of osteoclastic TRAP activity on different surfaces (Figure 
2C) showed a tendency of smooth surfaces to have higher TRAP activity than rougher 
surfaces. Specifically, the highest TRAP activity was found on Ti, followed by control 
and TiLR, which were significantly higher than TiMR and TiHR. The negative control 
without RANKL showed negligible TRAP activity (data not shown). To further confirm 
osteoclastic differentiation, a series of specific markers were analyzed by RT-PCR (Figure 
2D, E, F & G). Osteoclastogenic markers were generally expressed at significantly higher 
levels on control and Ti than on rougher surfaces. Among roughened surfaces, TiLR had 
significantly higher RANK and MMP-9 gene expression than TiMR and TiHR.
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Figure 2. Osteoclastogenic differentiation of RAW264.7 derived osteoclasts on different rough surfaces. 
RAW264.7 derived macrophages were cultured on glass control and different rough titanium with RANKL 
for 4 days. (A) Osteoclasts were then stained with TRAP biochemical staining (n = 4). (B) Their growth were 
quantified by DNA content (n = 4) and their osteoclastogenic differentiation were determined by (C) TRAP 
activity (n = 4) and gene expression of osteoclast makers including (D) TRAP (n = 3), (E) RANK (n = 3), (F) 
MMP-9 (n = 3) and (G) CTSK (n = 3). A significant was indicated by a, b, c d. Groups with different letters 
mean significant difference and groups sharing the same letter are not significantly different.
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For primary mouse osteoclasts, TRAP biochemical staining and TRAP activity displayed 
similar responses to the different surfaces (Figure 3). More specifically, with increasing 
surface roughness, primary mouse osteoclasts decreased in size on TiLR, TiMR and 
TiHR compared to control and Ti. The number of TRAP positive cells was generally 
higher on rougher surfaces (Figure 3A). Cell number evaluated with DNA content was 
also significantly higher on rougher surfaces and TRAP activity declined with increasing 
roughness (Figure 3B & C). However, TRAP activity was highest on controls for primary 
mouse osteoclasts (in contrast to Ti for RAW264.7 derived osteoclasts).
4. Osteoclasts number, size and cytoskeletal organization on different surface 
roughness
When osteoclast precursors differentiate into mature osteoclasts, they form clusters 
of dynamic, F-actin-rich adhesion structures enriched in integrin receptors called 
podosome that self-organize into actin rings at the cytomembrane periphery. We 
investigated effects of surface roughness on actin ring formation by analysis of F-actin 
(phalloidin stain), nuclei (DAPI stain) and endogenous phosphatase activity (ELF97 stain) 
organization. On all surfaces, osteoclasts from RAW264.7 exhibited multiple nuclei, a 
typical F-actin ring and endogenous phosphatase positivity (Figure 4A). Actin rings were 
typically big and heterogeneous on smoother surfaces. In contrast, osteoclasts cultured 
on rougher surfaces displayed small but homogeneous F-actin ring organization and 
cluster structure. To be specific, osteoclasts on control (average 1100 µm) and Ti 
(average 906 µm) exhibited significantly bigger actin rings than osteoclasts on TiLR 
(average 566 µm) and TiMR (average 491µm) surfaces, with TiHR having the lowest size 
(average 358 µm; Figure 4B). The number of osteoclasts was quantitatively determined 
on the different surfaces with the aid of F-actin ring and endogenous phosphatase 
staining. A significantly larger number of osteoclasts was found on rougher surfaces, 
especially on TiHR (37 ± 3.2 osteoclasts/cm2) and TiMR surfaces (26 ± 2.3 osteoclasts/
cm2), compared to the Ti (3.5 ± 0.5 osteoclasts/cm2) and control (2.7 ± 0.8 osteoclasts/
cm2) smoother surfaces (Figure 4C). The average nuclei number in each osteoclast, 
however, was significantly higher on smoother surfaces, especially on Ti (average 87 
nuclei/osteoclast). This was approximately 3 times more than TiLR, 4 times more than 
TiMR, and 8 times more than TiHR (Figure 4D). Osteoclast size, evaluated by cell area, 
was also analyzed based on F-actin ring and endogenous phosphatase staining. Both 
large and small osteoclasts were observed and measured on all surfaces, where the 
largest osteoclast areas were found on smoother surfaces (control and Ti; Figure 4E). 
More specifically, on smoother surfaces (control and Ti), large osteoclasts with an area 
>50 × 103 µm2 were predominant, constituting more than 71% of all osteoclasts, while 
small osteoclasts with a typical area of less than 25 × 103µm2 constituted only 15% 
of the population. On rougher surfaces (TiLR, TiMR and TiHR) an opposite trend was 
observed: osteoclasts with an area <25 × 103 µm2 were the predominant phenotype, 
constituting more than 51% of total osteoclast population, whereas large osteoclasts 
with an area >50 × 103 µm2 constituted less than 17%.
Compared to RAW264.7 derived osteoclasts, primary mouse osteoclasts also 
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generally exhibited bigger F-actin ring-like structures on smoother surfaces than 
rougher surfaces, except for that on controls, these cells did not display phalloidin-
labeled F-acting ring formation in three independent experiments (Figure 5A). When 
F-actin rings were measured on other surfaces for quantitative comparison, F-actin 
ring sizes of primary mouse osteoclasts on Ti (average 1746 µm) similarly displayed 
significantly larger size than those on TiLR (average 493 µm), TiMR (average 207 µm) 
and TiHR (average 196 µm; Figure 5B). The number of osteoclasts was also highest on 
TiHR (111±12 osteoclasts/mm2), followed by TiMR (65±4.1 osteoclasts/mm2) and TiLR 
(33±4.3 osteoclasts/mm2), all of which were significantly higher than on Ti and control 
(around 2 osteoclasts/mm2; Figure 5C). Also, primary mouse osteoclasts on Ti (average 
198 nuclei/osteoclast) and control (average 32 nuclei/osteoclast) had significantly 
more nuclei per osteoclast than those on rougher surfaces (all fewer than 19 nuclei/
osteoclast; Figure 5D). Regarding cell area, primary mouse osteoclasts displayed less 
diversity compared to RAW264.7 derived osteoclasts on all surfaces. Osteoclast areas 
<25 × 103 µm2 predominated for primary mouse osteoclasts on TiLR, TiMR and TiHR. 
However, primary mouse osteoclasts on control and Ti showed larger area, with an 
area <25 × 103 µm2 taking up less than 17% of the osteoclasts and an area >50 × 103 µm2 
Figure 3. Osteoclastogenic differentiation of primary osteoclasts on different rough surfaces. Primary 
mouse macrophages were cultured on glass control and different rough titanium with M-CSF and RANKL 
for 4 days. (A) Osteoclasts were then stained with TRAP biochemical staining (n = 4). (B) Their growth was 
quantified by DNA content (n = 4) and (C) their osteoclastogenic differentiation was determined by TRAP 
activity (n = 4). A significant difference was indicated by a, b, c d, e. Groups with different letters mean 
significant difference and groups sharing the same letter are not significantly different.
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approximately constituting 60% of the osteoclasts (Figure 5E).
Figure 4. Number, size and cytoskeletal organization of RAW264.7 derived osteoclasts on different 
rough surfaces. RAW264.7 derived macrophages were cultured on glass control and different rough 
titanium with RANKL for 4 days. (A) Osteoclasts were then stained with DAPI (blue), Alexa Fluor 568 
Phalloidin (red) and ELF 97 (green). (B) The perimeter of actin rings, (C) Osteoclasts density, (D) nuclei 
number per osteoclast and (E) osteoclast area on these different surfaces were determined to quantify 
the osteoclastogenic differentiation. Scale bar = 50 µm. A significant difference was indicated by a, b, c 
d. Groups with different letters mean significant difference and groups sharing the same letter are not 
significantly different.
5. Effect of osteoclast medium on osteogenic differentiation of osteoblastic cells
Given that osteoclast differentiation and cytoskeletal organization are affected by 
surface roughness, we hypothesized that these osteoclasts further differentially 
regulate the behavior of osteoblastic cells, possibly by expressing and/or secreting 
coupling factors. To this end, both mice osteoprogenitor cells and primary rat MSCs 
were cultured in medium collected from the osteoclasts cultured on the surface with 
different roughness (50% v/v; Figure 6). Osteoblastic cells subjected to conditioned 
medium harvested from osteoclasts displayed significantly higher alizarin red positive 
bone nodule formation than osteoblastic cells in normal osteogenic medium (Figure 
6A). More specifically, when MC3T3 osteoblastic cells were cultured with RAW264.7 
derived osteoclast conditioned medium, medium from osteoclasts cultured on 
control, Ti and TiLR showed 3 times more alizarin red than osteoblast control cultures 
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in osteogenic medium. Further, osteoclast conditioned medium from TiMR and TiHR 
showed twice more alizarin red than osteoblast control cultures and this effect was 
more obvious on TiMR (Figure 6B). This anabolic effect on osteoblastic cells was also 
observed for conditioned medium from primary osteoclasts on primary rat MSCs 
(Figure 6C). Conditioned medium from osteoclasts cultured on all surfaces except 
TiHR exhibited significantly higher alizarin red nodule formation than osteoblast 
control cultures in osteogenic medium. Particularly, conditioned medium from Ti 
induced approximately 5 times higher mineralization than osteoblast control cultures 
and 2.5 times higher than TiLR and TiMR. In agreement with our observations on 
mineralization, MC3T3 osteoblastic cells cultured in conditioned medium collected 
from RAW264.7 derived osteoclasts on control and Ti had significantly higher 
osteogenic marker gene expression than those from TiMR and TiHR, including ALP, 
Collagen I and OCN (Figure S2).
Figure 5. Number, size and cytoskeletal organization of primary osteoclasts on different rough surfaces. 
Primary mouse macrophages were cultured on glass control and different rough titanium with M-CSF and 
RANKL for 4 days. (A) Osteoclasts were then stained with DAPI (blue), Alexa Fluor 568 Phalloidin (red) and 
ELF 97 (green). (B) The perimeter of actin rings, (C) osteoclasts density, (D) nuclei number per osteoclast 
and (E) osteoclast area on these different surfaces were determined to quantify the osteoclastogenic 
differentiation. Scale bar = 100 µm. A significant difference was indicated by a, b, c d. Groups with different 
letters mean significant difference and groups sharing the same letter are not significantly different.
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Figure 6. The osteogenic differentiation of osteoblastic cells in conditioned medium of osteoclasts 
cultured on different rough surfaces. Mouse osteoprogenitor cells (MC3T3) and primary rat MSCs were 
cultured in the conditioned medium of osteoclasts cultured on glass control and different titanium rough 
surfaces. (A) The mineralization nodules were stained with alizarin red and quantified with alizarin red in 
mouse osteoprogenitor cells in (B) conditioned medium from RAW264.7 derived osteoclasts and (C) in 
primary rat MSCs in conditioned medium from primary mouse osteoclasts. A significant difference was 
indicated by a, b, c d, e. Groups with different letters mean significant difference and groups sharing the 
same letter are not significantly different.
6. Regression analysis between osteoclast characteristics and their anabolic effects 
on osteoblastic cells
In order to further reveal the dependent relationship of osteoclast anabolic effects 
and osteoclast subtypes induced by roughness, we correlated the main differentiation 
parameters of osteoclast subtypes (i.e. average osteoclast number, average nuclei 
number per osteoclast, average osteoclast perimeter and TRAP activity) with the 
mineralization content of osteoblastic cells cultured in conditioned medium from these 
different osteoclast subtypes. Both for RAW264.7 derived osteoclasts and primary 
mouse osteoclasts, the closest correlation of osteoclast anabolic effects was found to 
be with osteoclast average nuclei number (correlation coefficient R2 ≥ 0.95; Figure 7A 
& B). An increasing nuclei number per osteoclast was depicted to be logarithmically 
correlated with an increasing anabolic effect. The number of osteoclast per cm2 also 
showed correlation with osteoblastic cell mineralization (correlation coefficient of R2 ≥ 
0.74; Figure S3A & B). Nonetheless, the correlation of primary mouse osteoclast actin 
ring size and TRAP activity with its osteoclast anabolic effects was not obvious (Figure 
S3C & D).
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Figure 7. The regression analysis between osteoclast phenotype and its anabolic effects and the 
schematic of the hypothesis of interactions between osteoblastic cells, osteoclasts and surface 
roughness. The average nuclei number of each osteoclast on different surfaces was correlated with its 
anabolic effects on osteoblastic cells. Both (A) average nuclei number of osteoclasts from RAW264.7 and 
their anabolic effects on mouse osteoprogenitor cells and (B) average nuclei number of primary mouse 
osteoclasts and their anabolic effects on primary rat MSCs osteoblastic cells from displayed a logarithmic 
correlation respectively. (C) Based on our findings of different osteoclast phenotypes and their anabolic 
effects, the hypothesis of the role of roughness on osteoclastogenic differentiation and further osteogenic 
differentiation was proposed. On smoother surfaces, osteoclasts exhibit larger size and more nuclei in 
each osteoclast and secrete more anabolic clastokines to promote osteogenic differentiation of MSCs. 
In contrast, on rougher surfaces, osteoclasts exhibit smaller size and fewer nuclei in each osteoclast and 
secrete less anabolic clastokines to promote osteogenic differentiation. Yellow dots indicate clastokines 
secreted from osteoclasts.
Discussion
Surface properties play an important role in regulating cell and tissue responses to bone 
and dental implants and further determine the bone formation and osseointegration 
[9, 29]. The cross-talk between surface roughness and bone resorption cell osteoclasts 
and subsequent bone forming osteoblastic cells is of great importance but remains 
unclear. In this study, we demonstrated that osteoclasts are sensitive to the specific 
surface roughness and exhibit various phenotypes, characterized by different 
morphology, growth and differentiation capacity. Conditioned medium from these 
different osteoclastic phenotypes further promoted the osteogenic differentiation of 
osteoblastic cells to different degrees. The tight correlation of osteoclast nuclei number 
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with its anabolic effect of conditioned medium from osteoclasts with this phenotype 
was identified. This information highlights the importance of surface properties toward 
osteoclast phenotype and function, which differentially orchestrates osteogenic 
differentiation of osteoblastic cells via secreted clastokines. Additionally, the formation 
of osteoclasts with specific phenotypes on surfaces with different physical properties 
may provide a potential guide for developing biomedical devices with an optimal 
surface to stimulate osseointegration.
Both RAW264.7 and primary bone marrow derived macrophages formed osteoclasts 
upon stimulation with RANKL, evidenced by the presence of a cell population displaying 
TRAP activity, the presence of multinucleated cells with well-defined actin rings, and 
the expression of the osteoclast-related genes TRAP, RANK, CATK and MMP-9. Another 
multinucleated cell type, so-called foreign body multinucleated giant cells (FBGCs), are 
frequently formed at implant surfaces and related to foreign-body reactions. Similar to 
osteoclasts, FBGCs arise from the fusion of monocytes/macrophages, and hence share 
several characteristics with osteoclasts, such as multinuclearity, TRAP expression, and 
actin rings [30]. An important distinction between these two cell types on non-mineral 
surfaces is that only osteoclasts express the matrix degrading enzyme CTSK [30]. The 
high gene expression of CTSK here indicates the formation of osteoclasts rather than 
FBGCs on all surfaces in this work.
After cell seeding, significantly higher osteoclast cell growth was observed for rougher 
surfaces than for smoother surfaces, both for RAW264.7 derived osteoclasts and 
primary mouse macrophage derived osteoclasts. This finding is consistent with previous 
reports, in which rougher surfaces had higher osteoclast cell adhesion and growth than 
smoother surfaces [31, 32]. Regarding osteoclast differentiation on different surfaces, 
smoother surfaces generally more robustly induced osteoclast differentiation than 
rougher surfaces, evidenced by significantly higher TRAP activity and higher gene 
expression of osteoclastogenic markers. This is in line with previous studies reporting 
that the increase in surface roughness (1~2 µm) decreased osteoclast-associated 
features [33, 34], including TRAP activity and resorption capacity. However, it has 
also been observed that osteoclasts display an increased differentiation on increasing 
surfaces (0.1~0.5 µm), measured as TRAP activity and specific gene expression [31]. 
The different roughness range, high variety of osteoclast cellular origins, osteoclast 
culture protocols, and induction times may attribute to these conflicting conclusions. 
For example, primary osteoclasts were utilized and collected after a 21-day induction 
period by Costa-Rodrigues et.al [31]. However, as reported and proven in our study, 
osteoclasts appeared as early as 4 days after induction. Additionally, a difference 
between primary and RAW264.7 derived osteoclasts existed as primary osteoclasts 
could be grown for 7 days while apoptosis was apparent in RAW264.7 derived 
osteoclasts after 5 days of culture due to extremely high cell density. This is one of the 
reasons why we used two cell types to obtain osteoclasts, a cell line and primary cells, 
to obtain a reliable conclusion here.
Osteoclast functionality depends on its tight adhesion to the bone surface, which is 
mediated via an actin-rich integrin adhesion structure known as the podosome belt. 
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Podosome belt formation and turnover are highly sensitive to the local environment [24]. 
Generally, larger actin rings were found on smoother surfaces and small actin rings were 
found on rougher surfaces. One interesting finding is that primary osteoclasts on glass 
controls did not display this featured structure, perhaps due to a short-lived actin ring 
formation [35]. Actin ring on glass probably early appeared and disappeared after 4 days 
of osteoclastogenic induction. This finding further emphasizes the importance of culture 
protocols and treatment time when studying osteoclasts. Except for the difference in 
actin ring formation, we also found different phenotypes of osteoclasts on surfaces with 
different roughness. Generally, larger sized, a higher number of nuclei per osteoclast but 
lower osteoclast numbers were found on smoother surfaces than on rougher surfaces. 
This difference plausibly can be attributed to the effects of roughness on the cell fusion 
process required for osteoclast formation. On smoother surfaces, no topographical 
features are present to hinder this cell fusion process. Hence, cells effectively fuse to 
form fewer osteoclasts with a larger size on these surfaces. In contrast, on the rough 
surfaces, the topographic features might hinder cell fusion process leading to more 
osteoclasts with a smaller size [36]. Intriguingly, our findings of different osteoclast 
morphology correspond with some observations of osteoclasts in vivo. Two types of 
morphologically different osteoclasts are observed in mice [37]. One type exhibits an 
abundant “foamy”’, acidophilic staining of the cytoplasm and large oval vesicular nuclei. 
This type of osteoclast is abundant in young mice and at fracture sites in both young 
and old mice. The second osteoclast type exhibits considerably altered morphological 
characteristics and is smaller in size. These cells are found to be more abundant at the 
metaphysis of older animals. Furthermore, a significant shift from the former type to 
latter type occurs with increasing age. Therefore, it is tenable to conclude that different 
types may represent different functional states of osteoclasts. The osteoclasts with a 
larger size in young mice may have stronger anabolic but less resorption activity, while 
osteoclasts with smaller size may have weaker anabolic but stronger resorption activity. 
This idea is reinforced by the finding that osteoclasts with large surface area correspond 
to non-resorbing osteoclasts, while smaller osteoclasts correspond to actively resorbing 
osteoclasts [38-40]. This hypothesis then promoted us to further explore the effect of 
roughness induced osteoclast phenotypes on their anabolic activity.
Despite the observation that resorption and bone formation are coupled and implants 
induce the formation of multinuclear osteoclast-like cells around the new bone area 
[41, 42], the relation between osteoclasts and bone regeneration using bone implants 
is rarely reported. The conventional consensus regarding the relation between bone 
resorption and bone formation is that specific factors such as TGF-β and IGF-1 stored in 
the bone matrix are released and activated during bone resorption and then promote the 
osteogenic differentiation [43, 44]. This hypothesis is now being challenged by findings 
that non-resorbing osteoclasts still possess the ability to support bone formation 
[45-47], suggesting that osteoclast anabolic effects might not correlate directly with 
osteoclast resorption activity, but merely with the presence of osteoclasts. Several 
‘clastokines’ that regulate osteoblastic cell behavior have been identified, including 
Insulin-like Growth Factor (IGF-1), Transforming Growth Factor-β (TGF-β), and S1P [26, 
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27]. The data in present study corroborate the concept of non-resorbing osteoclasts 
on titanium and glass to have the potential to secrete certain clastokines that promote 
osteogenic differentiation. We also observed that surface roughness affects osteogenic 
differentiation through a cross-talk between osteoclast activity and osteoblastic cell 
activity. Smoother surfaces promoted osteoclastogenic differentiation and conditioned 
medium from osteoclast cultures thereon highly promoted osteogenic differentiation 
of osteoblast progenitors. In contrast, rougher surface evoked less osteoclastic 
differentiation and conditioned medium from osteoclast culture thereon promoted 
osteogenic differentiation of osteoblast progenitors to a lesser extent (Figure 7C). Since 
osteoclasts have shown to appear much earlier than osteoblastic cells around implants 
[19, 20], it is reasonable to hypothesize that effects of bone implant surface properties 
on osteoclasts and then on osseointegration overweighs effects of surface roughness 
directly on osteoblastic cells. Another hypothesis is that roughness modulates 
osteogenic differentiation through two separate ways: indirect effects on osteoblastic 
cells through osteoclasts and direct effects on osteoblastic cells. In this perspective, 
both roughness and osteoclast phenotype affect osteoblastic cell behavior, and in turn, 
both roughness and osteoblastic cell differentiation affect osteoclast behavior [48, 49]. 
The optimized roughness for osteogenic differentiation should be the sum effect from 
these two. Osteoblastic cell differentiation has shown to be enhanced on micro-rough 
surfaces (Ra=2 µm) compared to smooth surfaces while osteoclast activity was higher 
on smooth than on micro-rough surfaces [33]. Therefore, the optimal roughness for 
osseointegration was proposed to be 1~1.5 µm [10]. However, this hypothesis should 
be validated through well-designed animal studies. Whatever the mechanism is, our 
information further strengthens the previously proposed idea that maintaining non-
resorbing osteoclasts, as opposed to reducing osteoclast numbers, leads to increased 
bone formation, bone volume, and ultimately higher bone strength in vivo as sources 
of anabolic molecules for the osteoblasts [50].
The most innovative finding in this study was the identification of the different 
osteoclasts phenotypes and their differential anabolic effects, which we observed via 
osteoblastic cell cultures in conditioned medium. Various types of osteoclasts have 
been observed in physiological and pathological situations in vivo [51]; their bone 
catabolic and anabolic functions, which crucially determine the bone quality and 
treatment effects, remains unclear and debatable. We firstly revealed that osteoclast 
nuclei number positively correlates with these anabolic effects. This information might 
greatly aid future bone implant design, which can optimize physical surface properties 
to induce desired osteoclast phenotypes and enhance osseointegration. In addition, 
given the reported heterogeneity of osteoclasts under different physiological conditions 
(e.g. osteopetrosis, osteoporosis, osteonecrosis, and (rheumatoid) arthritis) and their 
differential effects on the balance between bone resorption and bone formation, the 
finding that anabolic effects are associated with osteoclast heterogeneity and nuclei 
number would help to elucidate the function of observed osteoclast types in these 
diseases and contribute to the design and development of specific therapeutic drugs 
for the treatment of these diseases [51].
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Conclusion
We here examined combinatorial effects of surface roughness on osteoclast behavior 
and anabolic effects on osteogenic differentiation of osteoblast progenitors. Osteoclasts 
cultured on smoother surfaces showed less growth, larger size and actin rings, and 
more nuclei per osteoclast compared to osteoclasts cultured on rougher surfaces. 
All conditioned medium from these different osteoclast phenotypes significantly 
promoted osteogenic differentiation of osteoblastic cells compared to conventional 
osteogenic medium and this effect was far more obvious for conditioned medium from 
osteoclasts cultured on smoother surfaces. This anabolic effect of conditioned medium 
on osteogenic differentiation was further revealed to logarithmically correlate with the 
number of nuclei per osteoclast. These results suggest that surface roughness is an 
important factor in mediating osteoclast-material interactions, which might determine 
osteogenic differentiation of osteoblast progenitor cells, and hence the process of 
osseo integration.
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1. Summary
To overcome the drawbacks of current bone graft materials, bone tissue engineering 
(BTE) using autologous stem cells has been proposed as a promising technique for 
treating bone defects. Indeed, various pre-clinical [1] and clinical studies [2] have shown 
the capacity of cell-based BTE constructs to heal bone defects and repair the damaged 
bone. On the other hand, there are also multiple studies that do not show bone 
formation or regeneration using cell-based BTE constructs [3, 4] and maybe even many 
more unpublished data with these results. Finally, the discrepancy in bone regenerative 
efficacy between cell-based BTE applications in preclinical versus clinical studies is 
puzzling and indicates substantial differences in bone healing and regeneration using 
human cells in human patients compared to using animal or human cells in available 
animal models.
Several severe challenges are hypothesized to limit the efficacy of cell-based BTE 
for bone repair in the clinic, including the adverse immune response and insufficient 
vascularization after bone graft implantation [5, 6]. On the one hand, immune cells are 
involved in the inflammatory response that is an essential stage in tissue regeneration, 
but might affect the viability of transplanted cells [7]. On the other hand, these immune 
cells secrete various types of chemokines, cytokines, and growth factors to affect the 
migration, proliferation and osteogenic differentiation of transplanted and host stem 
cells [8]. As the main cellular component of the innate immune system, monocytes 
and their successors macrophages and osteoclasts, have shown to play a pivotal 
role in orchestrating the inflammatory response, mesenchymal stromal cell (MSC) 
differentiation and further bone formation [9]. With recent findings of heterogeneous 
macrophage phenotypes and anabolic functions of osteoclasts, utilization of immune 
cells, in particular monocytes, macrophages and osteoclasts in BTE has become an 
appealing approach. From a practical view, monocytes/macrophages are one of the 
most abundant cells in patients and have a high proliferative ability and great phenotypic 
plasticity. Also, monocytes/macrophages are an accessible type of endogenous cells 
as their isolation is possible from blood, which is a standard procedure in and even 
outside hospitals. As such, using these cells is relatively less invasive, time-saving 
and more patient-friendly than harvesting other cell types. Further, monocytes, 
macrophages, and osteoclasts naturally appear around bone graft materials to become 
involved in the inflammatory response and bone healing process and display distinct 
pro-osteogenic effects on MSCs [9, 10]. Taken together, these aspects seem appealing 
for an exploration into the role of these immune cells in therapeutic strategies for bone 
regenerative applications.
This thesis aimed to exploit the potential of cells of the innate immune system, in particular 
monocytes and macrophages, to aid in bone regeneration and the development of cell-
based construct for BTE. Specifically, the applicability, heterogenicity, and effects on 
osteogenic cell differentiation in vitro and bone formation in vivo, were explored in a 
series of studies. Chapter 1 provides a general introduction to the challenges of current 
cell-based approaches in bone regeneration, functions of monocytes, macrophages, 
and osteoclasts in bone regeneration, and their potential for bone regeneration. 
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Each chapter after presents a separate study to address the research (sub)questions 
described in the last paragraph of Chapter 1 in a successive order.
(i) What is the state of and problem with current cell-based bone regenerative 
approaches and how can immune cells and other easily available cells be utilized for 
bone regeneration in an intraoperative manner?
Cell-based BTE has been developed in the last decades to overcome limitations 
associated with the use of auto- and allografts, which represent the current state-of-
the-art clinical treatment for bone defects and fractures. However, numerous problems 
were encountered upon translation from proof-of-principle in the laboratory to clinical 
practice. In particular, the procedure of construct preparation by combining a scaffold 
with (expanded) autologous MSCs appeared to be impractical and not cost-effective 
compared to autologous bone transplantation. Consequently, an engineering strategy 
circumventing any ex vivo cell manipulation or additional cumbersome surgery for the 
patient would be advantageous. Hereto, intraoperative preparation of cell-based BTE 
constructs, in which cell-based constructs are prepared with easily accessible autologous 
cells within the same surgical procedure as the bone regenerative treatment itself, 
was recently proposed [11]. In Chapter 2, we evaluated the concept of intraoperative 
BTE construct preparation and highlighted the available cellular options, including 
bone marrow aspiration concentrate cells (BMACs), stromal vascular fraction (SVF), 
and immune cells, such as monocytes, macrophages, and lymphocytes. Furthermore, 
we summarized methods to prepare intraoperative constructs and reviewed data of 
currently available preclinical and clinical studies on this topic for efficacy in bone 
regenerative applications. Based on this review, we concluded that intraoperative 
preparation of cell-based BTE constructs is promising for (future) clinical applications, 
although several technical issues and regulatory hurdles need to be addressed. New 
technologies and methods, such as the invention of optimized cell isolation devices, the 
introduction of immune cells and utilization of advanced cell carriers, would simplify 
and broaden the opportunities to translate this concept for cell-based construct 
preparation into clinical treatments.
(ii) How do different macrophage subtypes modulate osteogenic differentiation of 
adipose tissue MSCs?
More knowledge about the biology of bone healing is desirable to develop novel 
strategies to improve bone defect treatment. In bone regeneration, macrophages are 
one of the central components of physiological response in the early stage and bone 
remodeling in the late stage. During this process, a switch of macrophage phenotype 
from pro-inflammatory (M1) to pro-wound healing (M2) is observed [12]. An appealing 
option for bone regeneration would be to exploit this regulatory role for the benefit of 
osteogenic differentiation of MSCs and to eventually utilize this knowledge to improve 
therapeutic options for bone defect treatment. As such, Chapter 3 focused on the in 
vitro interaction of differently activated and/or polarized macrophages with adipose 
tissue MSCs (ADMSCs) to monitor the behavior (i.e. proliferation, differentiation, and 
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mineralization) of the latter in dedicated co-culture models. We found that co-culture 
of ADMSCs with M2 macrophages, but not with M1 macrophages or M0 macrophages, 
resulted in significantly higher mineralization, and that this effect resulted from cell-
cell interactions via soluble factors. Specifically, M2 macrophages promoted the 
proliferation and osteogenic differentiation of ADMSCs, while M0 and M1 macrophages 
solely stimulated the osteogenic differentiation of MSCs in the early stage. These effects 
were attributed to oncostatin M (OSM) and endogenous bone morphogenetic protein 
2 (BMP-2) signaling pathways. The observed effects of different macrophage types on 
osteogenic differentiation of MSCs extend the recognition of the role of macrophages 
from adverse effects in inflammation to beneficial effects in osteogenic differentiation, 
and can be capitalized for further improvements in the treatment of bone defects.
(iii) Does combining stromal vascular fraction or adipose MSCs with monocytes/
macrophages enhance bone regeneration compared to conventional MSC-based 
approaches in a rat bone defect model?
Due to the beneficial roles of monocytes/macrophages and their different phenotypes 
in the osteogenic differentiation of ADMSCs demonstrated in vitro in chapter 3, we 
used stromal vascular fraction (SVF) and ADMSCs from human adipose tissue and 
human monocytes to intra-operatively prepare bone constructs and evaluated their 
bone regenerative capacity in vivo in Chapter 4. Compared to conventionally expanded 
ADMSCs, SVF displayed equal in vitro osteogenic differentiation, which for both was 
significantly enhanced upon co-culture with monocytes. Upon implantation in rat 
femoral condyle bone defects, constructs with grafted SVF demonstrated a significantly 
higher bone formation compared to constructs grafted with ADMSCs and cell-free 
controls, which was attributed to distinct differences between immunoregulatory effects 
of SVF and ADMSCs. Whereas in vitro cultures showed profound effects of monocytes 
on osteogenic differentiation of SFV and ADMSCs, in vivo addition of monocytes to 
SVF- or ADMSC-grafted constructs did not further enhance bone regeneration.
(iv) Can material physical and chemical properties affect macrophage phenotype?
As macrophage phenotype plays a crucial role in the osteogenic differentiation of MSCs 
in vitro and bone formation in vivo, we aimed to investigate to what extent physical and 
chemical surface properties affect the macrophage phenotype, with the ultimate aim to 
facilitate the design of biomaterial surfaces capable of generating desired inflammatory 
and immunological responses that enhance bone healing. In Chapter 5 & 6, we created 
and characterized a series of titanium surface, which differed in surface roughness at 
the submicron to micron level and was used without or with hydroxyapatite (HA) and 
β-TCP coating. Human THP-1 derived macrophages were cultured on these different 
surfaces next to conventional M1 and M2 macrophage controls on glass slides. Our data 
demonstrated that chemistry rather than roughness remarkably affected macrophage 
adhesion. Compared to control M1 and M2 macrophages, the presence of differential 
roughness or a coating led to macrophage polarization into a specific surface-
associated state. Interestingly, arithmetic average surface roughness (Ra) from 0.51 to 
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1.36 µm revealed a tendency to polarize adherent macrophages toward M2 phenotype 
by downregulating pro-inflammatory and upregulating anti-inflammatory cytokine 
secretion, gene expression and surface marker expression. In contrast, the presence of 
an HA- and β-TCP- coating resulted in a hybrid macrophage subtype with both M1 and 
M2 characteristics and HA induced an earlier M1-M2 macrophage transformation than 
β-TCP. In conclusion, our data prove that adhesion and polarization of macrophages are 
critically influenced by surface physical and chemical properties.
(v) As the derivative of monocytes/macrophages, what is the role of osteoclasts in 
ectopic bone formation?
Except for differentiation into macrophages and polarization into different macrophage 
phenotypes, monocytes can fuse to form multinucleated osteoclasts. These osteoclasts 
represent one of the most important cells in regulating bone remodeling. Thus far, 
the majority of studies tried to induce bone formation by grafting MSCs, but these 
attempts resulted in unreliable and unsatisfactory bone forming and regenerative 
effects, particularly in clinical applications. Emerging data suggest that osteoclasts 
carry out crucial functions to initiate bone formation more than the intrinsic catabolic 
regulation of bone resorption [10, 13]. To prove this, in Chapter 7, we prepared 
constructs containing osteoclasts originating from either RAW264.7 or primary mouse 
macrophage by grafting these cells on bone substitute granulate. These osteoclast-
based constructs were confirmed to have osteoclastic activity in vitro and were 
subsequently subcutaneously implanted to assess their capacity to induce bone 
formation in vivo. After 6 weeks, we observed new bone formation in 100% of the 
constructs containing osteoclasts originating from primary mouse macrophages, and 
in positive control constructs loaded with BMP-2. In contrast, both negative controls 
(i.e. bone substitute granulate only) and constructs containing osteoclasts originating 
from RAW264.7 macrophages did not show bone formation. Further histological 
and histomophometrical evaluation demonstrated lower amounts and distinct bone 
patterns of newly formed bone in osteoclast-based constructs compared to positive 
controls. These data offer subversive insights into functions of osteoclasts in the 
biological context of bone initiation processes and open up a new dimension for 
designing and preparing BTE constructs for bone regenerative treatment.
(vi) How can we use material roughness to modulate osteoclast formation and 
characteristics to contribute to osteogenic differentiation?
Our finding in chapter 5 challenges the concept that osteoclasts only resorb mature 
bone during bone remolding as bone-resorbing cells. Osteoclasts likely not only 
initiate the new bone formation in an ectopic environment, but also contribute to 
bone formation by communicating with osteoblastic cells in a process called “coupling 
of the bone formation to resorption” in the context of bone remodeling [13]. In 
this process, osteoclasts locally promote osteoblastic cell recruitment and osteo-
genic differentiation through the secretion of coupling factors. However, to what 
extent osteoclasts respond to material surface roughness and subsequently affect 
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osteoblastic cell behavior remains unclear. Therefore, in Chapter 8, we prepared and 
characterized titanium surfaces with a series of roughness ranging from submicron 
to micron levels and evaluated their effects on osteoclastogenesis (i.e. morphology, 
growth, and differentiation) using both the murine RAW264.7 cell line and primary 
mouse macrophages. We further evaluated the coupling function of surface roughness 
induced osteoclast effects on osteoblastic cell differentiation and then correlated 
in vitro mineralization with osteoclast characteristics. We found that surfaces with 
different roughness induced the formation of osteoclasts with distinct phenotypes, 
based on total osteoclast numbers, morphology, size, cytoskeletal organization, nuclei 
number per osteoclast, and osteoclastic gene expression. Furthermore, these different 
osteoclast phenotypes displayed differential anabolic effects toward the osteogenic 
differentiation of osteoblastic cells, which was revealed to logarithmically correlate 
with the nuclei number per osteoclast. Our results demonstrate the existence of 
a combinatorial effect of surface roughness, osteoclastogenesis, and osteogenic 
differentiation. These insights open up a new dimension for designing bone grafts by 
considering the material characteristics to locally regulate bone formation through 
coupling osteoclastogenesis with osteogenesis.
2. Closing remarks and future perspectives
During bone regeneration, innate immune cells not only directly differentiate into 
bone-resorbing cells to get involved in bone remodeling, but also affect osteoblastic 
cell recruitment, migration, and osteogenic differentiation to establish bone formation. 
This knowledge encourages us to make use of immune response-based therapeutic 
strategies in bone regeneration. Although several challenges still remain before our 
approaches can be applied in the clinic, this thesis contributes to a better understanding 
and application of using immune response-based strategies in bone regeneration to 
overcome the current limitations of tissue-engineered bone grafts. Based on obtained 
data, several major conclusions can be drawn:
(i) Different phenotypes of macrophages have distinct cytokine profiles and particularly 
exert differential effects on the behavior of adipose tissue MSCs. M2 macrophages 
can increase the osteogenic differentiation of co-cultured MSCs, and this effect 
is proportional to the ratio of M2 macrophages to MSCs. In contrast, M0 and M1 
macrophages showed opposite effects at certain ratios.
(ii) SVF has equal in vitro osteogenic differentiation compared to expanded MSCs, 
which for both can be enhanced upon co-seeding with monocytes. However, although 
SVF is superior to adipose tissue MSCs in bone regeneration, the addition of monocytes 
to SVF- or ADMSC-grafted constructs does not further enhance bone regeneration in 
rat femoral bone defects. Furthermore, SVF has superior immunoregulatory effects to 
polarize M2 macrophages over osteogenically primed adipose tissue MSCs.
(iii) Both physical and chemical properties of material surfaces and stromal cell status 
affect the macrophage polarization. Rough surfaces ranging from 0.51 to 1.36 µm 
have a tendency to polarize macrophages into M2 phenotype, but not smoother and 
rougher surfaces. The presence of HA and β-TCP elicits a decreased proliferation of 
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macrophages and a non-typical, hybrid macrophage phenotype with both M1 and M2 
profiles compared to grit-blasted Ti. Furthermore, HA induced an earlier M1 macrophage 
polarization and an earlier M1-M2 macrophage transformation than β-TCP.
(iv) Osteoclasts, beyond their recognized bone-resorbing capacity, have the capacity 
to initiate ectopic bone formation. Additionally, osteoclast behavior and their anabolic 
effects can be modulated by the material physical properties, i.e. surface roughness. 
Surface roughness differences led to the formation of distinct types of osteoclasts, 
and their anabolic effects on the osteogenic differentiation of MSCs logarithmically 
correlate with the nuclei number per osteoclast.
Although our results provide a wealth of information for functions of cells of the 
innate immune system (i.e. monocytes, macrophages and osteoclasts) in BTE based 
bone regeneration, a number of limitations and challenges need to be addressed and 
investigated in the future for the ultimate success of using immune response-based 
approaches for bone regeneration.
First of all, as we observed, monocytes, macrophages, and osteoclasts are sensitive to 
the microenvironment they reside in. Both material physical and chemical properties 
affect monocyte activation, macrophage polarization and osteoclast behavior 
[14]. Furthermore, the surrounding cells, including MSCs and endothelial cells, can 
exert differential effects on these cells [15, 16]. This highlights the importance of 
incorporating rational control and modulation, and importantly not elimination, of 
immune cell behavior into the design of BTE graft materials. In addition, it reminds us 
that a comprehensive characterization of material properties and cell status is urgently 
required when we carry out studies on monocytes, macrophage, and osteoclasts. For 
example, modifying the material surface roughness probably also changes the surface 
hydrophilicity, which also affects (immune) cell adhesion and activation. In addition, 
even the source of culture medium used in (immune) cell culture was reported to affect 
the behavior of monocytes and macrophages [17]. In addition, we currently draw the 
conclusion of macrophage polarization based on the conventional classification of 
cytokine-induced macrophage phenotypes. However, specific material-activated 
macrophage phenotypes were observed in our and other studies, indicating the 
conventional classification of macrophages probably to be outdated. In the future, a 
detailed characterization of macrophage and osteoclast profiles and functions facing to 
different material properties would greatly aid our understanding of roles of immune 
cells in bone regeneration, but also aid in the development of favorable scaffolds to 
promote desired immune responses for bone regeneration.
Second, according to our discrepant findings of effects of monocytes/macrophages 
on the osteogenic differentiation of MSCs in vitro and bone formation in vivo, it 
is important to keep in mind that gaps exist between lab work, animal studies, and 
clinical application. In our studies, the question whether material properties and 
MSCs similarly affect macrophage polarization and osteoclast behavior in vivo remains 
unanswered. New technologies such as nonlinear intravital microscopy [18] and nano-
labeling [19] would characterize the participating macrophage populations, identify 
their origin and clarify their contributions to the decision of what repair mechanism 
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is initiated during bone regeneration. Such information will greatly contribute to the 
development of BTE constructs using immune cells. Similarly, in chapter 6, we found 
primary mouse osteoclasts rather than RAW264.7 derived osteoclasts to induce new 
bone formation when implanted ectopically in mice. This highlights the difference 
between cell lines and primary cells and the importance of choosing animal models. 
Given this information, follow-up studies with human cells in an orthotopic model will 
strengthen our demonstrated role of osteoclasts in bone formation.
Third, as a crucial part of the immune system, the adaptive immune response is not 
considered here due to the complexity of adaptive system and utilization of human 
cells in animal studies. Indeed, several studies have shown the various effects of 
adaptive immune cells during the healing process of a fractured bone. CD8+ T cells 
as part of the adaptive immune response were found to negatively influence wound 
healing. In contrast, CD4+ T cells can increase the osteogenic differentiation of MSCs 
[7]. The latter could hence be a promising therapeutic target in bone healing, because 
the bone marrow microenvironment has a higher percentage of CD8+ and CD4+ T cells 
compared to other tissues. When applying immune cell-based bone regeneration in 
the clinic, these beneficial or detrimental effects need to be taken into consideration. 
Additionally, modulating the T-cell response away from Th1 effector function and 
toward a Th2-tolerant phenotype by harnessing the macrophage M2 phenotype is 
becoming appealing and worthy of further investigation.
Last, when considering and using advantageous effects of innate immune cells on 
bone regeneration, the inflammatory response, also evoked by innate immune cells 
may exert negative effects on the survival and performance of BTE-based constructs. 
Previous studies have demonstrated that the inflammatory response and insufficient 
vascularization are the main limitations of cell-based BTE approaches for bone 
regeneration after constructs implantation [5]. Here, we also found that RAW264.7 
derived macrophages evoked an intense inflammation when subcutaneously implanted 
in nude mice. All this information indicates that immune cells are a double-edged sword 
and a balanced inflammatory response is desired for the superior bone regeneration 
capacity. In future studies, we can focus on finding the optimal inflammatory 
environment for bone regeneration and controlling the inflammatory response after 
construct implantation. All these targets depend on a deep understanding of the bone 
healing process and function of immune cells in bone formation and also the advanced 
techniques to control cell behavior, bone remodeling microenvironment in vivo. 
Therefore, scaffolds for bone regeneration should shift from traditionally immune-inert 
to immunomodulatory, which allows for desired cell-specific responses that accelerate 
bone regeneration.
In summary, bone regeneration via modulating the immune response and using innate 
immune cells involves many factors, including cell types, scaffold surface properties, 
animal models and interaction of these factors. Given the present time, abundance and 
versatile functions, manipulation of immune cells as an apex regulator appears to be a 
more successful approach in bone regeneration compared to conventional approaches 
that target downstream effector cells and/or molecular mediators. Although several 
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limitations and challenges exist for the translation of this approach toward the clinic, 
immune cell-based bone regeneration holds great promise for the future treatment of 
bone fracture and defects. To achieve this, an increasing knowledge of stem cells and 
immune cells, a profound advance of materials science, a thorough understanding of 
cell-material interactions, and a comprehensive investigation of this approach in pre-
clinical and clinical studies is required. This needs collaboration with many disciplines 
including physiology, cell biology, immunology, material science, chemical engineering 
and clinical feedbacks in an iterative manner.
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1. Samenvatting
Om de nadelen van de huidige botvervangers tegen te gaan, maakt bot tissue 
engineering (BTE) gebruik van lichaamseigen stamcellen en wordt derhalve gezien 
als een veelbelovende techniek voor de behandeling van botdefecten. Meerdere 
pre- klinische [1] en klinische [2] studies hebben aangetoond dat celgebaseerde BTE 
constructen daadwerkelijk botdefecten en beschadigd botweefsel kunnen regenereren. 
Daarentegen zijn er ook verschillende studies die geen botvorming of -regeneratie laten 
zien met het gebruik van celgebaseerde BTE constructen [3,4]; mogelijk zijn er daarnaast 
veel ongepubliceerde data met gelijkaardige resultaten. Tenslotte is de tegenstelling 
m.b.t. botregeneratieve capaciteit tussen pre-klinische en klinische studies lastig te 
verklaren en duidt dit op substantiële verschillen in botgenezing en -regeneratie met 
het gebruik van humane cellen tussen patiënten en beschikbare proefdiermodellen.
Enkele ernstige uitdagingen beperken de werkzaamheid van celgebaseerde BTE 
constructen voor klinische botregeneratie, waaronder immunologische reacties en 
gebrek aan vascularisatie na implantatie [5,6]. Enerzijds zijn immuuncellen betrokken 
bij de ontstekingsreactie die essentieel is voor weefselregeneratie, maar deze cellen 
tasten mogelijk tevens de levensvatbaarheid van de getransplanteerde cellen aan 
[7]. Anderzijds scheiden immuuncellen veel chemokines, cytokines en groeifactoren 
uit die migratie, proliferatie en osteogene differentiatie van getransplanteerde 
en eigen cellen beïnvloeden [8]. Als belangrijkste cellulaire component van het 
aangeboren immuunsysteem hebben monocyten (en daaruit voortkomende 
macrofagen en osteoclasten) aangetoond een centrale rol te spelen in het verloop 
van ontstekingsreacties, de differentiatie van mesenchymale stromale cel (MSC) 
differentiatie en botvorming [9]. Vanwege het recente bewijs voor heterogeniteit 
binnen macrofaag fenotype en de anabole functies van osteoclasten, is het gebruik van 
immuuncellen, met name monocyten, macrofagen en osteoclasten, in BTE interessant. 
Vanuit praktisch oogpunt zijn monocyten/macrofagen een veelvoorkomend celtype 
in patiënten met een hoog proliferatief vermogen en aanzienlijke fenotypische 
plasticiteit. Daarnaast zijn monocyten/macrofagen redelijk eenvoudig te winnen 
omdat ze uit bloed geïsoleerd kunnen worden, waaraan de standaard procedure 
van bloedafname voor nodig is binnen of eventueel buiten ziekenhuizen. Hierdoor 
vereist het gebruik van deze cellen relatief minimaal invasieve procedures, kost het 
weinig tijd en is het patiënt-vriendelijk in vergelijking met andere celtypes. Bovendien 
komen monocyten, macrofagen en osteoclasten van nature voor in de nabijheid van 
botvervangende materialen tijdens de onstekingsreactie en botregeneratie, waarbij 
ze specifieke pro-osteogene effecten hebben op MSCs [9,10]. Samenvattend is er 
daarmee rechtvaardiging voor het onderzoeken van de rol van deze immuuncellen 
t.b.v. therapeutische strategieën voor botregeneratie.
Dit proefschrift had als doel gebruik te maken van de potentie van cellen van het 
aangeboren immuunsysteem, specifiek monocyten en macrofagen, om bij te dragen 
aan botregeneratie en de ontwikkeling van cel-gebaseerde constructen voor BTE. 
Meer specifiek werd de toepasbaarheid, heterogeniteit en de effecten van deze cellen 
op osteogene differentiatie van cellen in vitro en botvorming in vivo onderzocht in 
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verschillende experimentele studies. Hoofdstuk 1 geeft een algemene introductie 
m.b.t. de uitdagingen van huidige cel-gebaseerde ontwikkelingen voor botregeneratie, 
de functie van monocyten/macrofagen/osteoclasten in botregeneratie en de potentie 
daarvan voor botregeneratie. Ieder volgend hoofdstuk beschrijft vervolgens een 
separate studie met een onderzoeksvraag zoals omschreven in de laatste paragraaf 
van Hoofdstuk 1.
(i) Wat is de status van en problematiek met huidige cel-gebaseerde botregeneratie en 
hoe kunnen immuuncellen (en andere eenvoudig te winnen cellen) gebruikt worden voor 
botregeneratie op een intra-operatieve manier?
Cel-gebaseerde BTE is ontwikkeld in de laatste decennia om de tekortkomingen m.b.t. 
het gebruik van autoloog en allogeen bot te ondervangen, welke de huidige state-
of-the-art zijn voor klinische behandeling van botdefecten en -fracturen. Echter, veel 
problemen komen kijken bij de translatie van experimentele proof-of-principle (binnen 
het laboratorium) naar de klinische praktijk. Vooral de procedure om een construct 
te maken middels de combinatie van een scaffold met (vermeerderde) autologe 
MSCs blijkt niet praktisch en kosteneffectief t.o.v. autologe bottransplantatie. Een 
engineering strategie zonder ex vivo manipulatie of additionele chirurgische ingrepen 
bij de patiënt is derhalve gewenst. De intra-operatieve preparatie van cel-gebaseerde 
BTE constructen, waarbij de constructen gemaakt worden met eenvoudig te winnen 
autologe cellen binnen dezelfde chirurgische procedure als de botregeneratieve 
ingreep zelf, is recent voorgesteld [11]. In Hoofdstuk 2 hebben we het concept van 
intra-operatieve BTE construct preparatie geëvalueerd en de cellulaire opties, inclusief 
bone marrow aspiration concentrate cells (BMACs), stromal vascular fraction (SVF) en 
immuuncellen (bijv. Monocyten, macrofagen en lymfocyten), aangegeven. Daarnaast 
hebben we 2 methoden van intra-operatieve BTE construct preparatie samengevat en 
een overzicht gegeven van beschikbare data op dit gebied betreffende pre-klinische 
en klinische studies naar werkzaamheid voor botregeneratieve toepassingen. Op basis 
van dit overzicht hebben we geconcludeerd dat intra-operatieve preparatie van cel-
gebaseerde BTE constructen veelbelovend is voor (toekomstige) klinische toepassingen, 
maar dat enkele technische en regulatoire aspecten opgelost moeten worden. 
Nieuwe technologieën en methodes, bijv. de ontwikkeling van verbeterde cel-isolatie 
apparatuur, het introduceren van immuuncellen en het gebruik van geavanceerde 
scaffolds, zouden de mogelijkheden vergroten om dit concept te transleren naar 
klinische behandeling.
(ii) Hoe moduleren verschillende macrofaag subtypes de osteogene differentiatie van 
vetweefsel MSCs?
Meer kennis over de biologie van botgenezing is gewenst om nieuwe strategieën 
te ontwikkelen ter verbetering van behandelingen voor botdefecten. Tijdens bot-
regeneratie zijn macrofagen een van de centrale componenten binnen de fysiologische 
reactie in een vroeg stadium en botremodelering in een laat stadium. Tijdens dit proces 
vindt een omschakeling in macrofaag fenotype plaats van pro-inflammatoir (M1) naar 
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pro-wondgenezing (M2) [12]. Een interessante mogelijkheid voor botregeneratie 
is het gebruik van deze omschakeling t.b.v. osteogene differentiatie van MSCs en 
hiermee uiteindelijk de therapeutische opties voor de behandeling van botdefecten 
te verbeteren. Hoofdstuk 3 richt zich op de in vitro interactie van verschillend 
geactiveerde/gepolariseerde macrofagen met vetweefsel MSCs om het gedrag 
(proliferatie, differentiatie en mineralisatie) ervan te bestuderen in cokweek-modellen. 
Onze resultaten lieten zien dat cokweek van MSCs met M2-macrofagen, maar niet met 
M1 of M0 macrofagen, resulteert in significant verhoogde mineralisatie, en dat dit effect 
wordt veroorzaakt door cel-cel interacties middels oplosbare factoren. M2 macrofagen 
bevorderden de proliferatie en osteogene differentiatie van MSCs, terwijl M0 en M1 
macrofagen enkel de osteogene differentiatie in een vroeg stadium stimuleerden. 
Deze effecten werden toegeschreven aan oncostatin M (OSM) en endogene BMP2 
signaling. De waargenomen effecten van verschillende typen macrofaag op osteogene 
differentiatie van MSCs versterkt de erkenning van macrofagen als belangrijke cellen 
voor osteogene differentiatie en kunnen gebruikt worden voor verbeteringen t.b.v. de 
behandeling van botdefecten.
(iii) Verbetert de combinatie van SVF of vetweefsel MSCs met monocyten/macrofagen 
botregeneratie in vergelijking met conventionele MSC-gebaseerde constructen in een 
rat botdefect model?
Vanwege de gunstige effecten van monocyten/macrofagen en hun verschillende 
fenotypes op de osteogene differentiatie van vetweefsel MSCs zoals aangetoond 
in hoofdstuk 3, hebben we SVF en vetweefsel MSCs gebruikt samen met humane 
mono cyten voor intra-operatieve preparatie van cel-gebaseerde constructen en 
het evalueren van de botregeneratieve capaciteit daarvan in vivo in Hoofdstuk 4. 
Vergeleken met conventioneel vermeerderde vetweefsel MSCs vertoonde SVF een 
gelijke in vitro osteogene differentiatie, welke voor beide celtypen werd gestimuleerd 
door cokweek met monocyten. In vivo implantatie in kniedefecten van ratten toonde 
dat SVF-constructen significant meer botvorming opleveren dan MSC- constructen 
en celvrije controles, hetgeen werd toegeschreven aan specifieke verschillen tussen 
immunoregulatoire effecten van SVF en MSCs. Hoewel in vitro het effect van monocyten 
op osteogene differentiatie overduidelijk was, bleek in vivo toevoeging van monocyten 
aan SVF- of MSC-constructen geen verdere verbetering van de botregeneratie op te 
leveren.
(iv) In hoeverre beïnvloeden fysische en chemische materiaaleigenschappen het fenotype 
van macrofagen?
Gezien de belangrijke rol van macrofaag fenotype in de osteogene differentiatie van 
MSCs in vitro en botvorming in vivo stelden wij ons tot doel om te onderzoeken in 
hoeverre fysische en chemische materiaaleigenschappen het macrofaag fenotype 
beïnvloeden; het uiteindelijke doel hiervan is gericht op het ontwikkelen van 
biomateriaal oppervlakken met het vermogen om gewenste ontstekings- en immuun-
reacties op te wekken teneinde botgenezing te bevorderen. In Hoofdstukken 5 & 6 
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hebben we verschillende titaanoppervlakken gemaakt en gekarakteriseerd door 
ruwheid te variëren op submicron en micron niveau en het al dan niet deponeren 
van een keramische coating. Humane THP-1-afgeleide macrofagen werden hierop 
gekweekt naast conventionele M1 en M2 macrofagen controles op glas. Onze data 
tonen dat vooral chemische eigenschappen de adhesie van macrofagen beïnvloedt. 
T.o.v. controle M1 en M2 macrofagen liet ruwheid of een coating een specifiek effect 
zien op macrofaag polarisatie. Een ruwheid Ra van 0.51-1.36 µm induceerde polarisatie 
in de richting van M2 vanwege het verminderen van pro-ontstekings- en verhoging 
van anti-ontstekingsfactoren, gen expressie en expressie van oppervlaktereceptoren. 
Anderzijds zorgde een keramische coating voor een hybride macrofaag fenotype met 
zowel M1 als M2 kenmerken, waarbij HA eerder een M1-M2 transformatie induceerde 
dan β-TCP. Samenvattend lieten onze data zien dat adhesie en polarisatie van 
macrofagen sterk afhankelijk zijn van fysische en chemische eigenschappen van het 
oppervlak waarop ze gekweekt worden.
(v) Als een afgeleide van monocyten/macrofagen, wat is de rol van osteoclasten in 
ectopische botvorming?
Naast differentiatie tot macrofaag en polarisatie tot een specifiek macrofaag fenotype, 
kunnen monocyten ook fuseren tot meerkernige osteoclasten. Deze osteoclasten zijn 
een van de belangrijke celtypen in de regulatie van botremodelering. Tot dusver heeft 
veel onderzoek zich gericht op het gebruik van MSCs om botvorming te induceren, 
maar deze inspanningen zijn veelal onbetrouwbaar gebleken met onbevredigende bot-
vormings- en regeneratieve effecten, vooral in klinische toepassingen. Recent onderzoek 
heeft suggereert dat osteoclasten naast de catabolische functie in botresorptie ook 
een belangrijke rol spelen bij de initiatie van botvorming [10,13]. Om dit te bewijzen 
hebben we in Hoofdstuk 7 constructen gemaakt met osteoclasten afkomstig van 
RAW264.7 cellijn of primaire muis macrofagen en botvervangend granulaat. Deze 
osteoclast-constructen vertoonden osteoclastische activiteit in vitro en werden 
vervolgens onderhuids geïmplanteerd in naakte muizen om hun osteoinductieve 
capaciteit te bepalen. Na 6 weken zagen we de novo botvorming in constructen met 
primaire osteoclasten en positieve controles geladen met BMP2. Echter, botvorming 
was niet aanwezig in de negatieve controles (alleen granulaat), noch constructen 
met osteoclasten afkomstig van RAW264.7 cellijn. Histologische en -morfometrische 
evaluatie toonde verder verschillen aan in hoeveelheid de novo botweefsel en het 
patroon van het gevormde botweefsel tussen primaire osteoclasten constructen en 
positieve controles. Deze bevindingen ondermijnen de huidige inzichten betreffende 
de functie(s) van osteoclasten in de context van biologische initiatie van botvorming en 
geven een nieuwe dimensie aan het design en de preparatie van BTE-constructen voor 
botregeneratieve behandelingen.
(vi) Kan biomateriaal ruwheid het gedrag van osteoclasten beïnvloeden en bijdragen 
aan botregeneratie?
Onze resultaten van hoofdstuk 5 tonen dat osteoclasten meer doen dan alleen botweefsel 
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resorberen gedurende botremodelering. Behalve de novo botvorming induceren 
op ectopische locaties, dragen ze ook bij aan de botvorming via communicatie met 
botvormende cellen [13]. In dit proces promoten osteoclasten lokaal de rekrutering en 
osteogene differentiatie van botvormende cellen via de secretie van factoren. Echter, 
in hoeverre osteoclasten reageren op oppervlakteruwheid en daaropvolgend gedrag 
van botvormende cellen reguleren is onbekend. Daartoe hebben we in Hoofdstuk 
8 titaanoppervlakken ruw gemaakt op submicron en micron schaal en bestudeerd 
wat het effect daarvan is op osteoclastogenese (morfologie, groei en differentiatie) 
van RAW264.7 cellijn en primaire muis macrofagen als voorlopers van osteoclasten. 
Vervolgens hebben we gekeken naar de correlatie tussen afgegeven factoren met 
osteogene differentiatie stimulatie en osteoclast kenmerken. Onze data toonden dat 
ruwheidsafhankelijke fenotypes van osteoclasten gevormd werden met verschillen in 
totaal aantal osteoclasten, morfologie, grootte, celskelet organisatie, aantal kernen 
per osteoclast, en genexpressie. Bovendien zorgden deze verschillende osteoclast 
fenotypes voor verschillende anabole effecten op de osteogene differentiatie van 
botvormende cellen, hetgeen een correlatie liet zien met het aantal kernen per 
osteoclast. Daarmee tonen onze data het bestaan van een gecombineerd effect 
van ruwheid, osteoclastogenese en osteogene differentiatie. Deze data verschaffen 
nieuwe inzichten voor de ontwikkeling van botvervangende materialen gebaseerd 
op materiaalkenmerken als regulerende factor voor botvorming via de koppeling van 
osteoclastogenese met botvorming.
2. Afsluitende opmerkingen en toekomstperspectieven
Tijdens botregeneratie differentiëren cellen van het aangeboren immuunsysteem 
niet alleen naar botresorberende cellen als speler in botremodelering, maar deze 
cellen beïnvloeden tevens de rekrutering, migratie en osteogene differentiatie van 
botvormende cellen om botvorming tot stand te brengen. Deze kennis stimuleert 
ons om therapeutische, botregeneratieve strategieën na te streven o.b.v. immuno-
modulering. Hoewel meerdere uitdagingen overwonnen moeten worden voordat 
toepassing ervan in de kliniek mogelijk is, draagt dit proefschrift bij aan het begrijpen en 
toepassen van dit nieuwe concept voor botregeneratie om de beperkingen van huidige 
tissue engineered constructen te verminderen. Onze data leiden tot de volgende 
conclusies:
(i) Verschillende fenotypen van macrofagen hebben verschillende cytokineprofielen en 
oefenen in het bijzonder verschillende effecten uit op het gedrag van vetweefsel MSCs. 
M2-macrofagen kunnen de osteogene differentiatie van gelijktijdig gekweekte MSCs 
verhogen, en dit effect is evenredig met de verhouding van M2-macrofagen tot MSCs. 
Daarentegen toonden M0- en M1-macrofagen tegengestelde effecten bij bepaalde 
verhoudingen.
(ii) SVF heeft een gelijke in vitro osteogene differentiatie in vergelijking met vermeerdere 
MSCs, die voor beiden kunnen worden verbeterd via cokweek met monocyten. Hoewel 
SVF superieur is aan MSCs van vetweefsel in botregeneratie, verbetert de toevoeging 
PSM 20180528 Proefschrift Yang Zhang BW.indd   187 13-06-18   17:55
Chapter 9
188
van monocyten aan SVF- of ADMSC-geënte constructen niet verder de botregeneratie 
bij femorale botdefecten in de rat. Verder heeft SVF superieure immunoregulatoire 
effecten om M2-macrofagen te polariseren in vergelijking met MSCs uit vetweefsel.
(iii) Zowel fysische als chemische eigenschappen van materiaaloppervlakken en de 
stromale celstatus beïnvloeden de macrofaagpolarisatie. Ruwe oppervlakken van 0,51 
tot 1,36 µm hebben de neiging om macrofagen in het M2-fenotype te polariseren, maar 
gladdere en ruwere oppervlakken niet. De aanwezigheid van HA en β-TCP roept een 
verminderde proliferatie van macrofagen en een niet-typerend hybride macrofagen 
fenotype met zowel M1- als M2-profielen op in vergelijking met met gestraald Ti. 
Verder induceerde HA een vroegere M1-macrofaagpolarisatie en een vroegere M1-M2-
macrofaagtransformatie dan β-TCP.
(iv) Osteoclasten hebben, buiten hun erkende botresorptiecapaciteit, het vermogen 
om ectopische botvorming te initiëren. Bovendien kunnen osteoclastgedrag en hun 
anabole effecten worden gemoduleerd door de materiële fysische eigenschappen, 
d.w.z. oppervlakteruwheid. Verschillen in oppervlakteruwheid leiden tot de vorming 
van verschillende soorten osteoclasten en hun anabole effecten op de osteogene 
differentiatie van MSCs correleren logaritmisch met het aantal kernen per osteoclast.
Hoewel onze resultaten een schat aan informatie bieden voor functies van cellen 
van het aangeboren immuunsysteem (bijv. monocyten, macrofagen en osteoclasten) 
in BTE-gebaseerde botregeneratie, moeten een aantal beperkingen en uitdagingen 
in de toekomst worden aangepakt en onderzocht voor het uiteindelijke succes van 
het gebruik van op het immuunsysteem gebaseerde conceptuele benaderingen voor 
botregeneratie.
Allereerst, zoals we hebben gezien, zijn monocyten, macrofagen en osteoclasten 
ge voelig voor de micro-omgeving waarin ze zich bevinden. Zowel materiële fysische 
als chemische eigenschappen beïnvloeden monocytenactivering, macrofaagpolarisatie 
en osteoclastgedrag [14]. Bovendien kunnen de omliggende cellen, inclusief MSCs 
en endotheelcellen, differentiële effecten op deze cellen uitoefenen [15, 16]. Dit 
benadrukt het belang van het opnemen van rationele controle en modulatie, en vooral 
niet eliminatie, van immuuncelgedrag in het ontwerp van BTE-transplantaatmaterialen. 
Bovendien herinnert het ons eraan dat een uitgebreide karakterisering van materiaal-
eigenschappen en celstatus dringend vereist is wanneer we onderzoeken uitvoeren op 
monocyten, macrofagen en osteoclasten. Het modificeren van de oppervlakteruwheid 
van het materiaal verandert bijvoorbeeld waarschijnlijk ook de hydrofiliciteit van het 
oppervlak, die ook de (immuun) celhechting en -activering beïnvloedt. Bovendien werd 
gerapporteerd dat zelfs de bron van het kweekmedium gebruikt in (immuun) celkweek 
het gedrag van monocyten en macrofagen beïnvloedde [17]. Bovendien trekken we 
momenteel de conclusie van macrofaagpolarisatie op basis van de conventionele 
classificatie van cytokine-geïnduceerde fenotypes van macrofagen. Specifieke, door 
materiaal geactiveerde fenotypes van macrofagen werden echter waargenomen 
in onze en andere onderzoeken, hetgeen aangeeft dat de conventionele indeling 
van macrofagen waarschijnlijk verouderd is. In de toekomst zou een gedetailleerde 
karakterisering van macrofaag- en osteoclastprofielen en -functies tegenover ver-
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schil lende materiaaleigenschappen ons begrip van de rol van immuuncellen bij de 
botregeneratie ten zeerste helpen, maar ook helpen bij de ontwikkeling van effectieve 
scaffolds om de gewenste immuunresponse voor botregeneratie te bevorderen.
Ten tweede, volgens onze discrepante bevindingen van effecten van monocyten/
macrofagen op de osteogene differentiatie van MSCs in vitro en botvorming in vivo, 
is het belangrijk om in gedachten te houden dat hiaten bestaan tussen laboratorium-
werk, dierstudies en klinische toepassing. In onze studies blijft de vraag onbeantwoord 
of materiaaleigenschappen en MSCs op vergelijkbare wijze invloed hebben op 
macrofaagpolarisatie en osteoclastgedrag in vivo. Nieuwe technologieën zoals 
niet-lineaire intravitale microscopie [18] en nano-labeling [19] karakteriseren de 
deelnemende macrofaagpopulaties, identificeren hun oorsprong en verduidelijken 
hun bijdragen aan de beslissing van welk herstelmechanisme wordt geïnitieerd tijdens 
botregeneratie. Dergelijke informatie zal in grote mate bijdragen aan de ontwikkeling 
van BTE-constructen met behulp van immuuncellen. Evenzo vonden we in hoofdstuk 6 
primaire muis-osteoclasten in plaats van RAW264.7-afgeleide osteoclasten in staat om 
nieuwe botvorming te induceren bij ectopische implantatie in muizen. Dit benadrukt 
het verschil tussen cellijnen en primaire cellen en het belang van het kiezen van 
diermodellen. Gegeven deze informatie, zullen vervolgstudies met menselijke cellen 
in een orthotopisch model onze aangetoonde rol van osteoclasten bij botvorming 
versterken.
Ten derde, als een cruciaal onderdeel van het immuunsysteem, wordt de adaptieve 
immuunrespons hier niet beschouwd vanwege de complexiteit van het adaptieve 
systeem en het gebruik van menselijke cellen in dierstudies. Inderdaad, verschillende 
onderzoeken hebben de verschillende effecten van adaptieve immuuncellen 
aangetoond tijdens het genezingsproces van een bot. CD8 + T-cellen als onderdeel van 
de adaptieve immuunrespons bleken de genezing van wonden negatief te beïnvloeden. 
CD4 + T-cellen daarentegen kunnen de osteogene differentiatie van MSCs verhogen 
[7]. Het laatste kan daarom een veelbelovend therapeutisch doel zijn bij botgenezing, 
omdat de micro-omgeving van het beenmerg een hoger percentage CD8+ en CD4+ 
T-cellen heeft in vergelijking met andere weefsels. Bij het toepassen van onze op het 
immuunsysteem gebaseerde botregeneratie in de kliniek, moeten deze gunstige of 
nadelige effecten in aanmerking worden genomen. Bovendien wordt het moduleren 
van de T-celreactie weg van de Th1-effectorfunctie en naar een Th2-tolerant fenotype 
door het macrofagen M2-fenotype te gebruiken aantrekkelijk en verdient verder 
onderzoek de voorkeur.
Als laatste, bij het overwegen en gebruiken van voordelige effecten van aangeboren 
immuuncellen op botregeneratie, kan de ontstekingsreactie, ook opgewekt door 
aangeboren immuuncellen, negatieve effecten hebben op de overleving en prestaties 
van op BTE-gebaseerde constructen. Eerdere studies hebben aangetoond dat de 
inflammatoire respons en onvoldoende vascularisatie de belangrijkste beperkingen 
zijn van cel-gebaseerde BTE-benaderingen voor botregeneratie na implantatie van con-
structen [5]. Hier vonden we ook dat RAW264.7-afgeleide osteoclasten een intense 
ontsteking opriepen na subcutane implantatie in naakte muizen. Al deze informatie 
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geeft aan dat immuuncellen een tweesnijdend zwaard zijn en een uitgebalanceerde 
ontstekingsreactie gewenst is voor de superieure botregeneratiecapaciteit. In 
toekomstige studies kunnen we ons concentreren op het vinden van de optimale 
ontstekingsomgeving voor botregeneratie en het beheersen van de ontstekingsreactie 
na constructimplantatie. Al deze doelen zijn afhankelijk van een diep begrip van 
het botgenezingproces en de functie van immuuncellen in botvorming en ook de 
geavanceerde technieken om celgedrag, botremodellerende micro-omgeving in 
vivo te controleren. Daarom moeten scaffolds voor botregeneratie verschuiven 
van traditioneel immuun-inert naar immuunmodulerend, wat zorgt voor gewenste 
celspecifieke responsen die de botregeneratie versnellen.
Samenvattend, botregeneratie door het moduleren van de immuunrespons en het 
gebruik van aangeboren immuuncellen omvat vele factoren, waaronder celtypes, 
opper vlakte eigenschappen van scaffolds, diermodellen en interactie van deze fac-
toren. Gezien de huidige tijd, overvloed en veelzijdige functies lijkt manipulatie 
van immuuncellen als een apex-regulator een meer succesvolle benadering in 
botregeneratie vergeleken met conventionele benaderingen die stroomafwaartse 
effectorcellen en/of moleculaire mediatoren als doel hebben. Hoewel er verschillende 
beperkingen en uitdagingen bestaan voor de vertaling van deze benadering naar de 
kliniek, vormen immuuncel-gebaseerde concepten voor botregeneratie een grote 
belofte voor de toekomstige behandeling van botbreuken en -defecten. Om dit te 
bereiken is een toenemende kennis van stamcellen en immuuncellen, een grondige 
vooruitgang van materiaalwetenschap, een grondig begrip van cel/materiaal interacties 
en een uitgebreid onderzoek van deze benadering in preklinische en klinische studies 
vereist. Dit vereist samenwerking tussen vele disciplines, waaronder fysiologie, cel-
biologie, immunologie, materiaalwetenschap, chemische technologie en klinische 
feedback op een iteratieve manier.
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Never forget why you started, and your mission can be accomplished.
-- Avatamsaka Sutra
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